id	sid	tid	token	lemma	pos
iajs-2653	1	1	special	special	ADJ
iajs-2653	1	2	issue	issue	NOUN
iajs-2653	1	3	1ihicpas	1ihicpas	NUM
iajs-2653	1	4	202	202	NUM
iajs-2653	1	5	ibn	ibn	PROPN
iajs-2653	1	6	al	al	PROPN
iajs-2653	1	7	-	-	PUNCT
iajs-2653	1	8	haitham	haitham	PROPN
iajs-2653	1	9	journal	journal	PROPN
iajs-2653	1	10	for	for	ADP
iajs-2653	1	11	pure	pure	ADJ
iajs-2653	1	12	and	and	CCONJ
iajs-2653	1	13	applied	apply	VERB
iajs-2653	1	14	science	science	NOUN
iajs-2653	1	15	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	1	16	for	for	ADP
iajs-2653	1	17	more	more	ADJ
iajs-2653	1	18	information	information	NOUN
iajs-2653	1	19	about	about	ADP
iajs-2653	1	20	the	the	DET
iajs-2653	1	21	conference	conference	NOUN
iajs-2653	1	22	please	please	INTJ
iajs-2653	1	23	visit	visit	VERB
iajs-2653	1	24	the	the	DET
iajs-2653	1	25	websites	website	NOUN
iajs-2653	1	26	:	:	PUNCT
iajs-2653	1	27	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	1	28	c	c	NOUN
iajs-2653	1	29	h	h	NOUN
iajs-2653	2	1	e	e	NOUN
iajs-2653	2	2	m	m	VERB
iajs-2653	2	3	i	i	NOUN
iajs-2653	2	4	s	s	VERB
iajs-2653	2	5	t	t	PROPN
iajs-2653	2	6	r	r	NOUN
iajs-2653	2	7	y	y	NOUN
iajs-2653	2	8	|	|	ADV
iajs-2653	2	9	68	68	NUM
iajs-2653	2	10	evaluation	evaluation	NOUN
iajs-2653	2	11	of	of	ADP
iajs-2653	2	12	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	2	13	oxidase	oxidase	NOUN
iajs-2653	2	14	activity	activity	NOUN
iajs-2653	2	15	in	in	ADP
iajs-2653	2	16	sera	sera	NOUN
iajs-2653	2	17	of	of	ADP
iajs-2653	2	18	breast	breast	NOUN
iajs-2653	2	19	cancer	cancer	NOUN
iajs-2653	2	20	individuals	individual	NOUN
iajs-2653	2	21	in	in	ADP
iajs-2653	2	22	kurdistan	kurdistan	PROPN
iajs-2653	2	23	region/	region/	PROPN
iajs-2653	2	24	iraq	iraq	PROPN
iajs-2653	2	25	shahlaa	shahlaa	PROPN
iajs-2653	2	26	shafiq	shafiq	PROPN
iajs-2653	2	27	rozoqi	rozoqi	PROPN
iajs-2653	2	28	shahla.biochem@epu.edu.iq	shahla.biochem@epu.edu.iq	PROPN
iajs-2653	2	29	department	department	PROPN
iajs-2653	2	30	of	of	ADP
iajs-2653	2	31	medical	medical	ADJ
iajs-2653	2	32	laboratory	laboratory	NOUN
iajs-2653	2	33	technology	technology	NOUN
iajs-2653	2	34	,	,	PUNCT
iajs-2653	2	35	erbil	erbil	PROPN
iajs-2653	2	36	health	health	PROPN
iajs-2653	2	37	technical	technical	PROPN
iajs-2653	2	38	college	college	PROPN
iajs-2653	2	39	,	,	PUNCT
iajs-2653	2	40	erbil	erbil	PROPN
iajs-2653	2	41	polytechnic	polytechnic	PROPN
iajs-2653	2	42	university	university	PROPN
iajs-2653	2	43	,	,	PUNCT
iajs-2653	2	44	erbil	erbil	PROPN
iajs-2653	2	45	,	,	PUNCT
iajs-2653	2	46	iraq	iraq	PROPN
iajs-2653	2	47	.	.	PUNCT
iajs-2653	3	1	abstract	abstract	ADJ
iajs-2653	3	2	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	3	3	is	be	AUX
iajs-2653	3	4	considered	consider	VERB
iajs-2653	3	5	the	the	DET
iajs-2653	3	6	main	main	ADJ
iajs-2653	3	7	copper	copper	NOUN
iajs-2653	3	8	transport	transport	NOUN
iajs-2653	3	9	protein	protein	NOUN
iajs-2653	3	10	which	which	PRON
iajs-2653	3	11	is	be	AUX
iajs-2653	3	12	proposed	propose	VERB
iajs-2653	3	13	to	to	PART
iajs-2653	3	14	have	have	VERB
iajs-2653	3	15	a	a	DET
iajs-2653	3	16	role	role	NOUN
iajs-2653	3	17	in	in	ADP
iajs-2653	3	18	cancer	cancer	NOUN
iajs-2653	3	19	.	.	PUNCT
iajs-2653	4	1	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	4	2	is	be	AUX
iajs-2653	4	3	an	an	DET
iajs-2653	4	4	acute	acute	ADJ
iajs-2653	4	5	phase	phase	NOUN
iajs-2653	4	6	reactant	reactant	NOUN
iajs-2653	4	7	and	and	CCONJ
iajs-2653	4	8	antioxidant	antioxidant	ADJ
iajs-2653	4	9	enzyme	enzyme	NOUN
iajs-2653	4	10	,	,	PUNCT
iajs-2653	4	11	has	have	AUX
iajs-2653	4	12	been	be	AUX
iajs-2653	4	13	found	find	VERB
iajs-2653	4	14	to	to	PART
iajs-2653	4	15	be	be	AUX
iajs-2653	4	16	increased	increase	VERB
iajs-2653	4	17	in	in	ADP
iajs-2653	4	18	sera	sera	NOUN
iajs-2653	4	19	of	of	ADP
iajs-2653	4	20	patients	patient	NOUN
iajs-2653	4	21	with	with	ADP
iajs-2653	4	22	several	several	ADJ
iajs-2653	4	23	types	type	NOUN
iajs-2653	4	24	of	of	ADP
iajs-2653	4	25	cancers	cancer	NOUN
iajs-2653	4	26	including	include	VERB
iajs-2653	4	27	breast	breast	NOUN
iajs-2653	4	28	cancer	cancer	NOUN
iajs-2653	4	29	.	.	PUNCT
iajs-2653	5	1	the	the	DET
iajs-2653	5	2	aim	aim	NOUN
iajs-2653	5	3	of	of	ADP
iajs-2653	5	4	present	present	ADJ
iajs-2653	5	5	study	study	NOUN
iajs-2653	5	6	was	be	AUX
iajs-2653	5	7	to	to	PART
iajs-2653	5	8	determine	determine	VERB
iajs-2653	5	9	of	of	ADP
iajs-2653	5	10	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	5	11	oxidase	oxidase	NOUN
iajs-2653	5	12	activity	activity	NOUN
iajs-2653	5	13	,	,	PUNCT
iajs-2653	5	14	specific	specific	ADJ
iajs-2653	5	15	activity	activity	NOUN
iajs-2653	5	16	,	,	PUNCT
iajs-2653	5	17	iron	iron	NOUN
iajs-2653	5	18	concentration	concentration	NOUN
iajs-2653	5	19	in	in	ADP
iajs-2653	5	20	sera	sera	NOUN
iajs-2653	5	21	of	of	ADP
iajs-2653	5	22	patients	patient	NOUN
iajs-2653	5	23	with	with	ADP
iajs-2653	5	24	breast	breast	NOUN
iajs-2653	5	25	cancer	cancer	NOUN
iajs-2653	5	26	and	and	CCONJ
iajs-2653	5	27	comparing	compare	VERB
iajs-2653	5	28	with	with	ADP
iajs-2653	5	29	healthy	healthy	ADJ
iajs-2653	5	30	group	group	NOUN
iajs-2653	5	31	,	,	PUNCT
iajs-2653	5	32	and	and	CCONJ
iajs-2653	5	33	the	the	DET
iajs-2653	5	34	ability	ability	NOUN
iajs-2653	5	35	of	of	ADP
iajs-2653	5	36	using	use	VERB
iajs-2653	5	37	enzyme	enzyme	NOUN
iajs-2653	5	38	as	as	ADP
iajs-2653	5	39	a	a	DET
iajs-2653	5	40	tumor	tumor	NOUN
iajs-2653	5	41	marker	marker	NOUN
iajs-2653	5	42	for	for	ADP
iajs-2653	5	43	breast	breast	NOUN
iajs-2653	5	44	cancer	cancer	NOUN
iajs-2653	5	45	.	.	PUNCT
iajs-2653	6	1	this	this	DET
iajs-2653	6	2	study	study	NOUN
iajs-2653	6	3	was	be	AUX
iajs-2653	6	4	performed	perform	VERB
iajs-2653	6	5	from	from	ADP
iajs-2653	6	6	november	november	PROPN
iajs-2653	6	7	2018	2018	NUM
iajs-2653	6	8	to	to	ADP
iajs-2653	6	9	january	january	PROPN
iajs-2653	6	10	2019	2019	NUM
iajs-2653	6	11	,	,	PUNCT
iajs-2653	6	12	blood	blood	NOUN
iajs-2653	6	13	samples	sample	NOUN
iajs-2653	6	14	were	be	AUX
iajs-2653	6	15	collected	collect	VERB
iajs-2653	6	16	from	from	ADP
iajs-2653	6	17	breast	breast	NOUN
iajs-2653	6	18	cancer	cancer	NOUN
iajs-2653	6	19	patients	patient	NOUN
iajs-2653	6	20	in	in	ADP
iajs-2653	6	21	nanakeli	nanakeli	ADJ
iajs-2653	6	22	hospital	hospital	PROPN
iajs-2653	6	23	in	in	ADP
iajs-2653	6	24	erbil	erbil	PROPN
iajs-2653	6	25	city	city	PROPN
iajs-2653	6	26	.	.	PUNCT
iajs-2653	7	1	study	study	NOUN
iajs-2653	7	2	was	be	AUX
iajs-2653	7	3	included	include	VERB
iajs-2653	7	4	(	(	PUNCT
iajs-2653	7	5	65	65	NUM
iajs-2653	7	6	)	)	PUNCT
iajs-2653	7	7	female	female	ADJ
iajs-2653	7	8	patients	patient	NOUN
iajs-2653	7	9	with	with	ADP
iajs-2653	7	10	breast	breast	NOUN
iajs-2653	7	11	cancer	cancer	NOUN
iajs-2653	7	12	and	and	CCONJ
iajs-2653	7	13	(	(	PUNCT
iajs-2653	7	14	20	20	NUM
iajs-2653	7	15	)	)	PUNCT
iajs-2653	7	16	healthy	healthy	ADJ
iajs-2653	7	17	donors	donor	NOUN
iajs-2653	7	18	as	as	ADP
iajs-2653	7	19	control	control	NOUN
iajs-2653	7	20	group	group	NOUN
iajs-2653	7	21	.	.	PUNCT
iajs-2653	8	1	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	8	2	activity	activity	NOUN
iajs-2653	8	3	,	,	PUNCT
iajs-2653	8	4	specific	specific	ADJ
iajs-2653	8	5	activity	activity	NOUN
iajs-2653	8	6	,	,	PUNCT
iajs-2653	8	7	serum	serum	NOUN
iajs-2653	8	8	total	total	ADJ
iajs-2653	8	9	protein	protein	NOUN
iajs-2653	8	10	concentration	concentration	NOUN
iajs-2653	8	11	,	,	PUNCT
iajs-2653	8	12	serum	serum	NOUN
iajs-2653	8	13	total	total	ADJ
iajs-2653	8	14	iron	iron	NOUN
iajs-2653	8	15	concentration	concentration	NOUN
iajs-2653	8	16	levels	level	NOUN
iajs-2653	8	17	were	be	AUX
iajs-2653	8	18	estimated	estimate	VERB
iajs-2653	8	19	for	for	ADP
iajs-2653	8	20	all	all	DET
iajs-2653	8	21	samples	sample	NOUN
iajs-2653	8	22	by	by	ADP
iajs-2653	8	23	colorimetric	colorimetric	ADJ
iajs-2653	8	24	methods	method	NOUN
iajs-2653	8	25	.	.	PUNCT
iajs-2653	9	1	the	the	DET
iajs-2653	9	2	results	result	NOUN
iajs-2653	9	3	shown	show	VERB
iajs-2653	9	4	that	that	SCONJ
iajs-2653	9	5	there	there	PRON
iajs-2653	9	6	was	be	VERB
iajs-2653	9	7	a	a	DET
iajs-2653	9	8	significant	significant	ADJ
iajs-2653	9	9	increase	increase	NOUN
iajs-2653	9	10	in	in	ADP
iajs-2653	9	11	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	9	12	activity	activity	NOUN
iajs-2653	9	13	level	level	NOUN
iajs-2653	9	14	for	for	ADP
iajs-2653	9	15	patients	patient	NOUN
iajs-2653	9	16	with	with	ADP
iajs-2653	9	17	breast	breast	NOUN
iajs-2653	9	18	cancer	cancer	NOUN
iajs-2653	9	19	(	(	PUNCT
iajs-2653	9	20	227.8	227.8	NUM
iajs-2653	9	21	u	u	NOUN
iajs-2653	9	22	/	/	SYM
iajs-2653	9	23	l	l	NOUN
iajs-2653	9	24	)	)	PUNCT
iajs-2653	9	25	compared	compare	VERB
iajs-2653	9	26	with	with	ADP
iajs-2653	9	27	control	control	NOUN
iajs-2653	9	28	group	group	NOUN
iajs-2653	9	29	(	(	PUNCT
iajs-2653	9	30	101.1	101.1	NUM
iajs-2653	9	31	u	u	NOUN
iajs-2653	9	32	/	/	SYM
iajs-2653	9	33	l	l	NOUN
iajs-2653	9	34	)	)	PUNCT
iajs-2653	9	35	while	while	SCONJ
iajs-2653	9	36	total	total	ADJ
iajs-2653	9	37	protein	protein	NOUN
iajs-2653	9	38	level	level	NOUN
iajs-2653	9	39	for	for	ADP
iajs-2653	9	40	breast	breast	NOUN
iajs-2653	9	41	cancer	cancer	NOUN
iajs-2653	9	42	patients	patient	NOUN
iajs-2653	9	43	(	(	PUNCT
iajs-2653	9	44	6.592	6.592	NUM
iajs-2653	9	45	g	g	NOUN
iajs-2653	9	46	/	/	SYM
iajs-2653	9	47	dl	dl	NOUN
iajs-2653	9	48	)	)	PUNCT
iajs-2653	9	49	showed	show	VERB
iajs-2653	9	50	no	no	DET
iajs-2653	9	51	significant	significant	ADJ
iajs-2653	9	52	change	change	NOUN
iajs-2653	9	53	compared	compare	VERB
iajs-2653	9	54	to	to	ADP
iajs-2653	9	55	control	control	NOUN
iajs-2653	9	56	group(7.127	group(7.127	NOUN
iajs-2653	9	57	g	g	PROPN
iajs-2653	9	58	/	/	SYM
iajs-2653	9	59	dl	dl	PROPN
iajs-2653	9	60	)	)	PUNCT
iajs-2653	9	61	likewise	likewise	ADV
iajs-2653	9	62	the	the	DET
iajs-2653	9	63	result	result	NOUN
iajs-2653	9	64	shown	show	VERB
iajs-2653	9	65	that	that	SCONJ
iajs-2653	9	66	there	there	PRON
iajs-2653	9	67	was	be	VERB
iajs-2653	9	68	a	a	DET
iajs-2653	9	69	significant	significant	ADJ
iajs-2653	9	70	increase	increase	NOUN
iajs-2653	9	71	in	in	ADP
iajs-2653	9	72	specific	specific	ADJ
iajs-2653	9	73	activity	activity	NOUN
iajs-2653	9	74	of	of	ADP
iajs-2653	9	75	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	9	76	and	and	CCONJ
iajs-2653	9	77	total	total	ADJ
iajs-2653	9	78	iron	iron	NOUN
iajs-2653	9	79	concentration	concentration	NOUN
iajs-2653	9	80	level	level	NOUN
iajs-2653	9	81	for	for	ADP
iajs-2653	9	82	patients	patient	NOUN
iajs-2653	9	83	with	with	ADP
iajs-2653	9	84	breast	breast	NOUN
iajs-2653	9	85	cancer	cancer	NOUN
iajs-2653	9	86	(	(	PUNCT
iajs-2653	9	87	34.74	34.74	NUM
iajs-2653	9	88	u	u	NOUN
iajs-2653	9	89	/	/	SYM
iajs-2653	9	90	mg	mg	PROPN
iajs-2653	9	91	)	)	PUNCT
iajs-2653	9	92	(	(	PUNCT
iajs-2653	9	93	334.2	334.2	NUM
iajs-2653	9	94	mg	mg	PROPN
iajs-2653	9	95	/	/	SYM
iajs-2653	9	96	dl	dl	NOUN
iajs-2653	9	97	)	)	PUNCT
iajs-2653	9	98	compared	compare	VERB
iajs-2653	9	99	to	to	ADP
iajs-2653	9	100	control	control	NOUN
iajs-2653	9	101	group	group	NOUN
iajs-2653	9	102	(	(	PUNCT
iajs-2653	9	103	14.14	14.14	NUM
iajs-2653	9	104	u	u	NOUN
iajs-2653	9	105	/	/	SYM
iajs-2653	9	106	mg	mg	PROPN
iajs-2653	9	107	)	)	PUNCT
iajs-2653	9	108	(	(	PUNCT
iajs-2653	9	109	128.6	128.6	NUM
iajs-2653	9	110	mg	mg	PROPN
iajs-2653	9	111	/	/	SYM
iajs-2653	9	112	dl	dl	PROPN
iajs-2653	9	113	)	)	PUNCT
iajs-2653	9	114	the	the	DET
iajs-2653	9	115	conclusion	conclusion	NOUN
iajs-2653	9	116	of	of	ADP
iajs-2653	9	117	this	this	DET
iajs-2653	9	118	study	study	NOUN
iajs-2653	9	119	was	be	AUX
iajs-2653	9	120	the	the	DET
iajs-2653	9	121	concentration	concentration	NOUN
iajs-2653	9	122	of	of	ADP
iajs-2653	9	123	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	9	124	activity	activity	NOUN
iajs-2653	9	125	,	,	PUNCT
iajs-2653	9	126	serum	serum	NOUN
iajs-2653	9	127	total	total	ADJ
iajs-2653	9	128	iron	iron	NOUN
iajs-2653	9	129	concentration	concentration	NOUN
iajs-2653	9	130	and	and	CCONJ
iajs-2653	9	131	specific	specific	ADJ
iajs-2653	9	132	activity	activity	NOUN
iajs-2653	9	133	of	of	ADP
iajs-2653	9	134	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	9	135	significantly	significantly	ADV
iajs-2653	9	136	increase	increase	VERB
iajs-2653	9	137	in	in	ADP
iajs-2653	9	138	breast	breast	NOUN
iajs-2653	9	139	cancer	cancer	NOUN
iajs-2653	9	140	patients	patient	NOUN
iajs-2653	9	141	while	while	SCONJ
iajs-2653	9	142	total	total	ADJ
iajs-2653	9	143	protein	protein	NOUN
iajs-2653	9	144	level	level	NOUN
iajs-2653	9	145	revealed	reveal	VERB
iajs-2653	9	146	no	no	DET
iajs-2653	9	147	significant	significant	ADJ
iajs-2653	9	148	change	change	NOUN
iajs-2653	9	149	.	.	PUNCT
iajs-2653	10	1	serum	serum	PROPN
iajs-2653	10	2	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	10	3	oxidase	oxidase	NOUN
iajs-2653	10	4	activity	activity	NOUN
iajs-2653	10	5	and	and	CCONJ
iajs-2653	10	6	specific	specific	ADJ
iajs-2653	10	7	activity	activity	NOUN
iajs-2653	10	8	were	be	AUX
iajs-2653	10	9	highly	highly	ADV
iajs-2653	10	10	significant	significant	ADJ
iajs-2653	10	11	elevated	elevate	VERB
iajs-2653	10	12	in	in	ADP
iajs-2653	10	13	patient	patient	ADJ
iajs-2653	10	14	group	group	NOUN
iajs-2653	10	15	when	when	SCONJ
iajs-2653	10	16	compared	compare	VERB
iajs-2653	10	17	with	with	ADP
iajs-2653	10	18	control	control	NOUN
iajs-2653	10	19	group	group	NOUN
iajs-2653	10	20	.	.	PUNCT
iajs-2653	11	1	also	also	ADV
iajs-2653	11	2	the	the	DET
iajs-2653	11	3	total	total	ADJ
iajs-2653	11	4	iron	iron	NOUN
iajs-2653	11	5	concentration	concentration	NOUN
iajs-2653	11	6	results	result	NOUN
iajs-2653	11	7	showed	show	VERB
iajs-2653	11	8	significant	significant	ADJ
iajs-2653	11	9	increasing	increase	VERB
iajs-2653	11	10	(	(	PUNCT
iajs-2653	11	11	p˂0.0001	p˂0.0001	NOUN
iajs-2653	11	12	)	)	PUNCT
iajs-2653	11	13	between	between	ADP
iajs-2653	11	14	of	of	ADP
iajs-2653	11	15	patient	patient	NOUN
iajs-2653	11	16	with	with	ADP
iajs-2653	11	17	breast	breast	NOUN
iajs-2653	11	18	cancer	cancer	NOUN
iajs-2653	11	19	and	and	CCONJ
iajs-2653	11	20	control	control	NOUN
iajs-2653	11	21	group	group	NOUN
iajs-2653	11	22	.	.	PUNCT
iajs-2653	12	1	key	key	ADJ
iajs-2653	12	2	words	word	NOUN
iajs-2653	12	3	:	:	PUNCT
iajs-2653	12	4	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	12	5	oxidase	oxidase	NOUN
iajs-2653	12	6	activity	activity	NOUN
iajs-2653	12	7	,	,	PUNCT
iajs-2653	12	8	breast	breast	NOUN
iajs-2653	12	9	tumor	tumor	NOUN
iajs-2653	12	10	,	,	PUNCT
iajs-2653	12	11	iron	iron	NOUN
iajs-2653	12	12	.	.	PUNCT
iajs-2653	13	1	1	1	X
iajs-2653	13	2	.	.	X
iajs-2653	13	3	introduction	introduction	NOUN
iajs-2653	13	4	breast	breast	NOUN
iajs-2653	13	5	cancer	cancer	NOUN
iajs-2653	13	6	is	be	AUX
iajs-2653	13	7	one	one	NUM
iajs-2653	13	8	of	of	ADP
iajs-2653	13	9	the	the	DET
iajs-2653	13	10	most	most	ADV
iajs-2653	13	11	common	common	ADJ
iajs-2653	13	12	cancers	cancer	NOUN
iajs-2653	13	13	among	among	ADP
iajs-2653	13	14	women	woman	NOUN
iajs-2653	13	15	around	around	ADP
iajs-2653	13	16	the	the	DET
iajs-2653	13	17	world	world	NOUN
iajs-2653	13	18	,	,	PUNCT
iajs-2653	13	19	accounting	account	VERB
iajs-2653	13	20	for	for	ADP
iajs-2653	13	21	about	about	ADV
iajs-2653	13	22	570,000	570,000	NUM
iajs-2653	13	23	deaths	death	NOUN
iajs-2653	13	24	in	in	ADP
iajs-2653	13	25	2015	2015	NUM
iajs-2653	13	26	[	[	X
iajs-2653	13	27	1	1	NUM
iajs-2653	13	28	]	]	PUNCT
iajs-2653	13	29	.	.	PUNCT
iajs-2653	14	1	more	more	ADJ
iajs-2653	14	2	than	than	ADP
iajs-2653	14	3	1,5	1,5	NUM
iajs-2653	14	4	million	million	NUM
iajs-2653	14	5	women	woman	NOUN
iajs-2653	14	6	(	(	PUNCT
iajs-2653	14	7	25	25	NUM
iajs-2653	14	8	%	%	NOUN
iajs-2653	14	9	of	of	ADP
iajs-2653	14	10	all	all	DET
iajs-2653	14	11	individuals	individual	NOUN
iajs-2653	14	12	with	with	ADP
iajs-2653	14	13	cancer	cancer	NOUN
iajs-2653	14	14	)	)	PUNCT
iajs-2653	14	15	were	be	AUX
iajs-2653	14	16	diagnosed	diagnose	VERB
iajs-2653	14	17	with	with	ADP
iajs-2653	14	18	breast	breast	NOUN
iajs-2653	14	19	cancer	cancer	NOUN
iajs-2653	14	20	worldwide	worldwide	ADV
iajs-2653	14	21	each	each	DET
iajs-2653	14	22	year	year	NOUN
iajs-2653	15	1	[	[	X
iajs-2653	15	2	2	2	NUM
iajs-2653	15	3	]	]	PUNCT
iajs-2653	15	4	.	.	PUNCT
iajs-2653	16	1	breast	breast	NOUN
iajs-2653	16	2	cancer	cancer	NOUN
iajs-2653	16	3	is	be	AUX
iajs-2653	16	4	a	a	DET
iajs-2653	16	5	metastatic	metastatic	ADJ
iajs-2653	16	6	cancer	cancer	NOUN
iajs-2653	16	7	which	which	PRON
iajs-2653	16	8	can	can	AUX
iajs-2653	16	9	usually	usually	ADV
iajs-2653	16	10	spread	spread	VERB
iajs-2653	16	11	to	to	ADP
iajs-2653	16	12	distant	distant	ADJ
iajs-2653	16	13	organs	organ	NOUN
iajs-2653	16	14	such	such	ADJ
iajs-2653	16	15	as	as	ADP
iajs-2653	16	16	the	the	DET
iajs-2653	16	17	bone	bone	NOUN
iajs-2653	16	18	,	,	PUNCT
iajs-2653	16	19	liver	liver	NOUN
iajs-2653	16	20	,	,	PUNCT
iajs-2653	16	21	lung	lung	NOUN
iajs-2653	16	22	and	and	CCONJ
iajs-2653	16	23	brain	brain	NOUN
iajs-2653	16	24	,	,	PUNCT
iajs-2653	16	25	which	which	PRON
iajs-2653	16	26	are	be	AUX
iajs-2653	16	27	primarily	primarily	ADV
iajs-2653	16	28	responsible	responsible	ADJ
iajs-2653	16	29	for	for	ADP
iajs-2653	16	30	its	its	PRON
iajs-2653	16	31	incurability	incurability	NOUN
iajs-2653	17	1	[	[	X
iajs-2653	17	2	3	3	NUM
iajs-2653	17	3	]	]	PUNCT
iajs-2653	17	4	.	.	PUNCT
iajs-2653	18	1	early	early	ADJ
iajs-2653	18	2	diagnosis	diagnosis	NOUN
iajs-2653	18	3	of	of	ADP
iajs-2653	18	4	the	the	DET
iajs-2653	18	5	illness	illness	NOUN
iajs-2653	18	6	can	can	AUX
iajs-2653	18	7	lead	lead	VERB
iajs-2653	18	8	to	to	ADP
iajs-2653	18	9	the	the	DET
iajs-2653	18	10	best	good	ADJ
iajs-2653	18	11	prognosis	prognosis	NOUN
iajs-2653	18	12	and	and	CCONJ
iajs-2653	18	13	increase	increase	VERB
iajs-2653	18	14	the	the	DET
iajs-2653	18	15	chance	chance	NOUN
iajs-2653	18	16	of	of	ADP
iajs-2653	18	17	survives	survive	VERB
iajs-2653	18	18	[	[	X
iajs-2653	18	19	4	4	NUM
iajs-2653	18	20	]	]	PUNCT
iajs-2653	18	21	.	.	PUNCT
iajs-2653	19	1	breast	breast	NOUN
iajs-2653	19	2	http://ihicps.com/	http://ihicps.com/	PROPN
iajs-2653	19	3	mailto:shahla.biochem@epu.edu.iq	mailto:shahla.biochem@epu.edu.iq	PROPN
iajs-2653	19	4	special	special	ADJ
iajs-2653	19	5	issue	issue	NOUN
iajs-2653	19	6	1ihicpas	1ihicpas	NUM
iajs-2653	19	7	202	202	NUM
iajs-2653	19	8	ibn	ibn	PROPN
iajs-2653	19	9	al	al	PROPN
iajs-2653	19	10	-	-	PUNCT
iajs-2653	19	11	haitham	haitham	PROPN
iajs-2653	19	12	journal	journal	PROPN
iajs-2653	19	13	for	for	ADP
iajs-2653	19	14	pure	pure	ADJ
iajs-2653	19	15	and	and	CCONJ
iajs-2653	19	16	applied	apply	VERB
iajs-2653	19	17	science	science	NOUN
iajs-2653	19	18	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	19	19	for	for	ADP
iajs-2653	19	20	more	more	ADJ
iajs-2653	19	21	information	information	NOUN
iajs-2653	19	22	about	about	ADP
iajs-2653	19	23	the	the	DET
iajs-2653	19	24	conference	conference	NOUN
iajs-2653	19	25	please	please	INTJ
iajs-2653	19	26	visit	visit	VERB
iajs-2653	19	27	the	the	DET
iajs-2653	19	28	websites	website	NOUN
iajs-2653	19	29	:	:	PUNCT
iajs-2653	19	30	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	19	31	c	c	NOUN
iajs-2653	19	32	h	h	NOUN
iajs-2653	20	1	e	e	NOUN
iajs-2653	20	2	m	m	VERB
iajs-2653	20	3	i	i	NOUN
iajs-2653	20	4	s	s	VERB
iajs-2653	20	5	t	t	PROPN
iajs-2653	20	6	r	r	NOUN
iajs-2653	20	7	y	y	PROPN
iajs-2653	20	8	|	|	ADV
iajs-2653	20	9	69	69	NUM
iajs-2653	20	10	cancer	cancer	NOUN
iajs-2653	20	11	has	have	VERB
iajs-2653	20	12	two	two	NUM
iajs-2653	20	13	main	main	ADJ
iajs-2653	20	14	types	type	NOUN
iajs-2653	20	15	:	:	PUNCT
iajs-2653	20	16	non	non	ADJ
iajs-2653	20	17	-	-	ADJ
iajs-2653	20	18	invasive	invasive	ADJ
iajs-2653	20	19	breast	breast	NOUN
iajs-2653	20	20	cancer	cancer	NOUN
iajs-2653	20	21	and	and	CCONJ
iajs-2653	20	22	invasive	invasive	ADJ
iajs-2653	20	23	breast	breast	NOUN
iajs-2653	20	24	cancer	cancer	NOUN
iajs-2653	21	1	[	[	X
iajs-2653	21	2	5	5	NUM
iajs-2653	21	3	]	]	PUNCT
iajs-2653	21	4	.ceruloplasmin	.ceruloplasmin	X
iajs-2653	21	5	(	(	PUNCT
iajs-2653	21	6	cp	cp	X
iajs-2653	21	7	)	)	PUNCT
iajs-2653	21	8	is	be	AUX
iajs-2653	21	9	an	an	DET
iajs-2653	21	10	enzyme	enzyme	NOUN
iajs-2653	21	11	that	that	PRON
iajs-2653	21	12	may	may	AUX
iajs-2653	21	13	play	play	VERB
iajs-2653	21	14	a	a	DET
iajs-2653	21	15	significant	significant	ADJ
iajs-2653	21	16	role	role	NOUN
iajs-2653	21	17	in	in	ADP
iajs-2653	21	18	the	the	DET
iajs-2653	21	19	progression	progression	NOUN
iajs-2653	21	20	of	of	ADP
iajs-2653	21	21	breast	breast	NOUN
iajs-2653	21	22	cancer	cancer	NOUN
iajs-2653	21	23	[	[	X
iajs-2653	21	24	6	6	NUM
iajs-2653	21	25	]	]	PUNCT
iajs-2653	21	26	.	.	PUNCT
iajs-2653	22	1	the	the	DET
iajs-2653	22	2	cp	cp	PROPN
iajs-2653	22	3	is	be	AUX
iajs-2653	22	4	an	an	DET
iajs-2653	22	5	acute	acute	ADJ
iajs-2653	22	6	-	-	PUNCT
iajs-2653	22	7	phase	phase	NOUN
iajs-2653	22	8	protein	protein	NOUN
iajs-2653	22	9	that	that	PRON
iajs-2653	22	10	is	be	AUX
iajs-2653	22	11	typically	typically	ADV
iajs-2653	22	12	produced	produce	VERB
iajs-2653	22	13	by	by	ADP
iajs-2653	22	14	hepatic	hepatic	ADJ
iajs-2653	22	15	cells	cell	NOUN
iajs-2653	22	16	[	[	X
iajs-2653	22	17	7	7	X
iajs-2653	22	18	]	]	PUNCT
iajs-2653	22	19	and	and	CCONJ
iajs-2653	22	20	is	be	AUX
iajs-2653	22	21	primarily	primarily	ADV
iajs-2653	22	22	secreted	secrete	VERB
iajs-2653	22	23	in	in	ADP
iajs-2653	22	24	the	the	DET
iajs-2653	22	25	plasma	plasma	NOUN
iajs-2653	23	1	[	[	X
iajs-2653	23	2	8	8	NUM
iajs-2653	23	3	]	]	PUNCT
iajs-2653	23	4	,	,	PUNCT
iajs-2653	23	5	whereas	whereas	SCONJ
iajs-2653	23	6	cp	cp	PROPN
iajs-2653	23	7	mrna	mrna	PROPN
iajs-2653	23	8	was	be	AUX
iajs-2653	23	9	found	find	VERB
iajs-2653	23	10	in	in	ADP
iajs-2653	23	11	cell	cell	NOUN
iajs-2653	23	12	lines	line	NOUN
iajs-2653	23	13	of	of	ADP
iajs-2653	23	14	breast	breast	NOUN
iajs-2653	23	15	cancer	cancer	NOUN
iajs-2653	23	16	patients	patient	NOUN
iajs-2653	23	17	[	[	X
iajs-2653	23	18	9	9	NUM
iajs-2653	23	19	]	]	PUNCT
iajs-2653	23	20	.	.	PUNCT
iajs-2653	24	1	it	it	PRON
iajs-2653	24	2	is	be	AUX
iajs-2653	24	3	comprised	comprise	VERB
iajs-2653	24	4	of	of	ADP
iajs-2653	24	5	angiogenesis	angiogenesis	NOUN
iajs-2653	24	6	and	and	CCONJ
iajs-2653	24	7	neovascularization	neovascularization	NOUN
iajs-2653	24	8	thus	thus	ADV
iajs-2653	24	9	it	it	PRON
iajs-2653	24	10	has	have	VERB
iajs-2653	24	11	a	a	DET
iajs-2653	24	12	role	role	NOUN
iajs-2653	24	13	in	in	ADP
iajs-2653	24	14	cancer	cancer	NOUN
iajs-2653	25	1	[	[	X
iajs-2653	25	2	10	10	NUM
iajs-2653	25	3	]	]	PUNCT
iajs-2653	25	4	.	.	PUNCT
iajs-2653	26	1	cp	cp	PROPN
iajs-2653	26	2	plays	play	VERB
iajs-2653	26	3	a	a	DET
iajs-2653	26	4	significant	significant	ADJ
iajs-2653	26	5	role	role	NOUN
iajs-2653	26	6	in	in	ADP
iajs-2653	26	7	iron	iron	NOUN
iajs-2653	26	8	homeostasis[8	homeostasis[8	PROPN
iajs-2653	26	9	]	]	PUNCT
iajs-2653	26	10	,	,	PUNCT
iajs-2653	26	11	consequently	consequently	ADV
iajs-2653	26	12	,	,	PUNCT
iajs-2653	26	13	it	it	PRON
iajs-2653	26	14	has	have	VERB
iajs-2653	26	15	a	a	DET
iajs-2653	26	16	contribution	contribution	NOUN
iajs-2653	26	17	to	to	ADP
iajs-2653	26	18	the	the	DET
iajs-2653	26	19	antioxidant	antioxidant	ADJ
iajs-2653	26	20	mechanism	mechanism	NOUN
iajs-2653	26	21	by	by	ADP
iajs-2653	26	22	preventing	prevent	VERB
iajs-2653	26	23	the	the	DET
iajs-2653	26	24	formation	formation	NOUN
iajs-2653	26	25	of	of	ADP
iajs-2653	26	26	free	free	ADJ
iajs-2653	26	27	radicals	radical	NOUN
iajs-2653	26	28	[	[	X
iajs-2653	26	29	11	11	NUM
iajs-2653	26	30	]	]	PUNCT
iajs-2653	26	31	or	or	CCONJ
iajs-2653	26	32	in	in	ADP
iajs-2653	26	33	oxidative	oxidative	ADJ
iajs-2653	26	34	damage	damage	NOUN
iajs-2653	26	35	mechanisms	mechanism	NOUN
iajs-2653	26	36	[	[	X
iajs-2653	26	37	12	12	NUM
iajs-2653	26	38	]	]	X
iajs-2653	26	39	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	26	40	has	have	VERB
iajs-2653	26	41	two	two	NUM
iajs-2653	26	42	major	major	ADJ
iajs-2653	26	43	functions	function	NOUN
iajs-2653	26	44	:	:	PUNCT
iajs-2653	26	45	oxidase	oxidase	NOUN
iajs-2653	26	46	and	and	CCONJ
iajs-2653	26	47	ferroxidase	ferroxidase	NOUN
iajs-2653	26	48	activities	activity	NOUN
iajs-2653	26	49	[	[	X
iajs-2653	26	50	13	13	NUM
iajs-2653	26	51	]	]	PUNCT
iajs-2653	26	52	,	,	PUNCT
iajs-2653	26	53	by	by	ADP
iajs-2653	26	54	its	its	PRON
iajs-2653	26	55	oxidase	oxidase	NOUN
iajs-2653	26	56	activity	activity	NOUN
iajs-2653	26	57	,	,	PUNCT
iajs-2653	26	58	play	play	VERB
iajs-2653	26	59	an	an	DET
iajs-2653	26	60	important	important	ADJ
iajs-2653	26	61	role	role	NOUN
iajs-2653	26	62	in	in	ADP
iajs-2653	26	63	a	a	DET
iajs-2653	26	64	variety	variety	NOUN
iajs-2653	26	65	of	of	ADP
iajs-2653	26	66	processes	process	NOUN
iajs-2653	26	67	relevant	relevant	ADJ
iajs-2653	26	68	to	to	ADP
iajs-2653	26	69	the	the	DET
iajs-2653	26	70	copper	copper	NOUN
iajs-2653	26	71	metabolism	metabolism	NOUN
iajs-2653	26	72	[	[	X
iajs-2653	26	73	14	14	NUM
iajs-2653	26	74	]	]	PUNCT
iajs-2653	26	75	,	,	PUNCT
iajs-2653	26	76	some	some	DET
iajs-2653	26	77	organic	organic	ADJ
iajs-2653	26	78	amines	amine	NOUN
iajs-2653	26	79	that	that	PRON
iajs-2653	26	80	produce	produce	VERB
iajs-2653	26	81	in	in	ADP
iajs-2653	26	82	the	the	DET
iajs-2653	26	83	body	body	NOUN
iajs-2653	26	84	[	[	X
iajs-2653	26	85	15	15	NUM
iajs-2653	26	86	]	]	PUNCT
iajs-2653	26	87	,	,	PUNCT
iajs-2653	26	88	and	and	CCONJ
iajs-2653	26	89	nitric	nitric	ADJ
iajs-2653	26	90	oxide	oxide	NOUN
iajs-2653	26	91	[	[	X
iajs-2653	26	92	16	16	NUM
iajs-2653	26	93	]	]	PUNCT
iajs-2653	26	94	,	,	PUNCT
iajs-2653	26	95	on	on	ADP
iajs-2653	26	96	the	the	DET
iajs-2653	26	97	other	other	ADJ
iajs-2653	26	98	hand	hand	NOUN
iajs-2653	26	99	,	,	PUNCT
iajs-2653	26	100	iron	iron	NOUN
iajs-2653	26	101	is	be	AUX
iajs-2653	26	102	one	one	NUM
iajs-2653	26	103	of	of	ADP
iajs-2653	26	104	the	the	DET
iajs-2653	26	105	sources	source	NOUN
iajs-2653	26	106	of	of	ADP
iajs-2653	26	107	free	free	ADJ
iajs-2653	26	108	radicals	radical	NOUN
iajs-2653	26	109	which	which	PRON
iajs-2653	26	110	release	release	VERB
iajs-2653	26	111	from	from	ADP
iajs-2653	26	112	fenton	fenton	PROPN
iajs-2653	26	113	/	/	SYM
iajs-2653	26	114	haber	haber	PROPN
iajs-2653	26	115	-	-	PUNCT
iajs-2653	26	116	weiss	weiss	PROPN
iajs-2653	26	117	or	or	CCONJ
iajs-2653	26	118	autoxidation	autoxidation	NOUN
iajs-2653	26	119	reactions	reaction	NOUN
iajs-2653	26	120	,	,	PUNCT
iajs-2653	26	121	that	that	PRON
iajs-2653	26	122	lead	lead	VERB
iajs-2653	26	123	to	to	ADP
iajs-2653	26	124	the	the	DET
iajs-2653	26	125	formation	formation	NOUN
iajs-2653	26	126	of	of	ADP
iajs-2653	26	127	reactive	reactive	ADJ
iajs-2653	26	128	oxygen	oxygen	NOUN
iajs-2653	26	129	species	specie	NOUN
iajs-2653	26	130	(	(	PUNCT
iajs-2653	26	131	ros	ros	PROPN
iajs-2653	26	132	)	)	PUNCT
iajs-2653	26	133	and	and	CCONJ
iajs-2653	26	134	lipid	lipid	NOUN
iajs-2653	26	135	peroxidation	peroxidation	NOUN
iajs-2653	27	1	[	[	X
iajs-2653	27	2	17	17	NUM
iajs-2653	27	3	]	]	PUNCT
iajs-2653	27	4	.	.	PUNCT
iajs-2653	28	1	cp	cp	PROPN
iajs-2653	28	2	acts	act	VERB
iajs-2653	28	3	as	as	ADP
iajs-2653	28	4	an	an	DET
iajs-2653	28	5	antioxidant	antioxidant	NOUN
iajs-2653	28	6	by	by	ADP
iajs-2653	28	7	oxidizing	oxidize	VERB
iajs-2653	28	8	iron	iron	NOUN
iajs-2653	28	9	from	from	ADP
iajs-2653	28	10	its	its	PRON
iajs-2653	28	11	ferrous	ferrous	NOUN
iajs-2653	28	12	to	to	ADP
iajs-2653	28	13	ferric	ferric	ADJ
iajs-2653	28	14	state	state	NOUN
iajs-2653	28	15	,	,	PUNCT
iajs-2653	28	16	thus	thus	ADV
iajs-2653	28	17	preventing	prevent	VERB
iajs-2653	28	18	oxidative	oxidative	ADJ
iajs-2653	28	19	damage	damage	NOUN
iajs-2653	28	20	induced	induce	VERB
iajs-2653	28	21	by	by	ADP
iajs-2653	28	22	ferrous	ferrous	ADJ
iajs-2653	28	23	mediated	mediate	VERB
iajs-2653	28	24	free	free	ADJ
iajs-2653	28	25	radical	radical	ADJ
iajs-2653	28	26	generation	generation	NOUN
iajs-2653	28	27	by	by	ADP
iajs-2653	28	28	the	the	DET
iajs-2653	28	29	fenton	fenton	PROPN
iajs-2653	28	30	reaction	reaction	NOUN
iajs-2653	28	31	[	[	X
iajs-2653	28	32	18	18	NUM
iajs-2653	28	33	]	]	PUNCT
iajs-2653	28	34	.	.	PUNCT
iajs-2653	29	1	by	by	ADP
iajs-2653	29	2	ferroxidase	ferroxidase	NOUN
iajs-2653	29	3	activity	activity	NOUN
iajs-2653	29	4	,	,	PUNCT
iajs-2653	29	5	cp	cp	X
iajs-2653	29	6	assists	assist	VERB
iajs-2653	29	7	the	the	DET
iajs-2653	29	8	export	export	NOUN
iajs-2653	29	9	of	of	ADP
iajs-2653	29	10	iron	iron	NOUN
iajs-2653	29	11	from	from	ADP
iajs-2653	29	12	the	the	DET
iajs-2653	29	13	cell	cell	NOUN
iajs-2653	29	14	because	because	SCONJ
iajs-2653	29	15	only	only	ADV
iajs-2653	29	16	ferric	ferric	ADJ
iajs-2653	29	17	iron	iron	NOUN
iajs-2653	29	18	can	can	AUX
iajs-2653	29	19	be	be	AUX
iajs-2653	29	20	incorporated	incorporate	VERB
iajs-2653	29	21	with	with	ADP
iajs-2653	29	22	transferrin	transferrin	NOUN
iajs-2653	29	23	in	in	ADP
iajs-2653	29	24	the	the	DET
iajs-2653	29	25	bloodstream	bloodstream	NOUN
iajs-2653	30	1	[	[	X
iajs-2653	30	2	19	19	NUM
iajs-2653	30	3	]	]	X
iajs-2653	30	4	;	;	PUNCT
iajs-2653	30	5	extracellular	extracellular	ADJ
iajs-2653	30	6	ferroxidases	ferroxidase	NOUN
iajs-2653	30	7	that	that	PRON
iajs-2653	30	8	included	include	VERB
iajs-2653	30	9	cp	cp	PROPN
iajs-2653	30	10	are	be	AUX
iajs-2653	30	11	essential	essential	ADJ
iajs-2653	30	12	in	in	ADP
iajs-2653	30	13	ferroxidation	ferroxidation	NOUN
iajs-2653	30	14	,	,	PUNCT
iajs-2653	30	15	which	which	PRON
iajs-2653	30	16	is	be	AUX
iajs-2653	30	17	therefore	therefore	ADV
iajs-2653	30	18	required	require	VERB
iajs-2653	30	19	for	for	ADP
iajs-2653	30	20	the	the	DET
iajs-2653	30	21	optimal	optimal	ADJ
iajs-2653	30	22	export	export	NOUN
iajs-2653	30	23	of	of	ADP
iajs-2653	30	24	iron	iron	NOUN
iajs-2653	30	25	,	,	PUNCT
iajs-2653	30	26	possibly	possibly	ADV
iajs-2653	30	27	through	through	ADP
iajs-2653	30	28	the	the	DET
iajs-2653	30	29	production	production	NOUN
iajs-2653	30	30	of	of	ADP
iajs-2653	30	31	ion	ion	NOUN
iajs-2653	30	32	gradients	gradient	NOUN
iajs-2653	30	33	[	[	X
iajs-2653	30	34	20	20	NUM
iajs-2653	30	35	]	]	PUNCT
iajs-2653	30	36	.	.	PUNCT
iajs-2653	31	1	the	the	DET
iajs-2653	31	2	present	present	ADJ
iajs-2653	31	3	study	study	NOUN
iajs-2653	31	4	aimed	aim	VERB
iajs-2653	31	5	to	to	PART
iajs-2653	31	6	find	find	VERB
iajs-2653	31	7	the	the	DET
iajs-2653	31	8	relation	relation	NOUN
iajs-2653	31	9	between	between	ADP
iajs-2653	31	10	the	the	DET
iajs-2653	31	11	oxidase	oxidase	NOUN
iajs-2653	31	12	activity	activity	NOUN
iajs-2653	31	13	of	of	ADP
iajs-2653	31	14	cp	cp	NUM
iajs-2653	31	15	and	and	CCONJ
iajs-2653	31	16	the	the	DET
iajs-2653	31	17	specific	specific	ADJ
iajs-2653	31	18	activity	activity	NOUN
iajs-2653	31	19	of	of	ADP
iajs-2653	31	20	this	this	DET
iajs-2653	31	21	enzyme	enzyme	NOUN
iajs-2653	31	22	with	with	ADP
iajs-2653	31	23	breast	breast	NOUN
iajs-2653	31	24	cancer	cancer	NOUN
iajs-2653	31	25	.	.	PUNCT
iajs-2653	32	1	also	also	ADV
iajs-2653	32	2	,	,	PUNCT
iajs-2653	32	3	the	the	DET
iajs-2653	32	4	relation	relation	NOUN
iajs-2653	32	5	between	between	ADP
iajs-2653	32	6	the	the	DET
iajs-2653	32	7	iron	iron	NOUN
iajs-2653	32	8	concentrations	concentration	NOUN
iajs-2653	32	9	which	which	PRON
iajs-2653	32	10	can	can	AUX
iajs-2653	32	11	cause	cause	VERB
iajs-2653	32	12	a	a	DET
iajs-2653	32	13	high	high	ADJ
iajs-2653	32	14	amount	amount	NOUN
iajs-2653	32	15	of	of	ADP
iajs-2653	32	16	free	free	ADJ
iajs-2653	32	17	radicals	radical	NOUN
iajs-2653	32	18	in	in	ADP
iajs-2653	32	19	breast	breast	NOUN
iajs-2653	32	20	cancer	cancer	NOUN
iajs-2653	32	21	and	and	CCONJ
iajs-2653	32	22	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	32	23	activity	activity	NOUN
iajs-2653	32	24	.	.	PUNCT
iajs-2653	33	1	in	in	ADP
iajs-2653	33	2	addition	addition	NOUN
iajs-2653	33	3	,	,	PUNCT
iajs-2653	33	4	the	the	DET
iajs-2653	33	5	ability	ability	NOUN
iajs-2653	33	6	to	to	PART
iajs-2653	33	7	use	use	VERB
iajs-2653	33	8	cp	cp	PROPN
iajs-2653	33	9	as	as	ADP
iajs-2653	33	10	a	a	DET
iajs-2653	33	11	tumor	tumor	NOUN
iajs-2653	33	12	marker	marker	NOUN
iajs-2653	33	13	for	for	ADP
iajs-2653	33	14	the	the	DET
iajs-2653	33	15	early	early	ADJ
iajs-2653	33	16	diagnosis	diagnosis	NOUN
iajs-2653	33	17	of	of	ADP
iajs-2653	33	18	breast	breast	NOUN
iajs-2653	33	19	cancer	cancer	NOUN
iajs-2653	33	20	is	be	AUX
iajs-2653	33	21	possible	possible	ADJ
iajs-2653	33	22	.	.	PUNCT
iajs-2653	34	1	2.materials	2.materials	NUM
iajs-2653	34	2	and	and	CCONJ
iajs-2653	34	3	methods	method	NOUN
iajs-2653	34	4	2.1.patients	2.1.patients	PROPN
iajs-2653	34	5	and	and	CCONJ
iajs-2653	34	6	sample	sample	NOUN
iajs-2653	34	7	age	age	NOUN
iajs-2653	34	8	this	this	DET
iajs-2653	34	9	study	study	NOUN
iajs-2653	34	10	is	be	AUX
iajs-2653	34	11	concerned	concern	VERB
iajs-2653	34	12	with	with	ADP
iajs-2653	34	13	malignant	malignant	ADJ
iajs-2653	34	14	breast	breast	NOUN
iajs-2653	34	15	cancer	cancer	NOUN
iajs-2653	34	16	patients	patient	NOUN
iajs-2653	34	17	from	from	ADP
iajs-2653	34	18	nanakeli	nanakeli	ADJ
iajs-2653	34	19	hospitalerbil	hospitalerbil	PROPN
iajs-2653	34	20	/	/	SYM
iajs-2653	34	21	kurdistan	kurdistan	PROPN
iajs-2653	34	22	region	region	NOUN
iajs-2653	34	23	of	of	ADP
iajs-2653	34	24	iraq	iraq	PROPN
iajs-2653	34	25	from	from	ADP
iajs-2653	34	26	november	november	PROPN
iajs-2653	34	27	2018	2018	NUM
iajs-2653	34	28	to	to	ADP
iajs-2653	34	29	january	january	PROPN
iajs-2653	34	30	2019	2019	NUM
iajs-2653	34	31	.	.	PUNCT
iajs-2653	35	1	the	the	DET
iajs-2653	35	2	diagnosis	diagnosis	NOUN
iajs-2653	35	3	of	of	ADP
iajs-2653	35	4	breast	breast	NOUN
iajs-2653	35	5	cancer	cancer	NOUN
iajs-2653	35	6	was	be	AUX
iajs-2653	35	7	confirmed	confirm	VERB
iajs-2653	35	8	by	by	ADP
iajs-2653	35	9	15	15	NUM
iajs-2653	35	10	-	-	SYM
iajs-2653	35	11	3	3	NUM
iajs-2653	35	12	(	(	PUNCT
iajs-2653	35	13	ca	ca	NOUN
iajs-2653	35	14	15	15	NUM
iajs-2653	35	15	-	-	SYM
iajs-2653	35	16	3	3	NUM
iajs-2653	35	17	)	)	PUNCT
iajs-2653	35	18	cancer	cancer	NOUN
iajs-2653	35	19	antigen	antigen	NOUN
iajs-2653	35	20	which	which	PRON
iajs-2653	35	21	is	be	AUX
iajs-2653	35	22	a	a	DET
iajs-2653	35	23	protein	protein	NOUN
iajs-2653	35	24	formed	form	VERB
iajs-2653	35	25	by	by	ADP
iajs-2653	35	26	normal	normal	ADJ
iajs-2653	35	27	breast	breast	NOUN
iajs-2653	35	28	cells	cell	NOUN
iajs-2653	35	29	;	;	PUNCT
iajs-2653	35	30	which	which	PRON
iajs-2653	35	31	were	be	AUX
iajs-2653	35	32	carried	carry	VERB
iajs-2653	35	33	in	in	ADP
iajs-2653	35	34	the	the	DET
iajs-2653	35	35	laboratories	laboratory	NOUN
iajs-2653	35	36	of	of	ADP
iajs-2653	35	37	the	the	DET
iajs-2653	35	38	hospital	hospital	NOUN
iajs-2653	35	39	mentioned	mention	VERB
iajs-2653	35	40	above	above	ADV
iajs-2653	35	41	.	.	PUNCT
iajs-2653	36	1	eighty	eighty	NUM
iajs-2653	36	2	-	-	PUNCT
iajs-2653	36	3	five	five	NUM
iajs-2653	36	4	(	(	PUNCT
iajs-2653	36	5	85	85	NUM
iajs-2653	36	6	)	)	PUNCT
iajs-2653	36	7	females	female	NOUN
iajs-2653	36	8	were	be	AUX
iajs-2653	36	9	involved	involve	VERB
iajs-2653	36	10	in	in	ADP
iajs-2653	36	11	this	this	DET
iajs-2653	36	12	study	study	NOUN
iajs-2653	36	13	.	.	PUNCT
iajs-2653	37	1	65	65	NUM
iajs-2653	37	2	of	of	ADP
iajs-2653	37	3	the	the	DET
iajs-2653	37	4	human	human	ADJ
iajs-2653	37	5	breast	breast	NOUN
iajs-2653	37	6	cancer	cancer	NOUN
iajs-2653	37	7	patients	patient	NOUN
iajs-2653	37	8	with	with	ADP
iajs-2653	37	9	age	age	NOUN
iajs-2653	37	10	between	between	ADP
iajs-2653	37	11	20	20	NUM
iajs-2653	37	12	-	-	SYM
iajs-2653	37	13	60	60	NUM
iajs-2653	37	14	years	year	NOUN
iajs-2653	37	15	as	as	ADP
iajs-2653	37	16	a	a	DET
iajs-2653	37	17	patient	patient	ADJ
iajs-2653	37	18	group	group	NOUN
iajs-2653	37	19	and	and	CCONJ
iajs-2653	37	20	20	20	NUM
iajs-2653	37	21	subjects	subject	NOUN
iajs-2653	37	22	as	as	ADP
iajs-2653	37	23	a	a	DET
iajs-2653	37	24	control	control	NOUN
iajs-2653	37	25	group	group	NOUN
iajs-2653	37	26	with	with	ADP
iajs-2653	37	27	age	age	NOUN
iajs-2653	37	28	between	between	ADP
iajs-2653	37	29	22	22	NUM
iajs-2653	37	30	-	-	SYM
iajs-2653	37	31	56	56	NUM
iajs-2653	37	32	years	year	NOUN
iajs-2653	37	33	old	old	ADJ
iajs-2653	37	34	,	,	PUNCT
iajs-2653	37	35	the	the	DET
iajs-2653	37	36	distribution	distribution	NOUN
iajs-2653	37	37	of	of	ADP
iajs-2653	37	38	patients	patient	NOUN
iajs-2653	37	39	age	age	NOUN
iajs-2653	37	40	is	be	AUX
iajs-2653	37	41	shown	show	VERB
iajs-2653	37	42	in	in	ADP
iajs-2653	37	43	figure	figure	NOUN
iajs-2653	37	44	(	(	PUNCT
iajs-2653	37	45	1	1	NUM
iajs-2653	37	46	)	)	PUNCT
iajs-2653	37	47	.	.	PUNCT
iajs-2653	38	1	shows	show	VERB
iajs-2653	38	2	that	that	SCONJ
iajs-2653	38	3	there	there	PRON
iajs-2653	38	4	were	be	VERB
iajs-2653	38	5	33	33	NUM
iajs-2653	38	6	%	%	NOUN
iajs-2653	38	7	(	(	PUNCT
iajs-2653	38	8	n=28	n=28	NOUN
iajs-2653	38	9	)	)	PUNCT
iajs-2653	38	10	of	of	ADP
iajs-2653	38	11	patients	patient	NOUN
iajs-2653	38	12	in	in	ADP
iajs-2653	38	13	age	age	NOUN
iajs-2653	38	14	between	between	ADP
iajs-2653	38	15	(	(	PUNCT
iajs-2653	38	16	20	20	NUM
iajs-2653	38	17	-	-	SYM
iajs-2653	38	18	35	35	NUM
iajs-2653	38	19	)	)	PUNCT
iajs-2653	38	20	years	year	NOUN
iajs-2653	38	21	&	&	CCONJ
iajs-2653	38	22	54	54	NUM
iajs-2653	38	23	%	%	NOUN
iajs-2653	38	24	(	(	PUNCT
iajs-2653	38	25	n=46	n=46	NOUN
iajs-2653	38	26	)	)	PUNCT
iajs-2653	38	27	of	of	ADP
iajs-2653	38	28	patients	patient	NOUN
iajs-2653	38	29	in	in	ADP
iajs-2653	38	30	age	age	NOUN
iajs-2653	38	31	between	between	ADP
iajs-2653	38	32	(	(	PUNCT
iajs-2653	38	33	36	36	NUM
iajs-2653	38	34	-	-	SYM
iajs-2653	38	35	55	55	NUM
iajs-2653	38	36	)	)	PUNCT
iajs-2653	38	37	years	year	NOUN
iajs-2653	38	38	and	and	CCONJ
iajs-2653	38	39	13	13	NUM
iajs-2653	38	40	%	%	NOUN
iajs-2653	38	41	(	(	PUNCT
iajs-2653	38	42	n=11	n=11	NOUN
iajs-2653	38	43	)	)	PUNCT
iajs-2653	38	44	of	of	ADP
iajs-2653	38	45	patients	patient	NOUN
iajs-2653	38	46	(	(	PUNCT
iajs-2653	38	47	up	up	ADP
iajs-2653	38	48	to	to	PART
iajs-2653	38	49	56	56	NUM
iajs-2653	38	50	)	)	PUNCT
iajs-2653	38	51	years	year	NOUN
iajs-2653	38	52	.	.	PUNCT
iajs-2653	39	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2653	39	2	special	special	ADJ
iajs-2653	39	3	issue	issue	NOUN
iajs-2653	39	4	1ihicpas	1ihicpas	NUM
iajs-2653	39	5	202	202	NUM
iajs-2653	39	6	ibn	ibn	PROPN
iajs-2653	39	7	al	al	PROPN
iajs-2653	39	8	-	-	PUNCT
iajs-2653	39	9	haitham	haitham	PROPN
iajs-2653	39	10	journal	journal	PROPN
iajs-2653	39	11	for	for	ADP
iajs-2653	39	12	pure	pure	ADJ
iajs-2653	39	13	and	and	CCONJ
iajs-2653	39	14	applied	apply	VERB
iajs-2653	39	15	science	science	NOUN
iajs-2653	39	16	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	39	17	for	for	ADP
iajs-2653	39	18	more	more	ADJ
iajs-2653	39	19	information	information	NOUN
iajs-2653	39	20	about	about	ADP
iajs-2653	39	21	the	the	DET
iajs-2653	39	22	conference	conference	NOUN
iajs-2653	39	23	please	please	INTJ
iajs-2653	39	24	visit	visit	VERB
iajs-2653	39	25	the	the	DET
iajs-2653	39	26	websites	website	NOUN
iajs-2653	39	27	:	:	PUNCT
iajs-2653	39	28	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	39	29	c	c	NOUN
iajs-2653	39	30	h	h	NOUN
iajs-2653	40	1	e	e	NOUN
iajs-2653	40	2	m	m	VERB
iajs-2653	40	3	i	i	NOUN
iajs-2653	40	4	s	s	VERB
iajs-2653	41	1	t	t	PROPN
iajs-2653	41	2	r	r	NOUN
iajs-2653	41	3	y	y	PROPN
iajs-2653	41	4	|	|	ADV
iajs-2653	41	5	70	70	NUM
iajs-2653	41	6	figure	figure	NOUN
iajs-2653	41	7	1	1	NUM
iajs-2653	41	8	.	.	PUNCT
iajs-2653	41	9	distribution	distribution	NOUN
iajs-2653	41	10	of	of	ADP
iajs-2653	41	11	patients	patient	NOUN
iajs-2653	41	12	’	'	PUNCT
iajs-2653	41	13	age	age	NOUN
iajs-2653	41	14	including	include	VERB
iajs-2653	41	15	in	in	ADP
iajs-2653	41	16	this	this	DET
iajs-2653	41	17	study	study	NOUN
iajs-2653	41	18	2.2	2.2	NUM
iajs-2653	41	19	.	.	PUNCT
iajs-2653	42	1	sample	sample	NOUN
iajs-2653	42	2	collection	collection	NOUN
iajs-2653	42	3	blood	blood	NOUN
iajs-2653	42	4	samples	sample	NOUN
iajs-2653	42	5	were	be	AUX
iajs-2653	42	6	collected	collect	VERB
iajs-2653	42	7	by	by	ADP
iajs-2653	42	8	taken	take	VERB
iajs-2653	42	9	3	3	NUM
iajs-2653	42	10	milliliters	milliliter	NOUN
iajs-2653	42	11	of	of	ADP
iajs-2653	42	12	venous	venous	ADJ
iajs-2653	42	13	blood	blood	NOUN
iajs-2653	42	14	from	from	ADP
iajs-2653	42	15	patients	patient	NOUN
iajs-2653	42	16	was	be	AUX
iajs-2653	42	17	put	put	VERB
iajs-2653	42	18	in	in	ADP
iajs-2653	42	19	a	a	DET
iajs-2653	42	20	gel	gel	NOUN
iajs-2653	42	21	tube	tube	NOUN
iajs-2653	42	22	and	and	CCONJ
iajs-2653	42	23	left	leave	VERB
iajs-2653	42	24	to	to	ADP
iajs-2653	42	25	clot	clot	NOUN
iajs-2653	42	26	then	then	ADV
iajs-2653	42	27	the	the	DET
iajs-2653	42	28	serum	serum	NOUN
iajs-2653	42	29	was	be	AUX
iajs-2653	42	30	separated	separate	VERB
iajs-2653	42	31	immediately	immediately	ADV
iajs-2653	42	32	from	from	ADP
iajs-2653	42	33	the	the	DET
iajs-2653	42	34	cells	cell	NOUN
iajs-2653	42	35	by	by	ADP
iajs-2653	42	36	centrifugation	centrifugation	NOUN
iajs-2653	42	37	at	at	ADP
iajs-2653	42	38	3000	3000	NUM
iajs-2653	42	39	rpm	rpm	NOUN
iajs-2653	42	40	for	for	ADP
iajs-2653	42	41	10	10	NUM
iajs-2653	42	42	minutes	minute	NOUN
iajs-2653	42	43	,	,	PUNCT
iajs-2653	42	44	stored	store	VERB
iajs-2653	42	45	until	until	ADP
iajs-2653	42	46	used	use	VERB
iajs-2653	42	47	.	.	PUNCT
iajs-2653	43	1	the	the	DET
iajs-2653	43	2	sera	sera	NOUN
iajs-2653	43	3	which	which	PRON
iajs-2653	43	4	were	be	AUX
iajs-2653	43	5	obtained	obtain	VERB
iajs-2653	43	6	from	from	ADP
iajs-2653	43	7	blood	blood	NOUN
iajs-2653	43	8	sample	sample	NOUN
iajs-2653	43	9	should	should	AUX
iajs-2653	43	10	be	be	AUX
iajs-2653	43	11	un	un	PROPN
iajs-2653	43	12	hemolyzed	hemolyze	VERB
iajs-2653	43	13	and	and	CCONJ
iajs-2653	43	14	non	non	ADJ
iajs-2653	43	15	-	-	NOUN
iajs-2653	43	16	jaundice	jaundice	NOUN
iajs-2653	43	17	to	to	PART
iajs-2653	43	18	avoid	avoid	VERB
iajs-2653	43	19	any	any	DET
iajs-2653	43	20	interference	interference	NOUN
iajs-2653	43	21	with	with	ADP
iajs-2653	43	22	the	the	DET
iajs-2653	43	23	obtained	obtain	VERB
iajs-2653	43	24	results	result	NOUN
iajs-2653	43	25	.	.	PUNCT
iajs-2653	44	1	any	any	DET
iajs-2653	44	2	case	case	NOUN
iajs-2653	44	3	with	with	ADP
iajs-2653	44	4	chronic	chronic	ADJ
iajs-2653	44	5	diseases	disease	NOUN
iajs-2653	44	6	or	or	CCONJ
iajs-2653	44	7	chemotherapy	chemotherapy	NOUN
iajs-2653	44	8	treatment	treatment	NOUN
iajs-2653	44	9	were	be	AUX
iajs-2653	44	10	excluded	exclude	VERB
iajs-2653	44	11	.	.	PUNCT
iajs-2653	45	1	2.3.methods	2.3.methods	NUM
iajs-2653	45	2	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	45	3	oxidase	oxidase	NOUN
iajs-2653	45	4	activity	activity	NOUN
iajs-2653	45	5	was	be	AUX
iajs-2653	45	6	performed	perform	VERB
iajs-2653	45	7	by	by	ADP
iajs-2653	45	8	using	use	VERB
iajs-2653	45	9	the	the	DET
iajs-2653	45	10	modified	modify	VERB
iajs-2653	45	11	rice	rice	NOUN
iajs-2653	45	12	method	method	NOUN
iajs-2653	45	13	and	and	CCONJ
iajs-2653	45	14	pphenylene	pphenylene	ADJ
iajs-2653	45	15	diamine	diamine	NOUN
iajs-2653	45	16	-2hcl	-2hcl	PROPN
iajs-2653	45	17	as	as	ADP
iajs-2653	45	18	a	a	DET
iajs-2653	45	19	substrate	substrate	NOUN
iajs-2653	45	20	[	[	X
iajs-2653	45	21	21	21	NUM
iajs-2653	45	22	]	]	PUNCT
iajs-2653	45	23	.	.	PUNCT
iajs-2653	46	1	colorimetric	colorimetric	ADJ
iajs-2653	46	2	method	method	NOUN
iajs-2653	46	3	described	describe	VERB
iajs-2653	46	4	by	by	ADP
iajs-2653	46	5	gornall	gornall	NOUN
iajs-2653	46	6	and	and	CCONJ
iajs-2653	46	7	et	et	NOUN
iajs-2653	46	8	al.[22.23	al.[22.23	ADV
iajs-2653	46	9	]	]	PUNCT
iajs-2653	46	10	was	be	AUX
iajs-2653	46	11	used	use	VERB
iajs-2653	46	12	to	to	PART
iajs-2653	46	13	determine	determine	VERB
iajs-2653	46	14	the	the	DET
iajs-2653	46	15	concentration	concentration	NOUN
iajs-2653	46	16	of	of	ADP
iajs-2653	46	17	total	total	ADJ
iajs-2653	46	18	protein	protein	NOUN
iajs-2653	46	19	in	in	ADP
iajs-2653	46	20	the	the	DET
iajs-2653	46	21	specimen	speciman	NOUN
iajs-2653	46	22	.	.	PUNCT
iajs-2653	47	1	the	the	DET
iajs-2653	47	2	specific	specific	ADJ
iajs-2653	47	3	enzyme	enzyme	NOUN
iajs-2653	47	4	activity	activity	NOUN
iajs-2653	47	5	is	be	AUX
iajs-2653	47	6	described	describe	VERB
iajs-2653	47	7	as	as	ADP
iajs-2653	47	8	follow	follow	VERB
iajs-2653	47	9	:	:	PUNCT
iajs-2653	47	10	specific	specific	ADJ
iajs-2653	47	11	activity	activity	NOUN
iajs-2653	47	12	(	(	PUNCT
iajs-2653	47	13	unit	unit	NOUN
iajs-2653	47	14	/	/	SYM
iajs-2653	47	15	g	g	NOUN
iajs-2653	47	16	)	)	PUNCT
iajs-2653	48	1	=	=	NOUN
iajs-2653	48	2	activity	activity	NOUN
iajs-2653	48	3	of	of	ADP
iajs-2653	48	4	enzyme	enzyme	NOUN
iajs-2653	48	5	(	(	PUNCT
iajs-2653	48	6	u	u	NOUN
iajs-2653	48	7	/	/	SYM
iajs-2653	48	8	l	l	NOUN
iajs-2653	48	9	)	)	PUNCT
iajs-2653	48	10	/	/	SYM
iajs-2653	48	11	protein	protein	NOUN
iajs-2653	48	12	concentration	concentration	NOUN
iajs-2653	48	13	(	(	PUNCT
iajs-2653	48	14	g	g	NOUN
iajs-2653	48	15	/	/	SYM
iajs-2653	48	16	l	l	NOUN
iajs-2653	48	17	)	)	PUNCT
iajs-2653	48	18	the	the	DET
iajs-2653	48	19	colorimetric	colorimetric	ADJ
iajs-2653	48	20	method	method	NOUN
iajs-2653	48	21	was	be	AUX
iajs-2653	48	22	used	use	VERB
iajs-2653	48	23	to	to	PART
iajs-2653	48	24	estimate	estimate	VERB
iajs-2653	48	25	the	the	DET
iajs-2653	48	26	total	total	ADJ
iajs-2653	48	27	iron	iron	NOUN
iajs-2653	48	28	concentration	concentration	NOUN
iajs-2653	48	29	in	in	ADP
iajs-2653	48	30	sera	sera	NOUN
iajs-2653	48	31	which	which	PRON
iajs-2653	48	32	depend	depend	VERB
iajs-2653	48	33	on	on	ADP
iajs-2653	48	34	the	the	DET
iajs-2653	48	35	dissociation	dissociation	NOUN
iajs-2653	48	36	of	of	ADP
iajs-2653	48	37	iron	iron	NOUN
iajs-2653	48	38	-	-	PUNCT
iajs-2653	48	39	transferrin	transferrin	NOUN
iajs-2653	48	40	bound	bind	VERB
iajs-2653	48	41	in	in	ADP
iajs-2653	48	42	an	an	DET
iajs-2653	48	43	acidic	acidic	ADJ
iajs-2653	48	44	medium	medium	NOUN
iajs-2653	48	45	,	,	PUNCT
iajs-2653	48	46	ascorbic	ascorbic	NOUN
iajs-2653	48	47	acid	acid	NOUN
iajs-2653	48	48	reduces	reduce	VERB
iajs-2653	48	49	ferric	ferric	NOUN
iajs-2653	48	50	to	to	ADP
iajs-2653	48	51	ferrous	ferrous	ADJ
iajs-2653	48	52	and	and	CCONJ
iajs-2653	48	53	then	then	ADV
iajs-2653	48	54	to	to	ADP
iajs-2653	48	55	a	a	DET
iajs-2653	48	56	colored	colored	ADJ
iajs-2653	48	57	complex	complex	NOUN
iajs-2653	48	58	of	of	ADP
iajs-2653	48	59	3-(2pyridyl)-5,-6difuryl-1,-2,-4triazine	3-(2pyridyl)-5,-6difuryl-1,-2,-4triazine	ADJ
iajs-2653	48	60	-	-	NOUN
iajs-2653	48	61	disulfonate	disulfonate	NOUN
iajs-2653	48	62	(	(	PUNCT
iajs-2653	48	63	ferene	ferene	NOUN
iajs-2653	48	64	)	)	PUNCT
iajs-2653	49	1	[	[	X
iajs-2653	49	2	24	24	NUM
iajs-2653	49	3	]	]	PUNCT
iajs-2653	49	4	.	.	PUNCT
iajs-2653	50	1	2.4.statistical	2.4.statistical	NUM
iajs-2653	50	2	analysis	analysis	NOUN
iajs-2653	50	3	statistical	statistical	ADJ
iajs-2653	50	4	analysis	analysis	NOUN
iajs-2653	50	5	for	for	ADP
iajs-2653	50	6	this	this	DET
iajs-2653	50	7	study	study	NOUN
iajs-2653	50	8	was	be	AUX
iajs-2653	50	9	done	do	VERB
iajs-2653	50	10	using	use	VERB
iajs-2653	50	11	the	the	DET
iajs-2653	50	12	graph	graph	NOUN
iajs-2653	50	13	pad	pad	NOUN
iajs-2653	50	14	prism	prism	NOUN
iajs-2653	50	15	7.1	7.1	NUM
iajs-2653	50	16	software	software	NOUN
iajs-2653	50	17	.	.	PUNCT
iajs-2653	51	1	the	the	DET
iajs-2653	51	2	unpaired	unpaired	ADJ
iajs-2653	51	3	t	t	NOUN
iajs-2653	51	4	-	-	PUNCT
iajs-2653	51	5	test	test	NOUN
iajs-2653	51	6	descriptive	descriptive	ADJ
iajs-2653	51	7	statistics	statistic	NOUN
iajs-2653	51	8	was	be	AUX
iajs-2653	51	9	used	use	VERB
iajs-2653	51	10	which	which	PRON
iajs-2653	51	11	is	be	AUX
iajs-2653	51	12	important	important	ADJ
iajs-2653	51	13	to	to	PART
iajs-2653	51	14	test	test	VERB
iajs-2653	51	15	for	for	ADP
iajs-2653	51	16	a	a	DET
iajs-2653	51	17	statistical	statistical	ADJ
iajs-2653	51	18	significance	significance	NOUN
iajs-2653	51	19	of	of	ADP
iajs-2653	51	20	the	the	DET
iajs-2653	51	21	difference	difference	NOUN
iajs-2653	51	22	in	in	ADP
iajs-2653	51	23	original	original	ADJ
iajs-2653	51	24	data	datum	NOUN
iajs-2653	51	25	.	.	PUNCT
iajs-2653	52	1	3.results	3.results	NUM
iajs-2653	52	2	and	and	CCONJ
iajs-2653	52	3	discussion	discussion	NOUN
iajs-2653	52	4	3.1.total	3.1.total	NUM
iajs-2653	52	5	protein	protein	NOUN
iajs-2653	52	6	concentration	concentration	NOUN
iajs-2653	52	7	and	and	CCONJ
iajs-2653	52	8	total	total	ADJ
iajs-2653	52	9	iron	iron	NOUN
iajs-2653	52	10	concentration	concentration	NOUN
iajs-2653	52	11	the	the	DET
iajs-2653	52	12	level	level	NOUN
iajs-2653	52	13	of	of	ADP
iajs-2653	52	14	serum	serum	NOUN
iajs-2653	52	15	total	total	ADJ
iajs-2653	52	16	protein	protein	NOUN
iajs-2653	52	17	concentration	concentration	NOUN
iajs-2653	52	18	was	be	AUX
iajs-2653	52	19	measured	measure	VERB
iajs-2653	52	20	in	in	ADP
iajs-2653	52	21	all	all	DET
iajs-2653	52	22	study	study	NOUN
iajs-2653	52	23	groups	group	NOUN
iajs-2653	52	24	sera	sera	VERB
iajs-2653	52	25	.	.	PUNCT
iajs-2653	53	1	the	the	DET
iajs-2653	53	2	results	result	NOUN
iajs-2653	53	3	of	of	ADP
iajs-2653	53	4	statistical	statistical	ADJ
iajs-2653	53	5	analysis	analysis	NOUN
iajs-2653	53	6	showed	show	VERB
iajs-2653	53	7	no	no	DET
iajs-2653	53	8	significant	significant	ADJ
iajs-2653	53	9	difference	difference	NOUN
iajs-2653	53	10	(	(	PUNCT
iajs-2653	53	11	p	p	NOUN
iajs-2653	53	12	0.0108	0.0108	NUM
iajs-2653	53	13	)	)	PUNCT
iajs-2653	53	14	between	between	ADP
iajs-2653	53	15	the	the	DET
iajs-2653	53	16	mean	mean	ADJ
iajs-2653	53	17	total	total	ADJ
iajs-2653	53	18	protein	protein	NOUN
iajs-2653	53	19	concentration	concentration	NOUN
iajs-2653	53	20	of	of	ADP
iajs-2653	53	21	the	the	DET
iajs-2653	53	22	breast	breast	NOUN
iajs-2653	53	23	cancer	cancer	NOUN
iajs-2653	53	24	patients	patient	NOUN
iajs-2653	53	25	(	(	PUNCT
iajs-2653	53	26	6.596	6.596	NUM
iajs-2653	53	27	g	g	NOUN
iajs-2653	53	28	/	/	SYM
iajs-2653	53	29	dl	dl	PROPN
iajs-2653	53	30	)	)	PUNCT
iajs-2653	53	31	and	and	CCONJ
iajs-2653	53	32	the	the	DET
iajs-2653	53	33	mean	mean	ADJ
iajs-2653	53	34	total	total	ADJ
iajs-2653	53	35	protein	protein	NOUN
iajs-2653	53	36	concentration	concentration	NOUN
iajs-2653	53	37	of	of	ADP
iajs-2653	53	38	the	the	DET
iajs-2653	53	39	control	control	NOUN
iajs-2653	53	40	group	group	NOUN
iajs-2653	53	41	(	(	PUNCT
iajs-2653	53	42	7.127	7.127	NUM
iajs-2653	53	43	g	g	NOUN
iajs-2653	53	44	/	/	SYM
iajs-2653	53	45	dl	dl	PROPN
iajs-2653	53	46	)	)	PUNCT
iajs-2653	53	47	,	,	PUNCT
iajs-2653	53	48	as	as	SCONJ
iajs-2653	53	49	shown	show	VERB
iajs-2653	53	50	in	in	ADP
iajs-2653	53	51	table	table	NOUN
iajs-2653	53	52	(	(	PUNCT
iajs-2653	53	53	1	1	NUM
iajs-2653	53	54	)	)	PUNCT
iajs-2653	53	55	.	.	PUNCT
iajs-2653	54	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2653	54	2	special	special	ADJ
iajs-2653	54	3	issue	issue	NOUN
iajs-2653	54	4	1ihicpas	1ihicpas	NUM
iajs-2653	54	5	202	202	NUM
iajs-2653	54	6	ibn	ibn	PROPN
iajs-2653	54	7	al	al	PROPN
iajs-2653	54	8	-	-	PUNCT
iajs-2653	54	9	haitham	haitham	PROPN
iajs-2653	54	10	journal	journal	PROPN
iajs-2653	54	11	for	for	ADP
iajs-2653	54	12	pure	pure	ADJ
iajs-2653	54	13	and	and	CCONJ
iajs-2653	54	14	applied	apply	VERB
iajs-2653	54	15	science	science	NOUN
iajs-2653	54	16	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	54	17	for	for	ADP
iajs-2653	54	18	more	more	ADJ
iajs-2653	54	19	information	information	NOUN
iajs-2653	54	20	about	about	ADP
iajs-2653	54	21	the	the	DET
iajs-2653	54	22	conference	conference	NOUN
iajs-2653	54	23	please	please	INTJ
iajs-2653	54	24	visit	visit	VERB
iajs-2653	54	25	the	the	DET
iajs-2653	54	26	websites	website	NOUN
iajs-2653	54	27	:	:	PUNCT
iajs-2653	54	28	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	54	29	c	c	NOUN
iajs-2653	54	30	h	h	NOUN
iajs-2653	55	1	e	e	NOUN
iajs-2653	55	2	m	m	VERB
iajs-2653	55	3	i	i	NOUN
iajs-2653	55	4	s	s	VERB
iajs-2653	55	5	t	t	PROPN
iajs-2653	55	6	r	r	NOUN
iajs-2653	55	7	y	y	PROPN
iajs-2653	56	1	|	|	ADV
iajs-2653	56	2	71	71	NUM
iajs-2653	56	3	the	the	DET
iajs-2653	56	4	level	level	NOUN
iajs-2653	56	5	of	of	ADP
iajs-2653	56	6	serum	serum	NOUN
iajs-2653	56	7	total	total	ADJ
iajs-2653	56	8	iron	iron	NOUN
iajs-2653	56	9	concentration	concentration	NOUN
iajs-2653	56	10	was	be	AUX
iajs-2653	56	11	measured	measure	VERB
iajs-2653	56	12	in	in	ADP
iajs-2653	56	13	all	all	DET
iajs-2653	56	14	study	study	NOUN
iajs-2653	56	15	groups	group	NOUN
iajs-2653	56	16	.	.	PUNCT
iajs-2653	57	1	according	accord	VERB
iajs-2653	57	2	to	to	ADP
iajs-2653	57	3	statistical	statistical	ADJ
iajs-2653	57	4	analysis	analysis	NOUN
iajs-2653	57	5	,	,	PUNCT
iajs-2653	57	6	the	the	DET
iajs-2653	57	7	results	result	NOUN
iajs-2653	57	8	show	show	VERB
iajs-2653	57	9	a	a	DET
iajs-2653	57	10	significant	significant	ADJ
iajs-2653	57	11	increase	increase	NOUN
iajs-2653	57	12	(	(	PUNCT
iajs-2653	57	13	p˂0.0001	p˂0.0001	NOUN
iajs-2653	57	14	)	)	PUNCT
iajs-2653	57	15	in	in	ADP
iajs-2653	57	16	the	the	DET
iajs-2653	57	17	patient	patient	NOUN
iajs-2653	57	18	group	group	NOUN
iajs-2653	57	19	compared	compare	VERB
iajs-2653	57	20	with	with	ADP
iajs-2653	57	21	the	the	DET
iajs-2653	57	22	control	control	NOUN
iajs-2653	57	23	group	group	NOUN
iajs-2653	57	24	as	as	SCONJ
iajs-2653	57	25	shown	show	VERB
iajs-2653	57	26	in	in	ADP
iajs-2653	57	27	table	table	NOUN
iajs-2653	57	28	(	(	PUNCT
iajs-2653	57	29	1	1	NUM
iajs-2653	57	30	)	)	PUNCT
iajs-2653	57	31	.	.	PUNCT
iajs-2653	58	1	table	table	NOUN
iajs-2653	58	2	1	1	NUM
iajs-2653	58	3	.	.	PUNCT
iajs-2653	59	1	the	the	DET
iajs-2653	59	2	concentration	concentration	NOUN
iajs-2653	59	3	of	of	ADP
iajs-2653	59	4	serum	serum	NOUN
iajs-2653	59	5	total	total	ADJ
iajs-2653	59	6	protein	protein	NOUN
iajs-2653	59	7	and	and	CCONJ
iajs-2653	59	8	serum	serum	VERB
iajs-2653	59	9	total	total	ADJ
iajs-2653	59	10	iron	iron	NOUN
iajs-2653	59	11	in	in	ADP
iajs-2653	59	12	control	control	NOUN
iajs-2653	59	13	and	and	CCONJ
iajs-2653	59	14	patient	patient	ADJ
iajs-2653	59	15	group	group	NOUN
iajs-2653	59	16	.	.	PUNCT
iajs-2653	60	1	parameters	parameter	NOUN
iajs-2653	60	2	mean±sd	mean±sd	ADP
iajs-2653	60	3	of	of	ADP
iajs-2653	60	4	control	control	PROPN
iajs-2653	60	5	group	group	PROPN
iajs-2653	60	6	mean(g	mean(g	PROPN
iajs-2653	60	7	/	/	SYM
iajs-2653	60	8	dl	dl	NOUN
iajs-2653	60	9	)	)	PUNCT
iajs-2653	60	10	±sd	±sd	PROPN
iajs-2653	60	11	of	of	ADP
iajs-2653	60	12	patient	patient	ADJ
iajs-2653	60	13	group	group	NOUN
iajs-2653	60	14	p	p	NOUN
iajs-2653	60	15	value	value	NOUN
iajs-2653	60	16	total	total	ADJ
iajs-2653	60	17	protein	protein	NOUN
iajs-2653	60	18	(	(	PUNCT
iajs-2653	60	19	g	g	PROPN
iajs-2653	60	20	/	/	SYM
iajs-2653	60	21	dl	dl	NOUN
iajs-2653	60	22	)	)	PUNCT
iajs-2653	60	23	7.127	7.127	NUM
iajs-2653	60	24	±	±	NUM
iajs-2653	60	25	0.3527	0.3527	NUM
iajs-2653	60	26	(	(	PUNCT
iajs-2653	60	27	n=20	n=20	PROPN
iajs-2653	60	28	)	)	PUNCT
iajs-2653	60	29	6.592	6.592	NUM
iajs-2653	60	30	±	±	NUM
iajs-2653	60	31	0.8926	0.8926	NUM
iajs-2653	60	32	(	(	PUNCT
iajs-2653	60	33	n=65	n=65	NOUN
iajs-2653	60	34	)	)	PUNCT
iajs-2653	60	35	0.0108	0.0108	NUM
iajs-2653	60	36	serum	serum	NOUN
iajs-2653	60	37	total	total	ADJ
iajs-2653	60	38	iron	iron	NOUN
iajs-2653	60	39	(	(	PUNCT
iajs-2653	60	40	µg	µg	NOUN
iajs-2653	60	41	/	/	SYM
iajs-2653	60	42	dl	dl	NOUN
iajs-2653	60	43	)	)	PUNCT
iajs-2653	60	44	128.6	128.6	NUM
iajs-2653	60	45	±	±	NUM
iajs-2653	60	46	46.02(n=20	46.02(n=20	NOUN
iajs-2653	60	47	)	)	PUNCT
iajs-2653	60	48	338.2	338.2	NUM
iajs-2653	60	49	±	±	NUM
iajs-2653	60	50	137.7	137.7	NUM
iajs-2653	60	51	(	(	PUNCT
iajs-2653	60	52	n=65	n=65	NUM
iajs-2653	60	53	)	)	PUNCT
iajs-2653	60	54	(	(	PUNCT
iajs-2653	60	55	p˂0.0001	p˂0.0001	NOUN
iajs-2653	60	56	)	)	PUNCT
iajs-2653	60	57	3.2	3.2	NUM
iajs-2653	60	58	.	.	PUNCT
iajs-2653	60	59	oxidase	oxidase	NOUN
iajs-2653	60	60	activity	activity	NOUN
iajs-2653	60	61	and	and	CCONJ
iajs-2653	60	62	specific	specific	ADJ
iajs-2653	60	63	activity	activity	NOUN
iajs-2653	60	64	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	60	65	the	the	DET
iajs-2653	60	66	level	level	NOUN
iajs-2653	60	67	of	of	ADP
iajs-2653	60	68	serum	serum	NOUN
iajs-2653	60	69	cp	cp	PROPN
iajs-2653	60	70	activity	activity	NOUN
iajs-2653	60	71	was	be	AUX
iajs-2653	60	72	measured	measure	VERB
iajs-2653	60	73	in	in	ADP
iajs-2653	60	74	sera	sera	NOUN
iajs-2653	60	75	of	of	ADP
iajs-2653	60	76	all	all	DET
iajs-2653	60	77	study	study	NOUN
iajs-2653	60	78	groups	group	NOUN
iajs-2653	60	79	,	,	PUNCT
iajs-2653	60	80	and	and	CCONJ
iajs-2653	60	81	the	the	DET
iajs-2653	60	82	statistical	statistical	ADJ
iajs-2653	60	83	analysis	analysis	NOUN
iajs-2653	60	84	of	of	ADP
iajs-2653	60	85	the	the	DET
iajs-2653	60	86	findings	finding	NOUN
iajs-2653	60	87	showed	show	VERB
iajs-2653	60	88	a	a	DET
iajs-2653	60	89	significant	significant	ADJ
iajs-2653	60	90	difference	difference	NOUN
iajs-2653	60	91	between	between	ADP
iajs-2653	60	92	the	the	DET
iajs-2653	60	93	mean	mean	ADJ
iajs-2653	60	94	concentration	concentration	NOUN
iajs-2653	60	95	of	of	ADP
iajs-2653	60	96	cp	cp	NUM
iajs-2653	60	97	in	in	ADP
iajs-2653	60	98	patients	patient	NOUN
iajs-2653	60	99	with	with	ADP
iajs-2653	60	100	breast	breast	NOUN
iajs-2653	60	101	cancer	cancer	NOUN
iajs-2653	60	102	(	(	PUNCT
iajs-2653	60	103	227.8	227.8	NUM
iajs-2653	60	104	u	u	NOUN
iajs-2653	60	105	/	/	SYM
iajs-2653	60	106	l	l	NOUN
iajs-2653	60	107	)	)	PUNCT
iajs-2653	60	108	and	and	CCONJ
iajs-2653	60	109	the	the	DET
iajs-2653	60	110	mean	mean	ADJ
iajs-2653	60	111	activity	activity	NOUN
iajs-2653	60	112	of	of	ADP
iajs-2653	60	113	cp	cp	NUM
iajs-2653	60	114	in	in	ADP
iajs-2653	60	115	the	the	DET
iajs-2653	60	116	control	control	NOUN
iajs-2653	60	117	group	group	NOUN
iajs-2653	60	118	(	(	PUNCT
iajs-2653	60	119	101.1	101.1	NUM
iajs-2653	60	120	u	u	NOUN
iajs-2653	60	121	/	/	SYM
iajs-2653	60	122	l	l	NOUN
iajs-2653	60	123	)	)	PUNCT
iajs-2653	60	124	as	as	SCONJ
iajs-2653	60	125	shown	show	VERB
iajs-2653	60	126	in	in	ADP
iajs-2653	60	127	table	table	NOUN
iajs-2653	60	128	(	(	PUNCT
iajs-2653	60	129	2	2	NUM
iajs-2653	60	130	)	)	PUNCT
iajs-2653	60	131	.	.	PUNCT
iajs-2653	61	1	cp	cp	PRON
iajs-2653	61	2	specific	specific	ADJ
iajs-2653	61	3	activity	activity	NOUN
iajs-2653	61	4	was	be	AUX
iajs-2653	61	5	calculated	calculate	VERB
iajs-2653	61	6	in	in	ADP
iajs-2653	61	7	all	all	DET
iajs-2653	61	8	study	study	NOUN
iajs-2653	61	9	groups	group	NOUN
iajs-2653	61	10	.	.	PUNCT
iajs-2653	62	1	the	the	DET
iajs-2653	62	2	results	result	NOUN
iajs-2653	62	3	appeared	appear	VERB
iajs-2653	62	4	a	a	DET
iajs-2653	62	5	significant	significant	ADJ
iajs-2653	62	6	increase	increase	NOUN
iajs-2653	62	7	in	in	ADP
iajs-2653	62	8	enzyme	enzyme	NOUN
iajs-2653	62	9	-	-	PUNCT
iajs-2653	62	10	specific	specific	ADJ
iajs-2653	62	11	activity	activity	NOUN
iajs-2653	62	12	for	for	ADP
iajs-2653	62	13	the	the	DET
iajs-2653	62	14	patient	patient	NOUN
iajs-2653	62	15	group	group	NOUN
iajs-2653	62	16	compared	compare	VERB
iajs-2653	62	17	with	with	ADP
iajs-2653	62	18	the	the	DET
iajs-2653	62	19	control	control	NOUN
iajs-2653	62	20	group	group	NOUN
iajs-2653	62	21	as	as	SCONJ
iajs-2653	62	22	shown	show	VERB
iajs-2653	62	23	in	in	ADP
iajs-2653	62	24	table	table	NOUN
iajs-2653	62	25	(	(	PUNCT
iajs-2653	62	26	2	2	NUM
iajs-2653	62	27	)	)	PUNCT
iajs-2653	62	28	.	.	PUNCT
iajs-2653	63	1	table	table	NOUN
iajs-2653	63	2	2	2	NUM
iajs-2653	63	3	:	:	PUNCT
iajs-2653	63	4	oxidase	oxidase	NOUN
iajs-2653	63	5	activity	activity	NOUN
iajs-2653	63	6	and	and	CCONJ
iajs-2653	63	7	specific	specific	ADJ
iajs-2653	63	8	activity	activity	NOUN
iajs-2653	63	9	of	of	ADP
iajs-2653	63	10	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	63	11	in	in	ADP
iajs-2653	63	12	patient	patient	NOUN
iajs-2653	63	13	and	and	CCONJ
iajs-2653	63	14	control	control	NOUN
iajs-2653	63	15	group	group	NOUN
iajs-2653	63	16	parameters	parameter	NOUN
iajs-2653	63	17	mean±sd	mean±sd	ADP
iajs-2653	63	18	of	of	ADP
iajs-2653	63	19	control	control	PROPN
iajs-2653	63	20	group	group	PROPN
iajs-2653	63	21	mean±sd	mean±sd	ADP
iajs-2653	63	22	of	of	ADP
iajs-2653	63	23	patient	patient	ADJ
iajs-2653	63	24	group	group	NOUN
iajs-2653	63	25	p	p	NOUN
iajs-2653	63	26	-	-	PUNCT
iajs-2653	63	27	value	value	NOUN
iajs-2653	63	28	cp	cp	NOUN
iajs-2653	63	29	oxidase	oxidase	NOUN
iajs-2653	63	30	activity	activity	NOUN
iajs-2653	63	31	(	(	PUNCT
iajs-2653	63	32	u	u	NOUN
iajs-2653	63	33	/	/	SYM
iajs-2653	63	34	l	l	NOUN
iajs-2653	63	35	)	)	PUNCT
iajs-2653	63	36	101.1	101.1	NUM
iajs-2653	63	37	±	±	NUM
iajs-2653	63	38	27.08	27.08	NUM
iajs-2653	63	39	227.8	227.8	NUM
iajs-2653	63	40	±	±	NUM
iajs-2653	63	41	54.99	54.99	NUM
iajs-2653	63	42	<	<	NOUN
iajs-2653	63	43	0.0001	0.0001	NUM
iajs-2653	63	44	specific	specific	ADJ
iajs-2653	63	45	activity	activity	NOUN
iajs-2653	63	46	of	of	ADP
iajs-2653	63	47	cp	cp	PROPN
iajs-2653	63	48	(	(	PUNCT
iajs-2653	63	49	u	u	NOUN
iajs-2653	63	50	/	/	SYM
iajs-2653	63	51	mg	mg	PROPN
iajs-2653	63	52	)	)	PUNCT
iajs-2653	63	53	14.14	14.14	NUM
iajs-2653	63	54	±	±	NUM
iajs-2653	63	55	3.665	3.665	NUM
iajs-2653	63	56	n=20	n=20	PROPN
iajs-2653	63	57	34.74	34.74	NUM
iajs-2653	63	58	±	±	NUM
iajs-2653	63	59	9.525	9.525	NUM
iajs-2653	63	60	n=65	n=65	NOUN
iajs-2653	63	61	<	<	X
iajs-2653	63	62	0.0001	0.0001	NUM
iajs-2653	63	63	3.3.the	3.3.the	DET
iajs-2653	63	64	relation	relation	NOUN
iajs-2653	63	65	between	between	ADP
iajs-2653	63	66	smoking	smoking	NOUN
iajs-2653	63	67	and	and	CCONJ
iajs-2653	63	68	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	63	69	oxidase	oxidase	NOUN
iajs-2653	63	70	activity	activity	NOUN
iajs-2653	63	71	.	.	PUNCT
iajs-2653	64	1	figure	figure	NOUN
iajs-2653	64	2	(	(	PUNCT
iajs-2653	64	3	2	2	NUM
iajs-2653	64	4	)	)	PUNCT
iajs-2653	64	5	was	be	AUX
iajs-2653	64	6	shown	show	VERB
iajs-2653	64	7	a	a	DET
iajs-2653	64	8	slight	slight	ADJ
iajs-2653	64	9	significant	significant	ADJ
iajs-2653	64	10	increase	increase	NOUN
iajs-2653	64	11	(	(	PUNCT
iajs-2653	64	12	<	<	NOUN
iajs-2653	64	13	0.05	0.05	NUM
iajs-2653	64	14	)	)	PUNCT
iajs-2653	64	15	between	between	ADP
iajs-2653	64	16	smokers	smoker	NOUN
iajs-2653	64	17	(	(	PUNCT
iajs-2653	64	18	mean	mean	X
iajs-2653	64	19	(	(	PUNCT
iajs-2653	64	20	u	u	NOUN
iajs-2653	64	21	/	/	SYM
iajs-2653	64	22	l	l	NOUN
iajs-2653	64	23	)	)	PUNCT
iajs-2653	64	24	218.7	218.7	NUM
iajs-2653	64	25	±sd	±sd	DET
iajs-2653	64	26	56	56	NUM
iajs-2653	64	27	.	.	NOUN
iajs-2653	64	28	64	64	NUM
iajs-2653	64	29	)	)	PUNCT
iajs-2653	64	30	and	and	CCONJ
iajs-2653	64	31	nonsmoker	nonsmoker	NOUN
iajs-2653	64	32	(	(	PUNCT
iajs-2653	64	33	mean	mean	VERB
iajs-2653	64	34	(	(	PUNCT
iajs-2653	64	35	u	u	NOUN
iajs-2653	64	36	/	/	SYM
iajs-2653	64	37	l	l	NOUN
iajs-2653	64	38	)	)	PUNCT
iajs-2653	64	39	229	229	NUM
iajs-2653	64	40	.	.	NOUN
iajs-2653	64	41	6	6	NUM
iajs-2653	64	42	±sd	±sd	NOUN
iajs-2653	64	43	55	55	NUM
iajs-2653	64	44	.	.	PUNCT
iajs-2653	64	45	)	)	PUNCT
iajs-2653	64	46	of	of	ADP
iajs-2653	64	47	the	the	DET
iajs-2653	64	48	patient	patient	NOUN
iajs-2653	64	49	group	group	NOUN
iajs-2653	64	50	.	.	PUNCT
iajs-2653	65	1	figure	figure	NOUN
iajs-2653	65	2	2	2	NUM
iajs-2653	65	3	.	.	PUNCT
iajs-2653	65	4	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	65	5	activity	activity	NOUN
iajs-2653	65	6	in	in	ADP
iajs-2653	65	7	smoker	smoker	NOUN
iajs-2653	65	8	and	and	CCONJ
iajs-2653	65	9	nonsmoker	nonsmoker	NOUN
iajs-2653	65	10	of	of	ADP
iajs-2653	65	11	the	the	DET
iajs-2653	65	12	patient	patient	NOUN
iajs-2653	65	13	group	group	NOUN
iajs-2653	65	14	.	.	PUNCT
iajs-2653	66	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2653	66	2	special	special	ADJ
iajs-2653	66	3	issue	issue	NOUN
iajs-2653	66	4	1ihicpas	1ihicpas	NUM
iajs-2653	66	5	202	202	NUM
iajs-2653	66	6	ibn	ibn	PROPN
iajs-2653	66	7	al	al	PROPN
iajs-2653	66	8	-	-	PUNCT
iajs-2653	66	9	haitham	haitham	PROPN
iajs-2653	66	10	journal	journal	PROPN
iajs-2653	66	11	for	for	ADP
iajs-2653	66	12	pure	pure	ADJ
iajs-2653	66	13	and	and	CCONJ
iajs-2653	66	14	applied	apply	VERB
iajs-2653	66	15	science	science	NOUN
iajs-2653	66	16	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	66	17	for	for	ADP
iajs-2653	66	18	more	more	ADJ
iajs-2653	66	19	information	information	NOUN
iajs-2653	66	20	about	about	ADP
iajs-2653	66	21	the	the	DET
iajs-2653	66	22	conference	conference	NOUN
iajs-2653	66	23	please	please	INTJ
iajs-2653	66	24	visit	visit	VERB
iajs-2653	66	25	the	the	DET
iajs-2653	66	26	websites	website	NOUN
iajs-2653	66	27	:	:	PUNCT
iajs-2653	66	28	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	66	29	c	c	NOUN
iajs-2653	66	30	h	h	NOUN
iajs-2653	67	1	e	e	NOUN
iajs-2653	67	2	m	m	VERB
iajs-2653	67	3	i	i	NOUN
iajs-2653	67	4	s	s	VERB
iajs-2653	67	5	t	t	PROPN
iajs-2653	67	6	r	r	NOUN
iajs-2653	67	7	y	y	NOUN
iajs-2653	68	1	|	|	ADV
iajs-2653	68	2	72	72	NUM
iajs-2653	68	3	in	in	ADP
iajs-2653	68	4	the	the	DET
iajs-2653	68	5	last	last	ADJ
iajs-2653	68	6	decade	decade	NOUN
iajs-2653	68	7	,	,	PUNCT
iajs-2653	68	8	researchers	researcher	NOUN
iajs-2653	68	9	have	have	AUX
iajs-2653	68	10	confirmed	confirm	VERB
iajs-2653	68	11	a	a	DET
iajs-2653	68	12	significant	significant	ADJ
iajs-2653	68	13	elevation	elevation	NOUN
iajs-2653	68	14	in	in	ADP
iajs-2653	68	15	free	free	ADJ
iajs-2653	68	16	radicals	radical	NOUN
iajs-2653	68	17	and	and	CCONJ
iajs-2653	68	18	their	their	PRON
iajs-2653	68	19	role	role	NOUN
iajs-2653	68	20	in	in	ADP
iajs-2653	68	21	the	the	DET
iajs-2653	68	22	micro	micro	NOUN
iajs-2653	68	23	-	-	ADJ
iajs-2653	68	24	environmental	environmental	ADJ
iajs-2653	68	25	tumor[25	tumor[25	NOUN
iajs-2653	68	26	]	]	PUNCT
iajs-2653	68	27	.	.	PUNCT
iajs-2653	69	1	antioxidants	antioxidant	NOUN
iajs-2653	69	2	are	be	AUX
iajs-2653	69	3	the	the	DET
iajs-2653	69	4	major	major	ADJ
iajs-2653	69	5	preservation	preservation	NOUN
iajs-2653	69	6	of	of	ADP
iajs-2653	69	7	the	the	DET
iajs-2653	69	8	body	body	NOUN
iajs-2653	69	9	against	against	ADP
iajs-2653	69	10	free	free	ADJ
iajs-2653	69	11	radicals	radical	NOUN
iajs-2653	69	12	and	and	CCONJ
iajs-2653	69	13	other	other	ADJ
iajs-2653	69	14	oxidants	oxidant	NOUN
iajs-2653	69	15	,	,	PUNCT
iajs-2653	69	16	being	be	AUX
iajs-2653	69	17	the	the	DET
iajs-2653	69	18	substances	substance	NOUN
iajs-2653	69	19	that	that	PRON
iajs-2653	69	20	stop	stop	VERB
iajs-2653	69	21	the	the	DET
iajs-2653	69	22	attack	attack	NOUN
iajs-2653	69	23	and	and	CCONJ
iajs-2653	69	24	the	the	DET
iajs-2653	69	25	production	production	NOUN
iajs-2653	69	26	of	of	ADP
iajs-2653	69	27	radical	radical	ADJ
iajs-2653	69	28	species	specie	NOUN
iajs-2653	69	29	inside	inside	ADP
iajs-2653	69	30	the	the	DET
iajs-2653	69	31	cells	cell	NOUN
iajs-2653	69	32	[	[	X
iajs-2653	69	33	26	26	NUM
iajs-2653	69	34	]	]	PUNCT
iajs-2653	69	35	.	.	PUNCT
iajs-2653	70	1	the	the	DET
iajs-2653	70	2	increase	increase	NOUN
iajs-2653	70	3	of	of	ADP
iajs-2653	70	4	iron	iron	NOUN
iajs-2653	70	5	concentrations	concentration	NOUN
iajs-2653	70	6	after	after	ADP
iajs-2653	70	7	menopause	menopause	NOUN
iajs-2653	70	8	could	could	AUX
iajs-2653	70	9	be	be	AUX
iajs-2653	70	10	an	an	DET
iajs-2653	70	11	important	important	ADJ
iajs-2653	70	12	etiological	etiological	ADJ
iajs-2653	70	13	factor	factor	NOUN
iajs-2653	70	14	in	in	ADP
iajs-2653	70	15	the	the	DET
iajs-2653	70	16	development	development	NOUN
iajs-2653	70	17	of	of	ADP
iajs-2653	70	18	breast	breast	NOUN
iajs-2653	70	19	cancer	cancer	NOUN
iajs-2653	70	20	[	[	X
iajs-2653	70	21	27	27	NUM
iajs-2653	70	22	]	]	PUNCT
iajs-2653	70	23	.	.	PUNCT
iajs-2653	71	1	the	the	DET
iajs-2653	71	2	cp	cp	PROPN
iajs-2653	71	3	is	be	AUX
iajs-2653	71	4	considered	consider	VERB
iajs-2653	71	5	one	one	NUM
iajs-2653	71	6	of	of	ADP
iajs-2653	71	7	important	important	ADJ
iajs-2653	71	8	antioxidant	antioxidant	NOUN
iajs-2653	71	9	that	that	PRON
iajs-2653	71	10	prevents	prevent	VERB
iajs-2653	71	11	the	the	DET
iajs-2653	71	12	formation	formation	NOUN
iajs-2653	71	13	of	of	ADP
iajs-2653	71	14	free	free	ADJ
iajs-2653	71	15	radicals	radical	NOUN
iajs-2653	71	16	by	by	ADP
iajs-2653	71	17	inhibiting	inhibit	VERB
iajs-2653	71	18	fenton	fenton	NOUN
iajs-2653	71	19	reaction	reaction	NOUN
iajs-2653	71	20	,	,	PUNCT
iajs-2653	71	21	it	it	PRON
iajs-2653	71	22	can	can	AUX
iajs-2653	71	23	change	change	VERB
iajs-2653	71	24	fe2	fe2	PROPN
iajs-2653	71	25	+	+	ADP
iajs-2653	71	26	to	to	PART
iajs-2653	71	27	fe3	fe3	VERB
iajs-2653	71	28	+	+	NOUN
iajs-2653	71	29	which	which	PRON
iajs-2653	71	30	represent	represent	VERB
iajs-2653	71	31	a	a	DET
iajs-2653	71	32	very	very	ADV
iajs-2653	71	33	important	important	ADJ
iajs-2653	71	34	step	step	NOUN
iajs-2653	71	35	to	to	PART
iajs-2653	71	36	load	load	VERB
iajs-2653	71	37	apo	apo	PROPN
iajs-2653	71	38	transferrin	transferrin	NOUN
iajs-2653	71	39	with	with	ADP
iajs-2653	71	40	iron	iron	NOUN
iajs-2653	71	41	[	[	X
iajs-2653	71	42	18	18	NUM
iajs-2653	71	43	]	]	PUNCT
iajs-2653	71	44	,	,	PUNCT
iajs-2653	71	45	furthermore	furthermore	ADV
iajs-2653	71	46	,	,	PUNCT
iajs-2653	71	47	it	it	PRON
iajs-2653	71	48	stimulates	stimulate	VERB
iajs-2653	71	49	the	the	DET
iajs-2653	71	50	reoxidation	reoxidation	NOUN
iajs-2653	71	51	of	of	ADP
iajs-2653	71	52	copper	copper	NOUN
iajs-2653	71	53	i	i	PRON
iajs-2653	71	54	to	to	ADP
iajs-2653	71	55	copper	copper	NOUN
iajs-2653	71	56	ii	ii	PROPN
iajs-2653	72	1	[	[	X
iajs-2653	72	2	28	28	NUM
iajs-2653	72	3	]	]	PUNCT
iajs-2653	72	4	.	.	PUNCT
iajs-2653	73	1	iron	iron	NOUN
iajs-2653	73	2	imbalance	imbalance	NOUN
iajs-2653	73	3	is	be	AUX
iajs-2653	73	4	a	a	DET
iajs-2653	73	5	distinct	distinct	ADJ
iajs-2653	73	6	physiological	physiological	ADJ
iajs-2653	73	7	phenomenon	phenomenon	NOUN
iajs-2653	73	8	in	in	ADP
iajs-2653	73	9	women	woman	NOUN
iajs-2653	73	10	,	,	PUNCT
iajs-2653	73	11	which	which	PRON
iajs-2653	73	12	is	be	AUX
iajs-2653	73	13	probably	probably	ADV
iajs-2653	73	14	to	to	PART
iajs-2653	73	15	affect	affect	VERB
iajs-2653	73	16	their	their	PRON
iajs-2653	73	17	health	health	NOUN
iajs-2653	73	18	before	before	ADV
iajs-2653	73	19	,	,	PUNCT
iajs-2653	73	20	during	during	ADP
iajs-2653	73	21	,	,	PUNCT
iajs-2653	73	22	and	and	CCONJ
iajs-2653	73	23	after	after	ADP
iajs-2653	73	24	menopause	menopause	NOUN
iajs-2653	73	25	[	[	X
iajs-2653	73	26	27	27	NUM
iajs-2653	73	27	]	]	PUNCT
iajs-2653	73	28	.	.	PUNCT
iajs-2653	74	1	there	there	PRON
iajs-2653	74	2	is	be	VERB
iajs-2653	74	3	a	a	DET
iajs-2653	74	4	possibility	possibility	NOUN
iajs-2653	74	5	that	that	SCONJ
iajs-2653	74	6	iron	iron	NOUN
iajs-2653	74	7	deficiency	deficiency	NOUN
iajs-2653	74	8	may	may	AUX
iajs-2653	74	9	contribute	contribute	VERB
iajs-2653	74	10	to	to	ADP
iajs-2653	74	11	a	a	DET
iajs-2653	74	12	high	high	ADJ
iajs-2653	74	13	recurrence	recurrence	NOUN
iajs-2653	74	14	of	of	ADP
iajs-2653	74	15	breast	breast	NOUN
iajs-2653	74	16	cancer	cancer	NOUN
iajs-2653	74	17	in	in	ADP
iajs-2653	74	18	premenopausal	premenopausal	ADJ
iajs-2653	74	19	women	woman	NOUN
iajs-2653	74	20	,	,	PUNCT
iajs-2653	74	21	while	while	SCONJ
iajs-2653	74	22	iron	iron	NOUN
iajs-2653	74	23	load	load	NOUN
iajs-2653	74	24	may	may	AUX
iajs-2653	74	25	play	play	VERB
iajs-2653	74	26	a	a	DET
iajs-2653	74	27	role	role	NOUN
iajs-2653	74	28	in	in	ADP
iajs-2653	74	29	the	the	DET
iajs-2653	74	30	incidence	incidence	NOUN
iajs-2653	74	31	of	of	ADP
iajs-2653	74	32	breast	breast	NOUN
iajs-2653	74	33	cancer	cancer	NOUN
iajs-2653	74	34	in	in	ADP
iajs-2653	74	35	postmenopausal	postmenopausal	ADJ
iajs-2653	74	36	women	woman	NOUN
iajs-2653	74	37	[	[	X
iajs-2653	74	38	28	28	NUM
iajs-2653	74	39	]	]	X
iajs-2653	74	40	high	high	ADJ
iajs-2653	74	41	concentrations	concentration	NOUN
iajs-2653	74	42	of	of	ADP
iajs-2653	74	43	iron	iron	NOUN
iajs-2653	74	44	,	,	PUNCT
iajs-2653	74	45	calculated	calculate	VERB
iajs-2653	74	46	as	as	ADP
iajs-2653	74	47	plasma	plasma	NOUN
iajs-2653	74	48	iron	iron	NOUN
iajs-2653	74	49	,	,	PUNCT
iajs-2653	74	50	transferrin	transferrin	NOUN
iajs-2653	74	51	saturation	saturation	NOUN
iajs-2653	74	52	and	and	CCONJ
iajs-2653	74	53	total	total	ADJ
iajs-2653	74	54	iron	iron	NOUN
iajs-2653	74	55	-	-	PUNCT
iajs-2653	74	56	binding	bind	VERB
iajs-2653	74	57	capacity	capacity	NOUN
iajs-2653	74	58	(	(	PUNCT
iajs-2653	74	59	tibc	tibc	ADJ
iajs-2653	74	60	)	)	PUNCT
iajs-2653	74	61	,	,	PUNCT
iajs-2653	74	62	have	have	AUX
iajs-2653	74	63	been	be	AUX
iajs-2653	74	64	correlated	correlate	VERB
iajs-2653	74	65	in	in	ADP
iajs-2653	74	66	human	human	ADJ
iajs-2653	74	67	studies	study	NOUN
iajs-2653	74	68	with	with	ADP
iajs-2653	74	69	elevated	elevated	ADJ
iajs-2653	74	70	overall	overall	ADJ
iajs-2653	74	71	cancer	cancer	NOUN
iajs-2653	74	72	risk	risk	NOUN
iajs-2653	74	73	[	[	X
iajs-2653	74	74	29	29	NUM
iajs-2653	74	75	]	]	PUNCT
iajs-2653	74	76	and	and	CCONJ
iajs-2653	74	77	increased	increase	VERB
iajs-2653	74	78	risk	risk	NOUN
iajs-2653	74	79	of	of	ADP
iajs-2653	74	80	death	death	NOUN
iajs-2653	74	81	from	from	ADP
iajs-2653	74	82	any	any	DET
iajs-2653	74	83	form	form	NOUN
iajs-2653	74	84	of	of	ADP
iajs-2653	74	85	cancer[30	cancer[30	PROPN
iajs-2653	74	86	]	]	PUNCT
iajs-2653	74	87	.	.	PUNCT
iajs-2653	75	1	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	75	2	plays	play	VERB
iajs-2653	75	3	a	a	DET
iajs-2653	75	4	critical	critical	ADJ
iajs-2653	75	5	role	role	NOUN
iajs-2653	75	6	in	in	ADP
iajs-2653	75	7	maintaining	maintain	VERB
iajs-2653	75	8	the	the	DET
iajs-2653	75	9	iron	iron	NOUN
iajs-2653	75	10	level	level	NOUN
iajs-2653	75	11	thus	thus	ADV
iajs-2653	75	12	it	it	PRON
iajs-2653	75	13	has	have	VERB
iajs-2653	75	14	potential	potential	ADJ
iajs-2653	75	15	influences	influence	NOUN
iajs-2653	75	16	in	in	ADP
iajs-2653	75	17	the	the	DET
iajs-2653	75	18	development	development	NOUN
iajs-2653	75	19	of	of	ADP
iajs-2653	75	20	breast	breast	NOUN
iajs-2653	75	21	cancer	cancer	NOUN
iajs-2653	75	22	[	[	X
iajs-2653	75	23	31	31	NUM
iajs-2653	75	24	]	]	PUNCT
iajs-2653	75	25	.	.	PUNCT
iajs-2653	76	1	furthermore	furthermore	ADV
iajs-2653	76	2	,	,	PUNCT
iajs-2653	76	3	plasma	plasma	NOUN
iajs-2653	76	4	copper	copper	NOUN
iajs-2653	76	5	rises	rise	VERB
iajs-2653	76	6	in	in	ADP
iajs-2653	76	7	the	the	DET
iajs-2653	76	8	case	case	NOUN
iajs-2653	76	9	of	of	ADP
iajs-2653	76	10	malignant	malignant	ADJ
iajs-2653	76	11	tumors	tumor	NOUN
iajs-2653	76	12	level	level	VERB
iajs-2653	76	13	[	[	X
iajs-2653	76	14	32	32	NUM
iajs-2653	76	15	]	]	PUNCT
iajs-2653	76	16	,	,	PUNCT
iajs-2653	76	17	contributes	contribute	VERB
iajs-2653	76	18	to	to	ADP
iajs-2653	76	19	an	an	DET
iajs-2653	76	20	increase	increase	NOUN
iajs-2653	76	21	in	in	ADP
iajs-2653	76	22	the	the	DET
iajs-2653	76	23	concentration	concentration	NOUN
iajs-2653	76	24	of	of	ADP
iajs-2653	76	25	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	77	1	[	[	X
iajs-2653	77	2	33	33	NUM
iajs-2653	77	3	]	]	PUNCT
iajs-2653	77	4	.	.	PUNCT
iajs-2653	78	1	there	there	PRON
iajs-2653	78	2	is	be	VERB
iajs-2653	78	3	also	also	ADV
iajs-2653	78	4	an	an	DET
iajs-2653	78	5	increase	increase	NOUN
iajs-2653	78	6	in	in	ADP
iajs-2653	78	7	the	the	DET
iajs-2653	78	8	rate	rate	NOUN
iajs-2653	78	9	of	of	ADP
iajs-2653	78	10	synthesis	synthesis	NOUN
iajs-2653	78	11	and	and	CCONJ
iajs-2653	78	12	secretion	secretion	NOUN
iajs-2653	78	13	of	of	ADP
iajs-2653	78	14	this	this	DET
iajs-2653	78	15	glycoprotein	glycoprotein	NOUN
iajs-2653	78	16	by	by	ADP
iajs-2653	78	17	the	the	DET
iajs-2653	78	18	liver[32	liver[32	NOUN
iajs-2653	78	19	]	]	PUNCT
iajs-2653	78	20	in	in	ADP
iajs-2653	78	21	the	the	DET
iajs-2653	78	22	tumor	tumor	NOUN
iajs-2653	78	23	state	state	NOUN
iajs-2653	78	24	.	.	PUNCT
iajs-2653	79	1	tumor	tumor	NOUN
iajs-2653	79	2	cells	cell	NOUN
iajs-2653	79	3	are	be	AUX
iajs-2653	79	4	capable	capable	ADJ
iajs-2653	79	5	of	of	ADP
iajs-2653	79	6	absorption	absorption	NOUN
iajs-2653	79	7	from	from	ADP
iajs-2653	79	8	plasma	plasma	NOUN
iajs-2653	79	9	so	so	SCONJ
iajs-2653	79	10	that	that	SCONJ
iajs-2653	79	11	they	they	PRON
iajs-2653	79	12	contain	contain	VERB
iajs-2653	79	13	a	a	DET
iajs-2653	79	14	relatively	relatively	ADV
iajs-2653	79	15	large	large	ADJ
iajs-2653	79	16	amount	amount	NOUN
iajs-2653	79	17	of	of	ADP
iajs-2653	79	18	copper	copper	NOUN
iajs-2653	79	19	that	that	PRON
iajs-2653	79	20	affects	affect	VERB
iajs-2653	79	21	pathogenic	pathogenic	ADJ
iajs-2653	79	22	angiogenesis	angiogenesis	NOUN
iajs-2653	80	1	[	[	X
iajs-2653	80	2	34	34	NUM
iajs-2653	80	3	]	]	PUNCT
iajs-2653	80	4	.	.	PUNCT
iajs-2653	81	1	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	81	2	was	be	AUX
iajs-2653	81	3	also	also	ADV
iajs-2653	81	4	reported	report	VERB
iajs-2653	81	5	to	to	PART
iajs-2653	81	6	be	be	AUX
iajs-2653	81	7	associated	associate	VERB
iajs-2653	81	8	with	with	ADP
iajs-2653	81	9	different	different	ADJ
iajs-2653	81	10	types	type	NOUN
iajs-2653	81	11	of	of	ADP
iajs-2653	81	12	cancers	cancer	NOUN
iajs-2653	81	13	[	[	X
iajs-2653	81	14	35	35	NUM
iajs-2653	81	15	]	]	PUNCT
iajs-2653	81	16	.	.	PUNCT
iajs-2653	82	1	increased	increase	VERB
iajs-2653	82	2	glycoconjugates	glycoconjugate	NOUN
iajs-2653	82	3	can	can	AUX
iajs-2653	82	4	be	be	AUX
iajs-2653	82	5	the	the	DET
iajs-2653	82	6	product	product	NOUN
iajs-2653	82	7	of	of	ADP
iajs-2653	82	8	an	an	DET
iajs-2653	82	9	inflammatory	inflammatory	ADJ
iajs-2653	82	10	reaction	reaction	NOUN
iajs-2653	82	11	correlated	correlate	VERB
iajs-2653	82	12	with	with	ADP
iajs-2653	82	13	neoplasm	neoplasm	NOUN
iajs-2653	82	14	since	since	SCONJ
iajs-2653	82	15	serum	serum	NOUN
iajs-2653	82	16	cp	cp	PROPN
iajs-2653	82	17	is	be	AUX
iajs-2653	82	18	an	an	DET
iajs-2653	82	19	acute	acute	ADJ
iajs-2653	82	20	phase	phase	NOUN
iajs-2653	82	21	reactant	reactant	NOUN
iajs-2653	82	22	[	[	X
iajs-2653	82	23	36	36	NUM
iajs-2653	82	24	]	]	PUNCT
iajs-2653	82	25	,	,	PUNCT
iajs-2653	82	26	it	it	PRON
iajs-2653	82	27	is	be	AUX
iajs-2653	82	28	also	also	ADV
iajs-2653	82	29	increased	increase	VERB
iajs-2653	82	30	in	in	ADP
iajs-2653	82	31	patients	patient	NOUN
iajs-2653	82	32	of	of	ADP
iajs-2653	82	33	the	the	DET
iajs-2653	82	34	uterine	uterine	ADJ
iajs-2653	82	35	cervix	cervix	NOUN
iajs-2653	83	1	[	[	X
iajs-2653	83	2	37	37	NUM
iajs-2653	83	3	]	]	PUNCT
iajs-2653	83	4	.	.	PUNCT
iajs-2653	84	1	several	several	ADJ
iajs-2653	84	2	studies	study	NOUN
iajs-2653	84	3	were	be	AUX
iajs-2653	84	4	occurred	occur	VERB
iajs-2653	84	5	on	on	ADP
iajs-2653	84	6	sera	sera	NOUN
iajs-2653	84	7	and	and	CCONJ
iajs-2653	84	8	solid	solid	ADJ
iajs-2653	84	9	tumor	tumor	NOUN
iajs-2653	84	10	tissue	tissue	NOUN
iajs-2653	84	11	to	to	PART
iajs-2653	84	12	figure	figure	VERB
iajs-2653	84	13	out	out	ADP
iajs-2653	84	14	the	the	DET
iajs-2653	84	15	concentration	concentration	NOUN
iajs-2653	84	16	of	of	ADP
iajs-2653	84	17	cp	cp	INTJ
iajs-2653	84	18	and	and	CCONJ
iajs-2653	84	19	some	some	DET
iajs-2653	84	20	analytes	analyte	NOUN
iajs-2653	84	21	that	that	PRON
iajs-2653	84	22	correlated	correlate	VERB
iajs-2653	84	23	with	with	ADP
iajs-2653	84	24	this	this	DET
iajs-2653	84	25	enzyme	enzyme	NOUN
iajs-2653	84	26	in	in	ADP
iajs-2653	84	27	cancer	cancer	NOUN
iajs-2653	84	28	patients	patient	NOUN
iajs-2653	84	29	which	which	PRON
iajs-2653	84	30	emphasizes	emphasize	VERB
iajs-2653	84	31	there	there	PRON
iajs-2653	84	32	is	be	VERB
iajs-2653	84	33	a	a	DET
iajs-2653	84	34	relation	relation	NOUN
iajs-2653	84	35	between	between	ADP
iajs-2653	84	36	cp	cp	PROPN
iajs-2653	84	37	and	and	CCONJ
iajs-2653	84	38	prostate	prostate	NOUN
iajs-2653	84	39	,	,	PUNCT
iajs-2653	84	40	colon	colon	NOUN
iajs-2653	84	41	cancer	cancer	NOUN
iajs-2653	84	42	patients	patient	NOUN
iajs-2653	84	43	[	[	X
iajs-2653	84	44	38	38	NUM
iajs-2653	84	45	]	]	PUNCT
iajs-2653	84	46	and	and	CCONJ
iajs-2653	84	47	with	with	ADP
iajs-2653	84	48	bile	bile	NOUN
iajs-2653	84	49	duct	duct	NOUN
iajs-2653	84	50	cancer	cancer	NOUN
iajs-2653	84	51	[	[	X
iajs-2653	84	52	35	35	NUM
iajs-2653	84	53	]	]	PUNCT
iajs-2653	84	54	.	.	PUNCT
iajs-2653	85	1	the	the	DET
iajs-2653	85	2	increase	increase	NOUN
iajs-2653	85	3	of	of	ADP
iajs-2653	85	4	cp	cp	NUM
iajs-2653	85	5	activity	activity	NOUN
iajs-2653	85	6	in	in	ADP
iajs-2653	85	7	this	this	DET
iajs-2653	85	8	study	study	NOUN
iajs-2653	85	9	has	have	AUX
iajs-2653	85	10	agreed	agree	VERB
iajs-2653	85	11	with	with	ADP
iajs-2653	85	12	a	a	DET
iajs-2653	85	13	study	study	NOUN
iajs-2653	85	14	by	by	ADP
iajs-2653	85	15	ozour	ozour	NOUN
iajs-2653	85	16	et	et	PROPN
iajs-2653	85	17	al	al	PROPN
iajs-2653	85	18	which	which	PRON
iajs-2653	85	19	found	find	VERB
iajs-2653	85	20	increasing	increase	VERB
iajs-2653	85	21	in	in	ADP
iajs-2653	85	22	cp	cp	NUM
iajs-2653	85	23	concentration	concentration	NOUN
iajs-2653	85	24	in	in	ADP
iajs-2653	85	25	breast	breast	NOUN
iajs-2653	85	26	disease	disease	NOUN
iajs-2653	85	27	[	[	X
iajs-2653	85	28	39	39	NUM
iajs-2653	85	29	]	]	PUNCT
iajs-2653	85	30	.	.	PUNCT
iajs-2653	86	1	further	further	ADJ
iajs-2653	86	2	study	study	NOUN
iajs-2653	86	3	confirmed	confirm	VERB
iajs-2653	86	4	that	that	SCONJ
iajs-2653	86	5	cp	cp	PROPN
iajs-2653	86	6	concentration	concentration	NOUN
iajs-2653	86	7	increased	increase	VERB
iajs-2653	86	8	in	in	ADP
iajs-2653	86	9	patients	patient	NOUN
iajs-2653	86	10	with	with	ADP
iajs-2653	86	11	metastatic	metastatic	ADJ
iajs-2653	86	12	breast	breast	NOUN
iajs-2653	86	13	cancer	cancer	NOUN
iajs-2653	86	14	(	(	PUNCT
iajs-2653	86	15	36	36	NUM
iajs-2653	86	16	)	)	PUNCT
iajs-2653	86	17	and	and	CCONJ
iajs-2653	86	18	patients	patient	NOUN
iajs-2653	86	19	with	with	ADP
iajs-2653	86	20	primary	primary	ADJ
iajs-2653	86	21	breast	breast	NOUN
iajs-2653	86	22	cancer	cancer	NOUN
iajs-2653	86	23	[	[	X
iajs-2653	86	24	40	40	NUM
iajs-2653	86	25	]	]	PUNCT
iajs-2653	86	26	.	.	PUNCT
iajs-2653	87	1	in	in	ADP
iajs-2653	87	2	addition	addition	NOUN
iajs-2653	87	3	,	,	PUNCT
iajs-2653	87	4	the	the	DET
iajs-2653	87	5	result	result	NOUN
iajs-2653	87	6	in	in	ADP
iajs-2653	87	7	the	the	DET
iajs-2653	87	8	current	current	ADJ
iajs-2653	87	9	study	study	NOUN
iajs-2653	87	10	agrees	agree	VERB
iajs-2653	87	11	with	with	ADP
iajs-2653	87	12	research	research	NOUN
iajs-2653	87	13	by	by	ADP
iajs-2653	87	14	jing	jing	PROPN
iajs-2653	87	15	fan	fan	PROPN
iajs-2653	87	16	et	et	PROPN
iajs-2653	87	17	al	al	PROPN
iajs-2653	87	18	which	which	PRON
iajs-2653	87	19	studied	study	VERB
iajs-2653	87	20	the	the	DET
iajs-2653	87	21	relationship	relationship	NOUN
iajs-2653	87	22	between	between	ADP
iajs-2653	87	23	serum	serum	NOUN
iajs-2653	87	24	level	level	NOUN
iajs-2653	87	25	of	of	ADP
iajs-2653	87	26	copper	copper	NOUN
iajs-2653	87	27	and	and	CCONJ
iajs-2653	87	28	cp	cp	NUM
iajs-2653	87	29	concentration	concentration	NOUN
iajs-2653	87	30	in	in	ADP
iajs-2653	87	31	sera	sera	NOUN
iajs-2653	87	32	of	of	ADP
iajs-2653	87	33	patients	patient	NOUN
iajs-2653	87	34	with	with	ADP
iajs-2653	87	35	early	early	ADJ
iajs-2653	87	36	breast	breast	NOUN
iajs-2653	87	37	cancer	cancer	NOUN
iajs-2653	87	38	patients	patient	NOUN
iajs-2653	87	39	by	by	ADP
iajs-2653	87	40	using	use	VERB
iajs-2653	87	41	atomic	atomic	ADJ
iajs-2653	87	42	absorption	absorption	NOUN
iajs-2653	87	43	spectroscopy	spectroscopy	NOUN
iajs-2653	87	44	and	and	CCONJ
iajs-2653	87	45	immunoturbidimetry	immunoturbidimetry	NOUN
iajs-2653	87	46	assay	assay	VERB
iajs-2653	88	1	[	[	X
iajs-2653	88	2	41	41	NUM
iajs-2653	88	3	]	]	PUNCT
iajs-2653	88	4	.	.	PUNCT
iajs-2653	89	1	on	on	ADP
iajs-2653	89	2	the	the	DET
iajs-2653	89	3	other	other	ADJ
iajs-2653	89	4	hand	hand	NOUN
iajs-2653	89	5	,	,	PUNCT
iajs-2653	89	6	the	the	DET
iajs-2653	89	7	result	result	NOUN
iajs-2653	89	8	in	in	ADP
iajs-2653	89	9	the	the	DET
iajs-2653	89	10	current	current	ADJ
iajs-2653	89	11	study	study	NOUN
iajs-2653	89	12	disagrees	disagree	VERB
iajs-2653	89	13	with	with	ADP
iajs-2653	89	14	debek	debek	PROPN
iajs-2653	89	15	jt	jt	PROPN
iajs-2653	89	16	et	et	PROPN
iajs-2653	89	17	al	al	PROPN
iajs-2653	89	18	which	which	PRON
iajs-2653	89	19	found	find	VERB
iajs-2653	89	20	the	the	DET
iajs-2653	89	21	cp	cp	NOUN
iajs-2653	89	22	activity	activity	NOUN
iajs-2653	89	23	was	be	AUX
iajs-2653	89	24	significantly	significantly	ADV
iajs-2653	89	25	decreased	decrease	VERB
iajs-2653	89	26	in	in	ADP
iajs-2653	89	27	postmenopausal	postmenopausal	ADJ
iajs-2653	89	28	stage	stage	NOUN
iajs-2653	89	29	i	i	PRON
iajs-2653	89	30	and	and	CCONJ
iajs-2653	89	31	ii	ii	PROPN
iajs-2653	89	32	breast	breast	NOUN
iajs-2653	89	33	cancer	cancer	NOUN
iajs-2653	89	34	patients	patient	NOUN
iajs-2653	89	35	[	[	X
iajs-2653	89	36	42	42	NUM
iajs-2653	89	37	]	]	PUNCT
iajs-2653	89	38	.	.	PUNCT
iajs-2653	90	1	4.conclusions	4.conclusion	NOUN
iajs-2653	90	2	according	accord	VERB
iajs-2653	90	3	to	to	ADP
iajs-2653	90	4	the	the	DET
iajs-2653	90	5	results	result	NOUN
iajs-2653	90	6	of	of	ADP
iajs-2653	90	7	this	this	DET
iajs-2653	90	8	study	study	NOUN
iajs-2653	90	9	,	,	PUNCT
iajs-2653	90	10	serum	serum	NOUN
iajs-2653	90	11	cp	cp	NOUN
iajs-2653	90	12	oxidase	oxidase	NOUN
iajs-2653	90	13	activity	activity	NOUN
iajs-2653	90	14	and	and	CCONJ
iajs-2653	90	15	specific	specific	ADJ
iajs-2653	90	16	activity	activity	NOUN
iajs-2653	90	17	were	be	AUX
iajs-2653	90	18	highly	highly	ADV
iajs-2653	90	19	significantly	significantly	ADV
iajs-2653	90	20	elevated	elevate	VERB
iajs-2653	90	21	in	in	ADP
iajs-2653	90	22	-	-	PUNCT
iajs-2653	90	23	patient	patient	NOUN
iajs-2653	90	24	group	group	NOUN
iajs-2653	90	25	when	when	SCONJ
iajs-2653	90	26	compared	compare	VERB
iajs-2653	90	27	with	with	ADP
iajs-2653	90	28	the	the	DET
iajs-2653	90	29	control	control	NOUN
iajs-2653	90	30	group	group	NOUN
iajs-2653	90	31	.	.	PUNCT
iajs-2653	91	1	likewise	likewise	ADV
iajs-2653	91	2	,	,	PUNCT
iajs-2653	91	3	the	the	DET
iajs-2653	91	4	results	result	NOUN
iajs-2653	91	5	showed	show	VERB
iajs-2653	91	6	a	a	DET
iajs-2653	91	7	significant	significant	ADJ
iajs-2653	91	8	increase	increase	NOUN
iajs-2653	91	9	(	(	PUNCT
iajs-2653	91	10	p˂0.0001	p˂0.0001	NOUN
iajs-2653	91	11	)	)	PUNCT
iajs-2653	91	12	between	between	ADP
iajs-2653	91	13	the	the	DET
iajs-2653	91	14	total	total	ADJ
iajs-2653	91	15	iron	iron	NOUN
iajs-2653	91	16	concentration	concentration	NOUN
iajs-2653	91	17	means	mean	NOUN
iajs-2653	91	18	of	of	ADP
iajs-2653	91	19	a	a	DET
iajs-2653	91	20	patient	patient	NOUN
iajs-2653	91	21	with	with	ADP
iajs-2653	91	22	breast	breast	NOUN
iajs-2653	91	23	cancer	cancer	NOUN
iajs-2653	91	24	and	and	CCONJ
iajs-2653	91	25	the	the	DET
iajs-2653	91	26	control	control	NOUN
iajs-2653	91	27	group	group	NOUN
iajs-2653	91	28	.	.	PUNCT
iajs-2653	92	1	protein	protein	NOUN
iajs-2653	92	2	concentration	concentration	NOUN
iajs-2653	92	3	was	be	AUX
iajs-2653	92	4	increased	increase	VERB
iajs-2653	92	5	but	but	CCONJ
iajs-2653	92	6	insignificantly	insignificantly	ADV
iajs-2653	92	7	(	(	PUNCT
iajs-2653	92	8	p	p	NOUN
iajs-2653	92	9	0.0108	0.0108	NUM
iajs-2653	92	10	)	)	PUNCT
iajs-2653	92	11	in	in	ADP
iajs-2653	92	12	the	the	DET
iajs-2653	92	13	patient	patient	NOUN
iajs-2653	92	14	group	group	NOUN
iajs-2653	92	15	when	when	SCONJ
iajs-2653	92	16	compared	compare	VERB
iajs-2653	92	17	with	with	ADP
iajs-2653	92	18	control	control	NOUN
iajs-2653	92	19	group	group	NOUN
iajs-2653	92	20	.	.	PUNCT
iajs-2653	93	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2653	93	2	special	special	ADJ
iajs-2653	93	3	issue	issue	NOUN
iajs-2653	93	4	1ihicpas	1ihicpas	NUM
iajs-2653	93	5	202	202	NUM
iajs-2653	93	6	ibn	ibn	PROPN
iajs-2653	93	7	al	al	PROPN
iajs-2653	93	8	-	-	PUNCT
iajs-2653	93	9	haitham	haitham	PROPN
iajs-2653	93	10	journal	journal	PROPN
iajs-2653	93	11	for	for	ADP
iajs-2653	93	12	pure	pure	ADJ
iajs-2653	93	13	and	and	CCONJ
iajs-2653	93	14	applied	apply	VERB
iajs-2653	93	15	science	science	NOUN
iajs-2653	93	16	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	93	17	for	for	ADP
iajs-2653	93	18	more	more	ADJ
iajs-2653	93	19	information	information	NOUN
iajs-2653	93	20	about	about	ADP
iajs-2653	93	21	the	the	DET
iajs-2653	93	22	conference	conference	NOUN
iajs-2653	93	23	please	please	INTJ
iajs-2653	93	24	visit	visit	VERB
iajs-2653	93	25	the	the	DET
iajs-2653	93	26	websites	website	NOUN
iajs-2653	93	27	:	:	PUNCT
iajs-2653	93	28	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	93	29	c	c	NOUN
iajs-2653	93	30	h	h	NOUN
iajs-2653	94	1	e	e	NOUN
iajs-2653	94	2	m	m	VERB
iajs-2653	94	3	i	i	NOUN
iajs-2653	94	4	s	s	VERB
iajs-2653	94	5	t	t	PROPN
iajs-2653	94	6	r	r	NOUN
iajs-2653	94	7	y	y	PROPN
iajs-2653	95	1	|	|	ADV
iajs-2653	95	2	73	73	NUM
iajs-2653	95	3	we	we	PRON
iajs-2653	95	4	propose	propose	VERB
iajs-2653	95	5	that	that	SCONJ
iajs-2653	95	6	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	95	7	can	can	AUX
iajs-2653	95	8	use	use	VERB
iajs-2653	95	9	as	as	ADP
iajs-2653	95	10	a	a	DET
iajs-2653	95	11	tumor	tumor	NOUN
iajs-2653	95	12	marker	marker	NOUN
iajs-2653	95	13	to	to	PART
iajs-2653	95	14	diagnose	diagnose	VERB
iajs-2653	95	15	or	or	CCONJ
iajs-2653	95	16	the	the	DET
iajs-2653	95	17	follow	follow	VERB
iajs-2653	95	18	-	-	PUNCT
iajs-2653	95	19	up	up	ADP
iajs-2653	95	20	patients	patient	NOUN
iajs-2653	95	21	with	with	ADP
iajs-2653	95	22	breast	breast	NOUN
iajs-2653	95	23	cancer	cancer	NOUN
iajs-2653	95	24	.	.	PUNCT
iajs-2653	96	1	further	further	ADJ
iajs-2653	96	2	study	study	NOUN
iajs-2653	96	3	can	can	AUX
iajs-2653	96	4	occur	occur	VERB
iajs-2653	96	5	for	for	ADP
iajs-2653	96	6	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	96	7	in	in	ADP
iajs-2653	96	8	malignant	malignant	ADJ
iajs-2653	96	9	and	and	CCONJ
iajs-2653	96	10	benign	benign	ADJ
iajs-2653	96	11	groups	group	NOUN
iajs-2653	96	12	like	like	ADP
iajs-2653	96	13	determination	determination	NOUN
iajs-2653	96	14	of	of	ADP
iajs-2653	96	15	molecular	molecular	ADJ
iajs-2653	96	16	weight	weight	NOUN
iajs-2653	96	17	and	and	CCONJ
iajs-2653	96	18	finding	find	VERB
iajs-2653	96	19	the	the	DET
iajs-2653	96	20	isomers	isomer	NOUN
iajs-2653	96	21	or	or	CCONJ
iajs-2653	96	22	forms	form	NOUN
iajs-2653	96	23	of	of	ADP
iajs-2653	96	24	this	this	DET
iajs-2653	96	25	enzyme	enzyme	NOUN
iajs-2653	96	26	to	to	PART
iajs-2653	96	27	find	find	VERB
iajs-2653	96	28	the	the	DET
iajs-2653	96	29	ability	ability	NOUN
iajs-2653	96	30	to	to	PART
iajs-2653	96	31	use	use	VERB
iajs-2653	96	32	this	this	DET
iajs-2653	96	33	enzyme	enzyme	NOUN
iajs-2653	96	34	as	as	ADP
iajs-2653	96	35	a	a	DET
iajs-2653	96	36	tumor	tumor	NOUN
iajs-2653	96	37	marker	marker	NOUN
iajs-2653	96	38	.	.	PUNCT
iajs-2653	97	1	and	and	CCONJ
iajs-2653	97	2	determine	determine	VERB
iajs-2653	97	3	other	other	ADJ
iajs-2653	97	4	activities	activity	NOUN
iajs-2653	97	5	of	of	ADP
iajs-2653	97	6	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	97	7	.	.	PUNCT
iajs-2653	98	1	finally	finally	ADV
iajs-2653	98	2	measure	measure	VERB
iajs-2653	98	3	other	other	ADJ
iajs-2653	98	4	parameters	parameter	NOUN
iajs-2653	98	5	such	such	ADJ
iajs-2653	98	6	as	as	ADP
iajs-2653	98	7	copper	copper	NOUN
iajs-2653	98	8	,	,	PUNCT
iajs-2653	98	9	transferrin	transferrin	NOUN
iajs-2653	98	10	that	that	PRON
iajs-2653	98	11	related	relate	VERB
iajs-2653	98	12	to	to	ADP
iajs-2653	98	13	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	98	14	.	.	PUNCT
iajs-2653	99	1	acknowledgment	acknowledgment	NOUN
iajs-2653	99	2	thanks	thank	NOUN
iajs-2653	99	3	to	to	ADP
iajs-2653	99	4	all	all	DET
iajs-2653	99	5	cancer	cancer	NOUN
iajs-2653	99	6	patients	patient	NOUN
iajs-2653	99	7	in	in	ADP
iajs-2653	99	8	nanakali	nanakali	ADJ
iajs-2653	99	9	hospital	hospital	NOUN
iajs-2653	99	10	-	-	PUNCT
iajs-2653	99	11	erbil	erbil	PROPN
iajs-2653	99	12	city	city	PROPN
iajs-2653	99	13	-	-	PUNCT
iajs-2653	99	14	kurdistan	kurdistan	PROPN
iajs-2653	99	15	region	region	PROPN
iajs-2653	99	16	/	/	SYM
iajs-2653	99	17	iraq	iraq	PROPN
iajs-2653	99	18	as	as	ADP
iajs-2653	99	19	participants	participant	NOUN
iajs-2653	99	20	.	.	PUNCT
iajs-2653	100	1	references	reference	NOUN
iajs-2653	100	2	1.zohre	1.zohre	NUM
iajs-2653	100	3	,	,	PUNCT
iajs-2653	100	4	m.	m.	NOUN
iajs-2653	100	5	;	;	PUNCT
iajs-2653	100	6	hamid	hamid	PROPN
iajs-2653	100	7	s.	s.	PROPN
iajs-2653	100	8	epidemiological	epidemiological	ADJ
iajs-2653	100	9	characteristics	characteristic	NOUN
iajs-2653	100	10	of	of	ADP
iajs-2653	100	11	and	and	CCONJ
iajs-2653	100	12	risk	risk	NOUN
iajs-2653	100	13	factors	factor	NOUN
iajs-2653	100	14	for	for	ADP
iajs-2653	100	15	breast	breast	NOUN
iajs-2653	100	16	cancer	cancer	NOUN
iajs-2653	100	17	in	in	ADP
iajs-2653	100	18	the	the	DET
iajs-2653	100	19	world	world	NOUN
iajs-2653	100	20	,	,	PUNCT
iajs-2653	100	21	breast	breast	NOUN
iajs-2653	100	22	cancer	cancer	NOUN
iajs-2653	100	23	:	:	PUNCT
iajs-2653	100	24	targets	target	NOUN
iajs-2653	100	25	and	and	CCONJ
iajs-2653	100	26	therapy	therapy	NOUN
iajs-2653	100	27	.	.	PUNCT
iajs-2653	101	1	2019	2019	NUM
iajs-2653	101	2	,	,	PUNCT
iajs-2653	101	3	11	11	NUM
iajs-2653	101	4	,	,	PUNCT
iajs-2653	101	5	151–164	151–164	NUM
iajs-2653	101	6	.	.	PUNCT
iajs-2653	102	1	2.stewart	2.stewart	NUM
iajs-2653	102	2	b	b	PROPN
iajs-2653	102	3	,	,	PUNCT
iajs-2653	102	4	w.	w.	NOUN
iajs-2653	102	5	;	;	PUNCT
iajs-2653	102	6	wild	wild	PROPN
iajs-2653	102	7	c	c	NOUN
iajs-2653	102	8	,	,	PUNCT
iajs-2653	102	9	p.	p.	NOUN
iajs-2653	102	10	world	world	NOUN
iajs-2653	102	11	cancer	cancer	NOUN
iajs-2653	102	12	report	report	NOUN
iajs-2653	102	13	.2014	.2014	PROPN
iajs-2653	102	14	.	.	PUNCT
iajs-2653	103	1	geneva	geneva	PROPN
iajs-2653	103	2	,	,	PUNCT
iajs-2653	103	3	switzerland	switzerland	PROPN
iajs-2653	103	4	:	:	PUNCT
iajs-2653	103	5	who	who	PRON
iajs-2653	103	6	press	press	VERB
iajs-2653	103	7	.	.	PUNCT
iajs-2653	104	1	3.yi	3.yi	NUM
iajs-2653	104	2	-	-	PUNCT
iajs-2653	104	3	sheng	sheng	NOUN
iajs-2653	104	4	,	,	PUNCT
iajs-2653	104	5	s.	s.	PROPN
iajs-2653	104	6	;	;	PUNCT
iajs-2653	104	7	zhao	zhao	PROPN
iajs-2653	104	8	,	,	PUNCT
iajs-2653	104	9	z.	z.	PROPN
iajs-2653	104	10	;	;	PUNCT
iajs-2653	104	11	zhang	zhang	PROPN
iajs-2653	104	12	-	-	PUNCT
iajs-2653	104	13	nv	nv	PROPN
iajs-2653	104	14	,	,	PUNCT
iajs-2653	104	15	y.	y.	PROPN
iajs-2653	104	16	;	;	PUNCT
iajs-2653	104	17	fang	fang	X
iajs-2653	104	18	,	,	PUNCT
iajs-2653	104	19	x.	x.	NOUN
iajs-2653	104	20	;	;	PUNCT
iajs-2653	104	21	hang	hang	PROPN
iajs-2653	104	22	-	-	PUNCT
iajs-2653	104	23	jing	jing	PROPN
iajs-2653	104	24	,	,	PUNCT
iajs-2653	104	25	l.	l.	PROPN
iajs-2653	104	26	;	;	PUNCT
iajs-2653	104	27	zhi	zhi	PROPN
iajs-2653	104	28	-	-	PROPN
iajs-2653	104	29	yong	yong	PROPN
iajs-2653	104	30	,	,	PUNCT
iajs-2653	104	31	z.	z.	PROPN
iajs-2653	104	32	;	;	PUNCT
iajs-2653	104	33	wen	wen	PROPN
iajs-2653	104	34	,	,	PUNCT
iajs-2653	104	35	s.	s.	PROPN
iajs-2653	104	36	;	;	PUNCT
iajs-2653	104	37	jianmin	jianmin	PROPN
iajs-2653	104	38	,	,	PUNCT
iajs-2653	104	39	j	j	PROPN
iajs-2653	104	40	.	.	PUNCT
iajs-2653	104	41	;	;	PUNCT
iajs-2653	104	42	ping	ping	NOUN
iajs-2653	104	43	-	-	PUNCT
iajs-2653	104	44	ping	ping	PROPN
iajs-2653	104	45	,	,	PUNCT
iajs-2653	104	46	y.	y.	PROPN
iajs-2653	104	47	;	;	PUNCT
iajs-2653	104	48	han	han	PROPN
iajs-2653	104	49	-	-	PUNCT
iajs-2653	104	50	ping	ping	PROPN
iajs-2653	104	51	,	,	PUNCT
iajs-2653	104	52	z.	z.	PROPN
iajs-2653	104	53	;	;	PUNCT
iajs-2653	104	54	risk	risk	NOUN
iajs-2653	104	55	factors	factor	NOUN
iajs-2653	104	56	and	and	CCONJ
iajs-2653	104	57	preventions	prevention	NOUN
iajs-2653	104	58	of	of	ADP
iajs-2653	104	59	breast	breast	NOUN
iajs-2653	104	60	cancer	cancer	NOUN
iajs-2653	104	61	,	,	PUNCT
iajs-2653	104	62	int	int	PROPN
iajs-2653	104	63	j	j	PROPN
iajs-2653	104	64	biol	biol	PROPN
iajs-2653	104	65	sci	sci	PROPN
iajs-2653	104	66	.	.	PROPN
iajs-2653	104	67	2017	2017	NUM
iajs-2653	104	68	,	,	PUNCT
iajs-2653	104	69	13(11	13(11	NUM
iajs-2653	104	70	)	)	PUNCT
iajs-2653	104	71	,	,	PUNCT
iajs-2653	104	72	1387–1397	1387–1397	NUM
iajs-2653	104	73	.	.	PUNCT
iajs-2653	104	74	4.wang	4.wang	NUM
iajs-2653	104	75	,	,	PUNCT
iajs-2653	104	76	l.	l.	NOUN
iajs-2653	104	77	early	early	ADJ
iajs-2653	104	78	diagnosis	diagnosis	NOUN
iajs-2653	104	79	of	of	ADP
iajs-2653	104	80	breast	breast	NOUN
iajs-2653	104	81	cancer	cancer	NOUN
iajs-2653	104	82	.	.	PUNCT
iajs-2653	105	1	sensors	sensor	NOUN
iajs-2653	105	2	.	.	PUNCT
iajs-2653	106	1	2017,17(7):1572	2017,17(7):1572	X
iajs-2653	106	2	-	-	SYM
iajs-2653	106	3	1600	1600	NUM
iajs-2653	106	4	.	.	PUNCT
iajs-2653	107	1	published	publish	VERB
iajs-2653	107	2	2017	2017	NUM
iajs-2653	107	3	jul	jul	PROPN
iajs-2653	107	4	5	5	NUM
iajs-2653	107	5	.	.	PUNCT
iajs-2653	107	6	doi:10.3390	doi:10.3390	PROPN
iajs-2653	107	7	/	/	SYM
iajs-2653	107	8	s17071572	s17071572	PROPN
iajs-2653	107	9	5.ganesh	5.ganesh	NUM
iajs-2653	107	10	,	,	PUNCT
iajs-2653	107	11	n.	n.	NOUN
iajs-2653	107	12	;	;	PUNCT
iajs-2653	107	13	sharma	sharma	PROPN
iajs-2653	107	14	,	,	PUNCT
iajs-2653	107	15	r.	r.	PROPN
iajs-2653	107	16	d.	d.	PROPN
iajs-2653	107	17	;	;	PUNCT
iajs-2653	107	18	jyotsana	jyotsana	PROPN
iajs-2653	107	19	,	,	PUNCT
iajs-2653	107	20	s.	s.	PROPN
iajs-2653	107	21	;	;	PUNCT
iajs-2653	107	22	piush	piush	PROPN
iajs-2653	107	23	,	,	PUNCT
iajs-2653	107	24	s	s	PART
iajs-2653	107	25	.	.	PUNCT
iajs-2653	107	26	;	;	PUNCT
iajs-2653	108	1	sharma	sharma	PROPN
iajs-2653	108	2	,	,	PUNCT
iajs-2653	108	3	k.k	k.k	PROPN
iajs-2653	108	4	.	.	PROPN
iajs-2653	108	5	various	various	ADJ
iajs-2653	108	6	types	type	NOUN
iajs-2653	108	7	and	and	CCONJ
iajs-2653	108	8	management	management	NOUN
iajs-2653	108	9	of	of	ADP
iajs-2653	108	10	breast	breast	NOUN
iajs-2653	108	11	cancer	cancer	NOUN
iajs-2653	108	12	:	:	PUNCT
iajs-2653	108	13	an	an	DET
iajs-2653	108	14	overview	overview	NOUN
iajs-2653	108	15	,	,	PUNCT
iajs-2653	108	16	j.	j.	PROPN
iajs-2653	108	17	adv	adv	PROPN
iajs-2653	108	18	.	.	PUNCT
iajs-2653	108	19	pharm	pharm	PROPN
iajs-2653	108	20	.	.	PUNCT
iajs-2653	109	1	technol	technol	PROPN
iajs-2653	109	2	.	.	PUNCT
iajs-2653	110	1	res	re	NOUN
iajs-2653	110	2	.	.	PUNCT
iajs-2653	110	3	2010	2010	NUM
iajs-2653	110	4	,	,	PUNCT
iajs-2653	110	5	1(2	1(2	NUM
iajs-2653	110	6	)	)	PUNCT
iajs-2653	110	7	,	,	PUNCT
iajs-2653	110	8	109	109	NUM
iajs-2653	110	9	–	–	PUNCT
iajs-2653	110	10	126	126	NUM
iajs-2653	110	11	.	.	PUNCT
iajs-2653	111	1	6.ryszard	6.ryszard	NUM
iajs-2653	111	2	,	,	PUNCT
iajs-2653	111	3	k	k	PROPN
iajs-2653	111	4	.	.	PUNCT
iajs-2653	111	5	;	;	PUNCT
iajs-2653	111	6	bernadeta	bernadeta	INTJ
iajs-2653	111	7	,	,	PUNCT
iajs-2653	111	8	d.	d.	PROPN
iajs-2653	111	9	;	;	PUNCT
iajs-2653	111	10	tomasz	tomasz	PROPN
iajs-2653	111	11	,	,	PUNCT
iajs-2653	111	12	k	k	PROPN
iajs-2653	111	13	.	.	PUNCT
iajs-2653	112	1	the	the	DET
iajs-2653	112	2	infuence	infuence	NOUN
iajs-2653	112	3	of	of	ADP
iajs-2653	112	4	radiotherapy	radiotherapy	NOUN
iajs-2653	112	5	on	on	ADP
iajs-2653	112	6	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	112	7	and	and	CCONJ
iajs-2653	112	8	transferrin	transferrin	NOUN
iajs-2653	112	9	in	in	ADP
iajs-2653	112	10	whole	whole	ADJ
iajs-2653	112	11	blood	blood	NOUN
iajs-2653	112	12	of	of	ADP
iajs-2653	112	13	breast	breast	NOUN
iajs-2653	112	14	cancer	cancer	NOUN
iajs-2653	112	15	patients	patient	NOUN
iajs-2653	112	16	.	.	PUNCT
iajs-2653	113	1	radiat	radiat	PROPN
iajs-2653	113	2	.	.	PUNCT
iajs-2653	114	1	environ	environ	PROPN
iajs-2653	114	2	.	.	PUNCT
iajs-2653	114	3	biophys	biophy	NOUN
iajs-2653	114	4	.	.	PUNCT
iajs-2653	115	1	2017	2017	NUM
iajs-2653	115	2	,	,	PUNCT
iajs-2653	115	3	56	56	NUM
iajs-2653	115	4	,	,	PUNCT
iajs-2653	115	5	345	345	NUM
iajs-2653	115	6	-	-	SYM
iajs-2653	115	7	352	352	NUM
iajs-2653	115	8	.	.	PUNCT
iajs-2653	116	1	7.podolsky	7.podolsky	NUM
iajs-2653	116	2	,	,	PUNCT
iajs-2653	117	1	d	d	NOUN
iajs-2653	117	2	.	.	PUNCT
iajs-2653	118	1	k	k	PROPN
iajs-2653	118	2	.	.	PUNCT
iajs-2653	118	3	;	;	PUNCT
iajs-2653	118	4	isselbacher	isselbacher	PROPN
iajs-2653	118	5	,	,	PUNCT
iajs-2653	118	6	k	k	PROPN
iajs-2653	118	7	.j	.j	PROPN
iajs-2653	118	8	.	.	PUNCT
iajs-2653	119	1	derangements	derangement	NOUN
iajs-2653	119	2	of	of	ADP
iajs-2653	119	3	hepatic	hepatic	ADJ
iajs-2653	119	4	metabolism	metabolism	NOUN
iajs-2653	119	5	.	.	PUNCT
iajs-2653	120	1	harrison	harrison	PROPN
iajs-2653	120	2	's	's	PART
iajs-2653	120	3	principles	principle	NOUN
iajs-2653	120	4	of	of	ADP
iajs-2653	120	5	internal	internal	ADJ
iajs-2653	120	6	medicine	medicine	NOUN
iajs-2653	120	7	,	,	PUNCT
iajs-2653	120	8	12thed	12thed	NUM
iajs-2653	120	9	,	,	PUNCT
iajs-2653	120	10	mc	mc	PROPN
iajs-2653	120	11	graw	graw	PROPN
iajs-2653	120	12	-	-	PUNCT
iajs-2653	120	13	hill	hill	NOUN
iajs-2653	120	14	co	co	NOUN
iajs-2653	120	15	,	,	PUNCT
iajs-2653	120	16	new	new	PROPN
iajs-2653	120	17	york	york	PROPN
iajs-2653	120	18	,	,	PUNCT
iajs-2653	120	19	1991	1991	NUM
iajs-2653	120	20	,	,	PUNCT
iajs-2653	120	21	p1311	p1311	NOUN
iajs-2653	120	22	-	-	PUNCT
iajs-2653	120	23	1317	1317	NUM
iajs-2653	120	24	.	.	PUNCT
iajs-2653	121	1	8.gitlin	8.gitlin	NUM
iajs-2653	121	2	,	,	PUNCT
iajs-2653	121	3	j.	j.	PROPN
iajs-2653	121	4	d.	d.	PROPN
iajs-2653	121	5	aceruloplasminemia	aceruloplasminemia	PROPN
iajs-2653	121	6	.	.	PUNCT
iajs-2653	122	1	pediatr	pediatr	ADJ
iajs-2653	122	2	.	.	PUNCT
iajs-2653	123	1	res.1998	res.1998	PROPN
iajs-2653	123	2	,	,	PUNCT
iajs-2653	123	3	44,271–276	44,271–276	PROPN
iajs-2653	123	4	.	.	PUNCT
iajs-2653	124	1	9.kunapuli	9.kunapuli	NUM
iajs-2653	124	2	,	,	PUNCT
iajs-2653	124	3	s.p	s.p	PROPN
iajs-2653	124	4	.	.	PROPN
iajs-2653	124	5	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	124	6	gene	gene	NOUN
iajs-2653	124	7	expression	expression	NOUN
iajs-2653	124	8	in	in	ADP
iajs-2653	124	9	human	human	ADJ
iajs-2653	124	10	cancer	cancer	NOUN
iajs-2653	124	11	cells	cell	NOUN
iajs-2653	124	12	,	,	PUNCT
iajs-2653	124	13	life	life	NOUN
iajs-2653	124	14	sci.1987	sci.1987	ADP
iajs-2653	124	15	,	,	PUNCT
iajs-2653	124	16	40(23),2225–2228	40(23),2225–2228	NUM
iajs-2653	124	17	.	.	PUNCT
iajs-2653	125	1	10.stivens	10.stivens	NUM
iajs-2653	125	2	,	,	PUNCT
iajs-2653	125	3	m.d	m.d	PROPN
iajs-2653	125	4	.	.	PROPN
iajs-2653	125	5	;	;	PUNCT
iajs-2653	125	6	di	di	PROPN
iajs-2653	125	7	silvestro	silvestro	PROPN
iajs-2653	125	8	,	,	PUNCT
iajs-2653	125	9	r.a	r.a	PROPN
iajs-2653	125	10	.	.	PROPN
iajs-2653	125	11	;	;	PUNCT
iajs-2653	125	12	harris	harris	PROPN
iajs-2653	125	13	,	,	PUNCT
iajs-2653	125	14	e.d	e.d	PROPN
iajs-2653	125	15	.	.	PROPN
iajs-2653	125	16	;	;	PUNCT
iajs-2653	125	17	specific	specific	ADJ
iajs-2653	125	18	receptor	receptor	NOUN
iajs-2653	125	19	for	for	ADP
iajs-2653	125	20	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	125	21	in	in	ADP
iajs-2653	125	22	membrane	membrane	NOUN
iajs-2653	125	23	fragments	fragment	NOUN
iajs-2653	125	24	from	from	ADP
iajs-2653	125	25	aortic	aortic	ADJ
iajs-2653	125	26	and	and	CCONJ
iajs-2653	125	27	heart	heart	NOUN
iajs-2653	125	28	tissues	tissue	NOUN
iajs-2653	125	29	,	,	PUNCT
iajs-2653	125	30	biochemistry	biochemistry	NOUN
iajs-2653	125	31	,	,	PUNCT
iajs-2653	125	32	1984	1984	NUM
iajs-2653	125	33	,	,	PUNCT
iajs-2653	125	34	23(2	23(2	NUM
iajs-2653	125	35	)	)	PUNCT
iajs-2653	125	36	,	,	PUNCT
iajs-2653	125	37	261–266	261–266	NUM
iajs-2653	125	38	.	.	PUNCT
iajs-2653	126	1	11.gutteridge	11.gutteridge	NUM
iajs-2653	126	2	,	,	PUNCT
iajs-2653	126	3	j.	j.	PROPN
iajs-2653	126	4	m.	m.	PROPN
iajs-2653	126	5	antioxidant	antioxidant	NOUN
iajs-2653	126	6	properties	property	NOUN
iajs-2653	126	7	of	of	ADP
iajs-2653	126	8	caeruloplasmin	caeruloplasmin	NOUN
iajs-2653	126	9	towards	towards	ADP
iajs-2653	126	10	ironand	ironand	NOUN
iajs-2653	126	11	copperdependent	copperdependent	PROPN
iajs-2653	126	12	oxygen	oxygen	NOUN
iajs-2653	126	13	radical	radical	ADJ
iajs-2653	126	14	formation	formation	NOUN
iajs-2653	126	15	.	.	PUNCT
iajs-2653	127	1	febs	febs	PROPN
iajs-2653	127	2	lett.1983	lett.1983	PROPN
iajs-2653	127	3	,	,	PUNCT
iajs-2653	127	4	157(1	157(1	NUM
iajs-2653	127	5	)	)	PUNCT
iajs-2653	127	6	,	,	PUNCT
iajs-2653	127	7	37–40	37–40	NUM
iajs-2653	127	8	.	.	PUNCT
iajs-2653	128	1	12.mukhopadhyay	12.mukhopadhyay	NUM
iajs-2653	128	2	,	,	PUNCT
iajs-2653	128	3	c	c	PROPN
iajs-2653	128	4	.	.	PUNCT
iajs-2653	129	1	k.	k.	PROPN
iajs-2653	129	2	b.	b.	PROPN
iajs-2653	129	3	;	;	PUNCT
iajs-2653	130	1	mazumder	mazumder	NOUN
iajs-2653	130	2	,	,	PUNCT
iajs-2653	130	3	p	p	PROPN
iajs-2653	130	4	.f	.f	PROPN
iajs-2653	130	5	.l	.l	PROPN
iajs-2653	130	6	.	.	PUNCT
iajs-2653	130	7	;	;	PUNCT
iajs-2653	131	1	fox	fox	PROPN
iajs-2653	131	2	,	,	PUNCT
iajs-2653	131	3	p	p	X
iajs-2653	131	4	.	.	PUNCT
iajs-2653	132	1	l	l	NOUN
iajs-2653	132	2	.	.	PUNCT
iajs-2653	133	1	identification	identification	NOUN
iajs-2653	133	2	of	of	ADP
iajs-2653	133	3	the	the	DET
iajs-2653	133	4	prooxidant	prooxidant	ADJ
iajs-2653	133	5	site	site	NOUN
iajs-2653	133	6	of	of	ADP
iajs-2653	133	7	human	human	PROPN
iajs-2653	133	8	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	133	9	:	:	PUNCT
iajs-2653	133	10	a	a	DET
iajs-2653	133	11	model	model	NOUN
iajs-2653	133	12	for	for	ADP
iajs-2653	133	13	oxidative	oxidative	ADJ
iajs-2653	133	14	damage	damage	NOUN
iajs-2653	133	15	by	by	ADP
iajs-2653	133	16	copper	copper	NOUN
iajs-2653	133	17	bound	bind	VERB
iajs-2653	133	18	to	to	ADP
iajs-2653	133	19	protein	protein	NOUN
iajs-2653	133	20	surfaces	surface	NOUN
iajs-2653	133	21	.	.	PUNCT
iajs-2653	134	1	proc	proc	PROPN
iajs-2653	134	2	natl	natl	PROPN
iajs-2653	134	3	acad	acad	PROPN
iajs-2653	134	4	sci	sci	PROPN
iajs-2653	134	5	u	u	PROPN
iajs-2653	134	6	s	s	PART
iajs-2653	134	7	a.1997	a.1997	NOUN
iajs-2653	134	8	,	,	PUNCT
iajs-2653	134	9	94	94	NUM
iajs-2653	134	10	(	(	PUNCT
iajs-2653	134	11	21),11546–11551	21),11546–11551	NOUN
iajs-2653	134	12	.	.	PUNCT
iajs-2653	135	1	13.bento	13.bento	NUM
iajs-2653	135	2	,	,	PUNCT
iajs-2653	135	3	i	i	INTJ
iajs-2653	135	4	.	.	PUNCT
iajs-2653	135	5	;	;	PUNCT
iajs-2653	135	6	peixoto	peixoto	NOUN
iajs-2653	135	7	,	,	PUNCT
iajs-2653	135	8	c	c	PROPN
iajs-2653	135	9	.	.	PUNCT
iajs-2653	135	10	;	;	PUNCT
iajs-2653	135	11	zaitsev	zaitsev	X
iajs-2653	135	12	,	,	PUNCT
iajs-2653	135	13	v.n	v.n	PROPN
iajs-2653	135	14	.	.	PROPN
iajs-2653	135	15	;	;	PUNCT
iajs-2653	135	16	lindley	lindley	NOUN
iajs-2653	135	17	,	,	PUNCT
iajs-2653	135	18	p	p	NOUN
iajs-2653	135	19	.f	.f	PROPN
iajs-2653	135	20	.	.	PUNCT
iajs-2653	136	1	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	136	2	revisited	revisit	VERB
iajs-2653	136	3	:	:	PUNCT
iajs-2653	136	4	structural	structural	ADJ
iajs-2653	136	5	and	and	CCONJ
iajs-2653	136	6	functional	functional	ADJ
iajs-2653	136	7	roles	role	NOUN
iajs-2653	136	8	of	of	ADP
iajs-2653	136	9	various	various	ADJ
iajs-2653	136	10	metal	metal	NOUN
iajs-2653	136	11	cationbinding	cationbinde	VERB
iajs-2653	136	12	sites	site	NOUN
iajs-2653	136	13	.	.	PUNCT
iajs-2653	137	1	acta	acta	PROPN
iajs-2653	137	2	cryst	cryst	PROPN
iajs-2653	137	3	.	.	PUNCT
iajs-2653	138	1	d	d	X
iajs-2653	138	2	,	,	PUNCT
iajs-2653	138	3	2007	2007	NUM
iajs-2653	138	4	,	,	PUNCT
iajs-2653	138	5	63(2	63(2	NUM
iajs-2653	138	6	)	)	PUNCT
iajs-2653	138	7	,	,	PUNCT
iajs-2653	138	8	240–248	240–248	NUM
iajs-2653	138	9	.	.	PUNCT
iajs-2653	139	1	14.harris	14.harris	NUM
iajs-2653	139	2	,	,	PUNCT
iajs-2653	139	3	e.	e.	PROPN
iajs-2653	139	4	d.	d.	PROPN
iajs-2653	139	5	the	the	DET
iajs-2653	139	6	transport	transport	NOUN
iajs-2653	139	7	of	of	ADP
iajs-2653	139	8	copper	copper	NOUN
iajs-2653	139	9	review	review	NOUN
iajs-2653	139	10	.	.	PUNCT
iajs-2653	140	1	prog	prog	PROPN
iajs-2653	140	2	.	.	PUNCT
iajs-2653	141	1	clin	clin	PROPN
iajs-2653	141	2	.	.	PUNCT
iajs-2653	142	1	biol	biol	PROPN
iajs-2653	142	2	.	.	PUNCT
iajs-2653	143	1	res	re	NOUN
iajs-2653	143	2	.	.	PROPN
iajs-2653	143	3	1993	1993	NUM
iajs-2653	143	4	,	,	PUNCT
iajs-2653	143	5	380:163–179	380:163–179	NUM
iajs-2653	143	6	.	.	PUNCT
iajs-2653	144	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2653	144	2	special	special	ADJ
iajs-2653	144	3	issue	issue	NOUN
iajs-2653	144	4	1ihicpas	1ihicpas	NUM
iajs-2653	144	5	202	202	NUM
iajs-2653	144	6	ibn	ibn	PROPN
iajs-2653	144	7	al	al	PROPN
iajs-2653	144	8	-	-	PUNCT
iajs-2653	144	9	haitham	haitham	PROPN
iajs-2653	144	10	journal	journal	PROPN
iajs-2653	144	11	for	for	ADP
iajs-2653	144	12	pure	pure	ADJ
iajs-2653	144	13	and	and	CCONJ
iajs-2653	144	14	applied	apply	VERB
iajs-2653	144	15	science	science	NOUN
iajs-2653	144	16	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	144	17	for	for	ADP
iajs-2653	144	18	more	more	ADJ
iajs-2653	144	19	information	information	NOUN
iajs-2653	144	20	about	about	ADP
iajs-2653	144	21	the	the	DET
iajs-2653	144	22	conference	conference	NOUN
iajs-2653	144	23	please	please	INTJ
iajs-2653	144	24	visit	visit	VERB
iajs-2653	144	25	the	the	DET
iajs-2653	144	26	websites	website	NOUN
iajs-2653	144	27	:	:	PUNCT
iajs-2653	144	28	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	144	29	c	c	NOUN
iajs-2653	144	30	h	h	NOUN
iajs-2653	145	1	e	e	NOUN
iajs-2653	145	2	m	m	VERB
iajs-2653	145	3	i	i	NOUN
iajs-2653	145	4	s	s	VERB
iajs-2653	145	5	t	t	PROPN
iajs-2653	145	6	r	r	NOUN
iajs-2653	145	7	y	y	PROPN
iajs-2653	146	1	|	|	ADV
iajs-2653	146	2	74	74	NUM
iajs-2653	146	3	15.zaitsev	15.zaitsev	NUM
iajs-2653	146	4	,	,	PUNCT
iajs-2653	146	5	v.n	v.n	PROPN
iajs-2653	146	6	.	.	PROPN
iajs-2653	146	7	;	;	PUNCT
iajs-2653	146	8	zaitseva	zaitseva	PROPN
iajs-2653	146	9	,	,	PUNCT
iajs-2653	146	10	i.;papiz	i.;papiz	PROPN
iajs-2653	146	11	,	,	PUNCT
iajs-2653	146	12	m.	m.	NOUN
iajs-2653	146	13	;	;	PUNCT
iajs-2653	146	14	lindley	lindley	PROPN
iajs-2653	146	15	,	,	PUNCT
iajs-2653	146	16	p.f	p.f	PROPN
iajs-2653	146	17	.	.	PROPN
iajs-2653	146	18	an	an	DET
iajs-2653	146	19	x	x	ADJ
iajs-2653	146	20	-	-	NOUN
iajs-2653	146	21	ray	ray	NOUN
iajs-2653	146	22	crystallographic	crystallographic	ADJ
iajs-2653	146	23	study	study	NOUN
iajs-2653	146	24	of	of	ADP
iajs-2653	146	25	the	the	DET
iajs-2653	146	26	binding	bind	VERB
iajs-2653	146	27	sites	site	NOUN
iajs-2653	146	28	of	of	ADP
iajs-2653	146	29	the	the	DET
iajs-2653	146	30	azide	azide	NOUN
iajs-2653	146	31	inhibitor	inhibitor	NOUN
iajs-2653	146	32	and	and	CCONJ
iajs-2653	146	33	organic	organic	ADJ
iajs-2653	146	34	substrates	substrate	NOUN
iajs-2653	146	35	to	to	ADP
iajs-2653	146	36	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	146	37	,	,	PUNCT
iajs-2653	146	38	a	a	DET
iajs-2653	146	39	multi	multi	ADJ
iajs-2653	146	40	-	-	ADJ
iajs-2653	146	41	copper	copper	ADJ
iajs-2653	146	42	oxidase	oxidase	NOUN
iajs-2653	146	43	in	in	ADP
iajs-2653	146	44	the	the	DET
iajs-2653	146	45	plasma	plasma	NOUN
iajs-2653	146	46	.	.	PUNCT
iajs-2653	147	1	j.	j.	PROPN
iajs-2653	147	2	biol	biol	PROPN
iajs-2653	147	3	.	.	PUNCT
iajs-2653	148	1	inorg	inorg	PROPN
iajs-2653	148	2	.	.	PUNCT
iajs-2653	149	1	chem	chem	PROPN
iajs-2653	149	2	.	.	PUNCT
iajs-2653	150	1	1999	1999	NUM
iajs-2653	150	2	,	,	PUNCT
iajs-2653	150	3	4(5	4(5	NUM
iajs-2653	150	4	)	)	PUNCT
iajs-2653	150	5	,	,	PUNCT
iajs-2653	150	6	579	579	NUM
iajs-2653	150	7	–	–	PUNCT
iajs-2653	150	8	587	587	NUM
iajs-2653	150	9	.	.	PUNCT
iajs-2653	151	1	16.bianchini	16.bianchini	NUM
iajs-2653	151	2	,	,	PUNCT
iajs-2653	151	3	a.	a.	NOUN
iajs-2653	151	4	;	;	PUNCT
iajs-2653	151	5	musci	musci	PROPN
iajs-2653	151	6	,	,	PUNCT
iajs-2653	151	7	g.	g.	PROPN
iajs-2653	151	8	;	;	PUNCT
iajs-2653	151	9	calabrese	calabrese	NOUN
iajs-2653	151	10	,	,	PUNCT
iajs-2653	151	11	l.	l.	NOUN
iajs-2653	151	12	inhibition	inhibition	NOUN
iajs-2653	151	13	of	of	ADP
iajs-2653	151	14	endothelial	endothelial	ADJ
iajs-2653	151	15	nitric	nitric	ADJ
iajs-2653	151	16	-	-	PUNCT
iajs-2653	151	17	oxide	oxide	NOUN
iajs-2653	151	18	synthase	synthase	NOUN
iajs-2653	151	19	by	by	ADP
iajs-2653	151	20	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	151	21	.	.	PUNCT
iajs-2653	152	1	j.	j.	PROPN
iajs-2653	152	2	biol	biol	PROPN
iajs-2653	152	3	.	.	PUNCT
iajs-2653	153	1	chem	chem	PROPN
iajs-2653	153	2	.	.	PUNCT
iajs-2653	154	1	1999	1999	NUM
iajs-2653	154	2	,	,	PUNCT
iajs-2653	154	3	274(29	274(29	NUM
iajs-2653	154	4	)	)	PUNCT
iajs-2653	154	5	,	,	PUNCT
iajs-2653	154	6	20265–20270	20265–20270	NUM
iajs-2653	154	7	.	.	PUNCT
iajs-2653	155	1	17.huang	17.huang	NUM
iajs-2653	155	2	,	,	PUNCT
iajs-2653	155	3	x.	x.	NOUN
iajs-2653	155	4	iron	iron	NOUN
iajs-2653	155	5	overload	overload	NOUN
iajs-2653	155	6	and	and	CCONJ
iajs-2653	155	7	its	its	PRON
iajs-2653	155	8	association	association	NOUN
iajs-2653	155	9	with	with	ADP
iajs-2653	155	10	cancer	cancer	NOUN
iajs-2653	155	11	risk	risk	NOUN
iajs-2653	155	12	in	in	ADP
iajs-2653	155	13	humans	human	NOUN
iajs-2653	155	14	:	:	PUNCT
iajs-2653	155	15	evidence	evidence	NOUN
iajs-2653	155	16	for	for	ADP
iajs-2653	155	17	iron	iron	NOUN
iajs-2653	155	18	as	as	ADP
iajs-2653	155	19	a	a	DET
iajs-2653	155	20	carcinogenic	carcinogenic	ADJ
iajs-2653	155	21	metal	metal	NOUN
iajs-2653	155	22	.	.	PUNCT
iajs-2653	156	1	mutat	mutat	ADJ
iajs-2653	156	2	res	re	NOUN
iajs-2653	156	3	-	-	PUNCT
iajs-2653	156	4	fund	fund	NOUN
iajs-2653	156	5	mol	mol	ADP
iajs-2653	156	6	m.	m.	NOUN
iajs-2653	156	7	2003	2003	NUM
iajs-2653	156	8	,	,	PUNCT
iajs-2653	156	9	533(1	533(1	NUM
iajs-2653	156	10	-	-	SYM
iajs-2653	156	11	2	2	NUM
iajs-2653	156	12	)	)	PUNCT
iajs-2653	156	13	,	,	PUNCT
iajs-2653	156	14	153–171	153–171	NUM
iajs-2653	156	15	.	.	PUNCT
iajs-2653	157	1	18.osaki	18.osaki	NUM
iajs-2653	157	2	,	,	PUNCT
iajs-2653	157	3	s.	s.	PROPN
iajs-2653	157	4	kinetic	kinetic	PROPN
iajs-2653	157	5	studies	study	NOUN
iajs-2653	157	6	of	of	ADP
iajs-2653	157	7	ferrous	ferrous	ADJ
iajs-2653	157	8	ion	ion	NOUN
iajs-2653	157	9	oxidation	oxidation	NOUN
iajs-2653	157	10	with	with	ADP
iajs-2653	157	11	crystalline	crystalline	ADJ
iajs-2653	157	12	human	human	ADJ
iajs-2653	157	13	ferroxidase	ferroxidase	NOUN
iajs-2653	157	14	(	(	PUNCT
iajs-2653	157	15	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	157	16	)	)	PUNCT
iajs-2653	157	17	.	.	PUNCT
iajs-2653	158	1	j.	j.	PROPN
iajs-2653	158	2	biol	biol	PROPN
iajs-2653	158	3	.	.	PUNCT
iajs-2653	159	1	chem	chem	NOUN
iajs-2653	159	2	.	.	PUNCT
iajs-2653	160	1	1966	1966	NUM
iajs-2653	160	2	,	,	PUNCT
iajs-2653	160	3	241(21	241(21	NUM
iajs-2653	160	4	)	)	PUNCT
iajs-2653	160	5	,	,	PUNCT
iajs-2653	160	6	5053–5059	5053–5059	NUM
iajs-2653	160	7	.	.	PUNCT
iajs-2653	161	1	19.osaki	19.osaki	NUM
iajs-2653	161	2	,	,	PUNCT
iajs-2653	161	3	s.	s.	PROPN
iajs-2653	161	4	;	;	PUNCT
iajs-2653	161	5	johnson	johnson	PROPN
iajs-2653	161	6	,	,	PUNCT
iajs-2653	161	7	d	d	PROPN
iajs-2653	161	8	.	.	PUNCT
iajs-2653	161	9	a.	a.	NOUN
iajs-2653	161	10	;	;	PUNCT
iajs-2653	161	11	frieden	frieden	PROPN
iajs-2653	161	12	,	,	PUNCT
iajs-2653	161	13	e.	e.	PROPN
iajs-2653	161	14	the	the	DET
iajs-2653	161	15	possible	possible	ADJ
iajs-2653	161	16	significance	significance	NOUN
iajs-2653	161	17	of	of	ADP
iajs-2653	161	18	the	the	DET
iajs-2653	161	19	ferrous	ferrous	ADJ
iajs-2653	161	20	oxidase	oxidase	NOUN
iajs-2653	161	21	activity	activity	NOUN
iajs-2653	161	22	of	of	ADP
iajs-2653	161	23	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	161	24	in	in	ADP
iajs-2653	161	25	normal	normal	ADJ
iajs-2653	161	26	human	human	ADJ
iajs-2653	161	27	serum	serum	NOUN
iajs-2653	161	28	.	.	PUNCT
iajs-2653	162	1	j.	j.	PROPN
iajs-2653	162	2	biol	biol	PROPN
iajs-2653	162	3	.	.	PUNCT
iajs-2653	163	1	chem	chem	PROPN
iajs-2653	163	2	.	.	PUNCT
iajs-2653	164	1	1966	1966	NUM
iajs-2653	164	2	,	,	PUNCT
iajs-2653	164	3	241(12	241(12	NUM
iajs-2653	164	4	)	)	PUNCT
iajs-2653	164	5	,	,	PUNCT
iajs-2653	164	6	2746–2751	2746–2751	PROPN
iajs-2653	164	7	20.sarkar	20.sarkar	NUM
iajs-2653	164	8	,	,	PUNCT
iajs-2653	164	9	j.	j.	PROPN
iajs-2653	164	10	;	;	PUNCT
iajs-2653	164	11	seshadri	seshadri	PROPN
iajs-2653	164	12	,	,	PUNCT
iajs-2653	164	13	v.	v.	ADV
iajs-2653	164	14	;	;	PUNCT
iajs-2653	164	15	tripoulas	tripoula	NOUN
iajs-2653	164	16	,	,	PUNCT
iajs-2653	164	17	n.	n.	PROPN
iajs-2653	164	18	a.	a.	NOUN
iajs-2653	164	19	;	;	PUNCT
iajs-2653	164	20	ketterer	ketterer	PROPN
iajs-2653	164	21	,	,	PUNCT
iajs-2653	164	22	m	m	PROPN
iajs-2653	164	23	.	.	PUNCT
iajs-2653	165	1	e.	e.	PROPN
iajs-2653	165	2	;	;	PUNCT
iajs-2653	165	3	fox	fox	PROPN
iajs-2653	165	4	,	,	PUNCT
iajs-2653	165	5	p	p	X
iajs-2653	165	6	.	.	PUNCT
iajs-2653	166	1	l.	l.	PROPN
iajs-2653	166	2	role	role	NOUN
iajs-2653	166	3	of	of	ADP
iajs-2653	166	4	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	166	5	in	in	ADP
iajs-2653	166	6	macrophage	macrophage	ADJ
iajs-2653	166	7	iron	iron	NOUN
iajs-2653	166	8	efflux	efflux	NOUN
iajs-2653	166	9	during	during	ADP
iajs-2653	166	10	hypoxia	hypoxia	NOUN
iajs-2653	166	11	.	.	PUNCT
iajs-2653	167	1	j.	j.	PROPN
iajs-2653	167	2	biol	biol	PROPN
iajs-2653	167	3	.	.	PUNCT
iajs-2653	168	1	chem.2003	chem.2003	ADJ
iajs-2653	168	2	,	,	PUNCT
iajs-2653	168	3	278(45	278(45	NUM
iajs-2653	168	4	)	)	PUNCT
iajs-2653	168	5	,	,	PUNCT
iajs-2653	168	6	4401844024	4401844024	NUM
iajs-2653	168	7	.	.	PUNCT
iajs-2653	169	1	21.rice	21.rice	NUM
iajs-2653	169	2	,	,	PUNCT
iajs-2653	169	3	e.w	e.w	PROPN
iajs-2653	169	4	.	.	NOUN
iajs-2653	169	5	standardization	standardization	NOUN
iajs-2653	169	6	of	of	ADP
iajs-2653	169	7	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	169	8	activity	activity	NOUN
iajs-2653	169	9	in	in	ADP
iajs-2653	169	10	terms	term	NOUN
iajs-2653	169	11	of	of	ADP
iajs-2653	169	12	international	international	ADJ
iajs-2653	169	13	enzyme	enzyme	NOUN
iajs-2653	169	14	units	unit	NOUN
iajs-2653	169	15	.	.	PUNCT
iajs-2653	170	1	anal	anal	PROPN
iajs-2653	170	2	.	.	PUNCT
iajs-2653	170	3	biochem	biochem	PROPN
iajs-2653	170	4	..	..	PUNCT
iajs-2653	170	5	1962	1962	NUM
iajs-2653	170	6	,	,	PUNCT
iajs-2653	170	7	3(6),452	3(6),452	PROPN
iajs-2653	170	8	-	-	SYM
iajs-2653	170	9	456	456	NUM
iajs-2653	170	10	.	.	PUNCT
iajs-2653	171	1	22.gornall	22.gornall	X
iajs-2653	171	2	,	,	PUNCT
iajs-2653	171	3	a.	a.	NOUN
iajs-2653	171	4	g.	g.	PROPN
iajs-2653	171	5	;	;	PUNCT
iajs-2653	171	6	bardawill	bardawill	PROPN
iajs-2653	171	7	,	,	PUNCT
iajs-2653	171	8	c.	c.	PROPN
iajs-2653	171	9	j.	j.	PROPN
iajs-2653	171	10	;	;	PUNCT
iajs-2653	171	11	david	david	PROPN
iajs-2653	171	12	,	,	PUNCT
iajs-2653	171	13	m.	m.	NOUN
iajs-2653	171	14	m.	m.	NOUN
iajs-2653	171	15	.	.	PUNCT
iajs-2653	172	1	;	;	PUNCT
iajs-2653	172	2	determination	determination	NOUN
iajs-2653	172	3	of	of	ADP
iajs-2653	172	4	serum	serum	NOUN
iajs-2653	172	5	proteins	protein	NOUN
iajs-2653	172	6	by	by	ADP
iajs-2653	172	7	means	mean	NOUN
iajs-2653	172	8	of	of	ADP
iajs-2653	172	9	the	the	DET
iajs-2653	172	10	biuret	biuret	NOUN
iajs-2653	172	11	reaction	reaction	NOUN
iajs-2653	172	12	.	.	PUNCT
iajs-2653	173	1	j.	j.	PROPN
iajs-2653	173	2	biol	biol	PROPN
iajs-2653	173	3	.	.	PUNCT
iajs-2653	174	1	chem.1949	chem.1949	X
iajs-2653	174	2	,	,	PUNCT
iajs-2653	174	3	177(2	177(2	NUM
iajs-2653	174	4	)	)	PUNCT
iajs-2653	174	5	,	,	PUNCT
iajs-2653	174	6	751	751	NUM
iajs-2653	174	7	-	-	SYM
iajs-2653	174	8	766	766	NUM
iajs-2653	174	9	.	.	PUNCT
iajs-2653	175	1	23.tietz	23.tietz	NUM
iajs-2653	175	2	,	,	PUNCT
iajs-2653	175	3	n	n	X
iajs-2653	175	4	.	.	PUNCT
iajs-2653	176	1	w.	w.	NOUN
iajs-2653	176	2	text	text	NOUN
iajs-2653	176	3	book	book	NOUN
iajs-2653	176	4	of	of	ADP
iajs-2653	176	5	chlinical	chlinical	ADJ
iajs-2653	176	6	chemistry	chemistry	NOUN
iajs-2653	176	7	,	,	PUNCT
iajs-2653	176	8	3rd	3rd	ADJ
iajs-2653	176	9	ed	ed	NOUN
iajs-2653	176	10	.	.	PUNCT
iajs-2653	177	1	c.a	c.a	PROPN
iajs-2653	177	2	.	.	PROPN
iajs-2653	177	3	curtis	curtis	PROPN
iajs-2653	177	4	,	,	PUNCT
iajs-2653	177	5	e.r	e.r	PROPN
iajs-2653	177	6	.	.	PROPN
iajs-2653	177	7	silverman	silverman	PROPN
iajs-2653	177	8	l.	l.	PROPN
iajs-2653	177	9	m.	m.	PROPN
iajs-2653	177	10	,	,	PUNCT
iajs-2653	177	11	christensen	christensen	PROPN
iajs-2653	177	12	r.	r.	PROPN
iajs-2653	177	13	h.1995	h.1995	PROPN
iajs-2653	177	14	,	,	PUNCT
iajs-2653	177	15	p.	p.	NOUN
iajs-2653	177	16	523	523	NUM
iajs-2653	177	17	-	-	SYM
iajs-2653	177	18	524	524	NUM
iajs-2653	177	19	.	.	PUNCT
iajs-2653	178	1	24.hennessy	24.hennessy	NUM
iajs-2653	178	2	,	,	PUNCT
iajs-2653	178	3	d.j	d.j	PROPN
iajs-2653	178	4	.	.	PROPN
iajs-2653	178	5	;	;	PUNCT
iajs-2653	178	6	reid	reid	PROPN
iajs-2653	178	7	,	,	PUNCT
iajs-2653	178	8	g.r	g.r	PROPN
iajs-2653	178	9	.	.	PROPN
iajs-2653	178	10	;	;	PUNCT
iajs-2653	178	11	smith	smith	PROPN
iajs-2653	178	12	,	,	PUNCT
iajs-2653	178	13	f.e	f.e	PROPN
iajs-2653	178	14	.	.	PROPN
iajs-2653	178	15	;	;	PUNCT
iajs-2653	179	1	thompson	thompson	PROPN
iajs-2653	179	2	,	,	PUNCT
iajs-2653	179	3	s.l	s.l	PROPN
iajs-2653	179	4	.	.	PROPN
iajs-2653	179	5	ferene	ferene	PROPN
iajs-2653	179	6	—	—	PUNCT
iajs-2653	179	7	a	a	DET
iajs-2653	179	8	new	new	ADJ
iajs-2653	179	9	spectrophotometric	spectrophotometric	ADJ
iajs-2653	179	10	reagent	reagent	NOUN
iajs-2653	179	11	for	for	ADP
iajs-2653	179	12	iron	iron	NOUN
iajs-2653	179	13	.	.	PUNCT
iajs-2653	180	1	can	can	AUX
iajs-2653	180	2	.	.	PUNCT
iajs-2653	181	1	j.	j.	PROPN
iajs-2653	181	2	chem	chem	PROPN
iajs-2653	181	3	..	..	PUNCT
iajs-2653	181	4	1984	1984	NUM
iajs-2653	181	5	,	,	PUNCT
iajs-2653	181	6	62(4	62(4	NUM
iajs-2653	181	7	)	)	PUNCT
iajs-2653	181	8	.	.	PUNCT
iajs-2653	182	1	721	721	NUM
iajs-2653	182	2	-	-	SYM
iajs-2653	182	3	724	724	NUM
iajs-2653	182	4	25.ríos	25.ríos	NUM
iajs-2653	182	5	-	-	NUM
iajs-2653	182	6	arrabal	arrabal	ADJ
iajs-2653	182	7	,	,	PUNCT
iajs-2653	182	8	s.	s.	PROPN
iajs-2653	182	9	;	;	PUNCT
iajs-2653	182	10	artacho	artacho	PROPN
iajs-2653	182	11	-	-	PUNCT
iajs-2653	182	12	cordón	cordón	NOUN
iajs-2653	182	13	,	,	PUNCT
iajs-2653	182	14	f.	f.	PROPN
iajs-2653	182	15	;	;	PUNCT
iajs-2653	182	16	león	león	PROPN
iajs-2653	182	17	,	,	PUNCT
iajs-2653	182	18	j.	j.	PROPN
iajs-2653	182	19	;	;	PUNCT
iajs-2653	182	20	román	román	NOUN
iajs-2653	182	21	-	-	PUNCT
iajs-2653	182	22	marinetto	marinetto	NOUN
iajs-2653	182	23	,	,	PUNCT
iajs-2653	182	24	e.	e.	PROPN
iajs-2653	182	25	;	;	PUNCT
iajs-2653	182	26	del	del	PROPN
iajs-2653	182	27	mar	mar	PROPN
iajs-2653	182	28	salinasasensio	salinasasensio	NOUN
iajs-2653	182	29	,	,	PUNCT
iajs-2653	182	30	m.	m.	NOUN
iajs-2653	182	31	;	;	PUNCT
iajs-2653	182	32	calvente	calvente	PROPN
iajs-2653	182	33	,	,	PUNCT
iajs-2653	182	34	i.	i.	PROPN
iajs-2653	182	35	;	;	PUNCT
iajs-2653	182	36	núñez	núñez	PROPN
iajs-2653	182	37	,	,	PUNCT
iajs-2653	182	38	m.i	m.i	PROPN
iajs-2653	182	39	.	.	PROPN
iajs-2653	182	40	involvement	involvement	NOUN
iajs-2653	182	41	of	of	ADP
iajs-2653	182	42	free	free	ADJ
iajs-2653	182	43	radicals	radical	NOUN
iajs-2653	182	44	in	in	ADP
iajs-2653	182	45	breast	breast	NOUN
iajs-2653	182	46	cancer	cancer	NOUN
iajs-2653	182	47	.	.	PUNCT
iajs-2653	183	1	nvolvement	nvolvement	ADJ
iajs-2653	183	2	of	of	ADP
iajs-2653	183	3	free	free	ADJ
iajs-2653	183	4	radicals	radical	NOUN
iajs-2653	183	5	in	in	ADP
iajs-2653	183	6	breast	breast	NOUN
iajs-2653	183	7	cancer	cancer	NOUN
iajs-2653	183	8	.	.	PUNCT
iajs-2653	184	1	springerplus	springerplus	PROPN
iajs-2653	184	2	.	.	PROPN
iajs-2653	184	3	2013	2013	NUM
iajs-2653	184	4	,	,	PUNCT
iajs-2653	184	5	2(1	2(1	NUM
iajs-2653	184	6	)	)	PUNCT
iajs-2653	184	7	,	,	PUNCT
iajs-2653	184	8	1	1	NUM
iajs-2653	184	9	-	-	SYM
iajs-2653	184	10	12	12	NUM
iajs-2653	184	11	.	.	PUNCT
iajs-2653	185	1	26.teixeira	26.teixeira	NUM
iajs-2653	185	2	,	,	PUNCT
iajs-2653	185	3	v	v	NOUN
iajs-2653	185	4	.	.	PUNCT
iajs-2653	185	5	;	;	PUNCT
iajs-2653	186	1	valente	valente	PROPN
iajs-2653	186	2	,	,	PUNCT
iajs-2653	186	3	h.	h.	PROPN
iajs-2653	186	4	;	;	PUNCT
iajs-2653	186	5	casal	casal	PROPN
iajs-2653	186	6	,	,	PUNCT
iajs-2653	186	7	s.	s.	PROPN
iajs-2653	186	8	;	;	PUNCT
iajs-2653	186	9	marques	marques	PROPN
iajs-2653	186	10	,	,	PUNCT
iajs-2653	186	11	f.	f.	PROPN
iajs-2653	186	12	;	;	PUNCT
iajs-2653	186	13	moreira	moreira	PROPN
iajs-2653	186	14	,	,	PUNCT
iajs-2653	186	15	p.	p.	NOUN
iajs-2653	186	16	blood	blood	NOUN
iajs-2653	186	17	antioxidant	antioxidant	NOUN
iajs-2653	186	18	and	and	CCONJ
iajs-2653	186	19	oxidative	oxidative	ADJ
iajs-2653	186	20	stress	stress	NOUN
iajs-2653	186	21	biomarkers	biomarker	NOUN
iajs-2653	186	22	acute	acute	ADJ
iajs-2653	186	23	responses	response	NOUN
iajs-2653	186	24	to	to	ADP
iajs-2653	186	25	a	a	DET
iajs-2653	186	26	1000	1000	NUM
iajs-2653	186	27	-	-	PUNCT
iajs-2653	186	28	m	m	NOUN
iajs-2653	186	29	kayak	kayak	NOUN
iajs-2653	186	30	sprint	sprint	NOUN
iajs-2653	186	31	in	in	ADP
iajs-2653	186	32	elite	elite	ADJ
iajs-2653	186	33	male	male	ADJ
iajs-2653	186	34	kayakers	kayaker	NOUN
iajs-2653	186	35	.	.	PUNCT
iajs-2653	187	1	j	j	PROPN
iajs-2653	187	2	sports	sport	NOUN
iajs-2653	187	3	med	med	PROPN
iajs-2653	187	4	phys	phy	NOUN
iajs-2653	187	5	fitness	fitness	NOUN
iajs-2653	187	6	.	.	PUNCT
iajs-2653	188	1	2013	2013	NUM
iajs-2653	188	2	,	,	PUNCT
iajs-2653	188	3	53(1),71–79	53(1),71–79	NUM
iajs-2653	188	4	.	.	PUNCT
iajs-2653	189	1	27.huang	27.huang	NUM
iajs-2653	189	2	,	,	PUNCT
iajs-2653	189	3	x.	x.	NOUN
iajs-2653	189	4	does	do	AUX
iajs-2653	189	5	iron	iron	NOUN
iajs-2653	189	6	have	have	VERB
iajs-2653	189	7	a	a	DET
iajs-2653	189	8	role	role	NOUN
iajs-2653	189	9	in	in	ADP
iajs-2653	189	10	breast	breast	NOUN
iajs-2653	189	11	cancer	cancer	NOUN
iajs-2653	189	12	.	.	PUNCT
iajs-2653	190	1	lancet	lancet	PROPN
iajs-2653	190	2	oncol	oncol	PROPN
iajs-2653	190	3	.2008	.2008	PROPN
iajs-2653	190	4	,	,	PUNCT
iajs-2653	190	5	9(8	9(8	NUM
iajs-2653	190	6	)	)	PUNCT
iajs-2653	190	7	,	,	PUNCT
iajs-2653	190	8	803–807	803–807	NUM
iajs-2653	190	9	.	.	PUNCT
iajs-2653	191	1	28.wherland	28.wherland	NUM
iajs-2653	191	2	,	,	PUNCT
iajs-2653	191	3	s.	s.	PROPN
iajs-2653	191	4	;	;	PUNCT
iajs-2653	191	5	farver	farver	PROPN
iajs-2653	191	6	,	,	PUNCT
iajs-2653	191	7	o.	o.	INTJ
iajs-2653	191	8	;	;	PUNCT
iajs-2653	191	9	pecht	pecht	NOUN
iajs-2653	191	10	,	,	PUNCT
iajs-2653	191	11	i.	i.	PROPN
iajs-2653	191	12	multicopper	multicopper	PROPN
iajs-2653	191	13	oxidases	oxidase	NOUN
iajs-2653	191	14	:	:	PUNCT
iajs-2653	191	15	intramolecular	intramolecular	ADJ
iajs-2653	191	16	electron	electron	NOUN
iajs-2653	191	17	transfer	transfer	NOUN
iajs-2653	191	18	and	and	CCONJ
iajs-2653	191	19	o2	o2	ADJ
iajs-2653	191	20	reduction	reduction	NOUN
iajs-2653	191	21	.	.	PUNCT
iajs-2653	192	1	j.	j.	PROPN
iajs-2653	192	2	biol	biol	PROPN
iajs-2653	192	3	.	.	PUNCT
iajs-2653	193	1	inorg	inorg	PROPN
iajs-2653	193	2	.	.	PUNCT
iajs-2653	194	1	chem	chem	PROPN
iajs-2653	194	2	.	.	PUNCT
iajs-2653	195	1	2014	2014	NUM
iajs-2653	195	2	,	,	PUNCT
iajs-2653	195	3	19(4	19(4	NOUN
iajs-2653	195	4	-	-	SYM
iajs-2653	195	5	5	5	NUM
iajs-2653	195	6	)	)	PUNCT
iajs-2653	195	7	,	,	PUNCT
iajs-2653	195	8	541	541	NUM
iajs-2653	195	9	-	-	SYM
iajs-2653	195	10	554	554	NUM
iajs-2653	195	11	.	.	PUNCT
iajs-2653	196	1	29.mainous	29.mainous	NUM
iajs-2653	196	2	,	,	PUNCT
iajs-2653	196	3	a.g	a.g	PROPN
iajs-2653	196	4	.	.	PROPN
iajs-2653	196	5	;	;	PUNCT
iajs-2653	196	6	wells	wells	PROPN
iajs-2653	196	7	,	,	PUNCT
iajs-2653	196	8	b.j	b.j	PROPN
iajs-2653	196	9	.	.	PROPN
iajs-2653	196	10	;	;	PUNCT
iajs-2653	196	11	koopman	koopman	PROPN
iajs-2653	196	12	,	,	PUNCT
iajs-2653	196	13	r.j	r.j	PROPN
iajs-2653	196	14	.	.	PROPN
iajs-2653	196	15	;	;	PUNCT
iajs-2653	196	16	everett	everett	PROPN
iajs-2653	196	17	,	,	PUNCT
iajs-2653	196	18	c.j	c.j	PROPN
iajs-2653	196	19	.	.	PROPN
iajs-2653	196	20	;	;	PUNCT
iajs-2653	196	21	gill	gill	NOUN
iajs-2653	196	22	,	,	PUNCT
iajs-2653	196	23	j.m	j.m	PROPN
iajs-2653	196	24	.	.	PROPN
iajs-2653	196	25	,	,	PUNCT
iajs-2653	196	26	2005	2005	NUM
iajs-2653	196	27	.	.	PUNCT
iajs-2653	197	1	iron	iron	NOUN
iajs-2653	197	2	,	,	PUNCT
iajs-2653	197	3	lipids	lipid	NOUN
iajs-2653	197	4	,	,	PUNCT
iajs-2653	197	5	and	and	CCONJ
iajs-2653	197	6	risk	risk	NOUN
iajs-2653	197	7	of	of	ADP
iajs-2653	197	8	cancer	cancer	NOUN
iajs-2653	197	9	in	in	ADP
iajs-2653	197	10	the	the	DET
iajs-2653	197	11	framingham	framingham	PROPN
iajs-2653	197	12	offspring	offspring	NOUN
iajs-2653	197	13	cohort	cohort	NOUN
iajs-2653	197	14	.	.	PUNCT
iajs-2653	198	1	am	be	AUX
iajs-2653	198	2	.	.	PUNCT
iajs-2653	199	1	j.	j.	PROPN
iajs-2653	199	2	epidemiol.2005,161(12),1115	epidemiol.2005,161(12),1115	PROPN
iajs-2653	199	3	–	–	PUNCT
iajs-2653	199	4	1122	1122	NUM
iajs-2653	199	5	.	.	PUNCT
iajs-2653	200	1	30.amber	30.amber	NUM
iajs-2653	200	2	,	,	PUNCT
iajs-2653	200	3	b.m	b.m	AUX
iajs-2653	200	4	.	.	PROPN
iajs-2653	200	5	;	;	PUNCT
iajs-2653	200	6	jackilen	jackilen	VERB
iajs-2653	200	7	,	,	PUNCT
iajs-2653	200	8	s	s	PART
iajs-2653	200	9	.	.	PUNCT
iajs-2653	200	10	;	;	PUNCT
iajs-2653	201	1	david	david	PROPN
iajs-2653	201	2	,	,	PUNCT
iajs-2653	201	3	b.	b.	PROPN
iajs-2653	201	4	t	t	PROPN
iajs-2653	201	5	.dietary	.dietary	NOUN
iajs-2653	201	6	and	and	CCONJ
iajs-2653	201	7	stored	store	VERB
iajs-2653	201	8	iron	iron	NOUN
iajs-2653	201	9	as	as	ADP
iajs-2653	201	10	predictors	predictor	NOUN
iajs-2653	201	11	of	of	ADP
iajs-2653	201	12	breast	breast	NOUN
iajs-2653	201	13	cancer	cancer	NOUN
iajs-2653	201	14	risk	risk	NOUN
iajs-2653	201	15	:	:	PUNCT
iajs-2653	201	16	a	a	DET
iajs-2653	201	17	nested	nested	ADJ
iajs-2653	201	18	case	case	NOUN
iajs-2653	201	19	–	–	PUNCT
iajs-2653	201	20	control	control	NOUN
iajs-2653	201	21	study	study	NOUN
iajs-2653	201	22	in	in	ADP
iajs-2653	201	23	shanghai	shanghai	PROPN
iajs-2653	201	24	.	.	PUNCT
iajs-2653	202	1	int	int	PROPN
iajs-2653	202	2	j	j	PROPN
iajs-2653	202	3	cancer	cancer	NOUN
iajs-2653	202	4	.	.	PUNCT
iajs-2653	203	1	2009	2009	NUM
iajs-2653	203	2	,	,	PUNCT
iajs-2653	203	3	125(5	125(5	NUM
iajs-2653	203	4	)	)	PUNCT
iajs-2653	203	5	,	,	PUNCT
iajs-2653	203	6	1110–1117	1110–1117	NUM
iajs-2653	203	7	.	.	PUNCT
iajs-2653	204	1	31.vaidya	31.vaidya	NUM
iajs-2653	204	2	,	,	PUNCT
iajs-2653	204	3	s.m	s.m	PROPN
iajs-2653	204	4	.	.	PUNCT
iajs-2653	204	5	;	;	PUNCT
iajs-2653	205	1	kamalakar	kamalakar	PROPN
iajs-2653	205	2	,	,	PUNCT
iajs-2653	205	3	p.l	p.l	PROPN
iajs-2653	205	4	.	.	PROPN
iajs-2653	205	5	copper	copper	PROPN
iajs-2653	205	6	and	and	CCONJ
iajs-2653	205	7	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	205	8	levels	level	NOUN
iajs-2653	205	9	in	in	ADP
iajs-2653	205	10	serum	serum	NOUN
iajs-2653	205	11	of	of	ADP
iajs-2653	205	12	women	woman	NOUN
iajs-2653	205	13	with	with	ADP
iajs-2653	205	14	breast	breast	NOUN
iajs-2653	205	15	cancer	cancer	NOUN
iajs-2653	205	16	.	.	PUNCT
iajs-2653	206	1	indian	indian	PROPN
iajs-2653	206	2	j.	j.	PROPN
iajs-2653	206	3	med	med	PROPN
iajs-2653	206	4	.	.	PUNCT
iajs-2653	207	1	sci	sci	PROPN
iajs-2653	207	2	.	.	PROPN
iajs-2653	207	3	1998	1998	NUM
iajs-2653	207	4	,	,	PUNCT
iajs-2653	207	5	52(5),184	52(5),184	NOUN
iajs-2653	207	6	-	-	SYM
iajs-2653	207	7	187	187	NUM
iajs-2653	207	8	.	.	PUNCT
iajs-2653	208	1	32.zowczak	32.zowczak	NUM
iajs-2653	208	2	,	,	PUNCT
iajs-2653	208	3	m.	m.	NOUN
iajs-2653	208	4	;	;	PUNCT
iajs-2653	208	5	iskra	iskra	PROPN
iajs-2653	208	6	,	,	PUNCT
iajs-2653	208	7	m.	m.	NOUN
iajs-2653	208	8	;	;	PUNCT
iajs-2653	208	9	torliński	torliński	PROPN
iajs-2653	208	10	,	,	PUNCT
iajs-2653	208	11	l.	l.	PROPN
iajs-2653	208	12	;	;	PUNCT
iajs-2653	208	13	cofta	cofta	ADV
iajs-2653	208	14	,	,	PUNCT
iajs-2653	208	15	s.	s.	PROPN
iajs-2653	208	16	,analysis	,analysis	PUNCT
iajs-2653	208	17	of	of	ADP
iajs-2653	208	18	serum	serum	PROPN
iajs-2653	208	19	copper	copper	NOUN
iajs-2653	208	20	and	and	CCONJ
iajs-2653	208	21	zinc	zinc	NOUN
iajs-2653	208	22	concentrations	concentration	NOUN
iajs-2653	208	23	in	in	ADP
iajs-2653	208	24	cancer	cancer	NOUN
iajs-2653	208	25	patients	patient	NOUN
iajs-2653	208	26	.	.	PUNCT
iajs-2653	209	1	biol	biol	PROPN
iajs-2653	209	2	.	.	PUNCT
iajs-2653	210	1	trace	trace	NOUN
iajs-2653	210	2	elem	elem	NOUN
iajs-2653	210	3	.	.	PUNCT
iajs-2653	211	1	res	re	NOUN
iajs-2653	211	2	.	.	PROPN
iajs-2653	211	3	2001	2001	NUM
iajs-2653	211	4	,	,	PUNCT
iajs-2653	211	5	82(1),1–8	82(1),1–8	NUM
iajs-2653	211	6	.	.	PUNCT
iajs-2653	212	1	33.varela	33.varela	NUM
iajs-2653	212	2	,	,	PUNCT
iajs-2653	212	3	a.s	a.s	PROPN
iajs-2653	212	4	.	.	PROPN
iajs-2653	212	5	;	;	PUNCT
iajs-2653	213	1	saez	saez	PROPN
iajs-2653	213	2	,	,	PUNCT
iajs-2653	213	3	j.b.l	j.b.l	PROPN
iajs-2653	213	4	.	.	PUNCT
iajs-2653	213	5	;	;	PUNCT
iajs-2653	213	6	senra	senra	NOUN
iajs-2653	213	7	,	,	PUNCT
iajs-2653	213	8	d.q	d.q	PROPN
iajs-2653	213	9	.	.	PROPN
iajs-2653	213	10	serum	serum	PROPN
iajs-2653	213	11	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	213	12	as	as	ADP
iajs-2653	213	13	a	a	DET
iajs-2653	213	14	diagnostic	diagnostic	ADJ
iajs-2653	213	15	marker	marker	NOUN
iajs-2653	213	16	of	of	ADP
iajs-2653	213	17	cancer	cancer	NOUN
iajs-2653	213	18	.	.	PUNCT
iajs-2653	214	1	cancer	cancer	PROPN
iajs-2653	214	2	lett	lett	PROPN
iajs-2653	214	3	.	.	PROPN
iajs-2653	215	1	,1997	,1997	PUNCT
iajs-2653	215	2	,	,	PUNCT
iajs-2653	215	3	121(2),139–145	121(2),139–145	PROPN
iajs-2653	215	4	.	.	PUNCT
iajs-2653	216	1	34.pan	34.pan	PROPN
iajs-2653	216	2	,	,	PUNCT
iajs-2653	216	3	q.	q.	PROPN
iajs-2653	216	4	;	;	PUNCT
iajs-2653	216	5	kleer	kleer	PROPN
iajs-2653	216	6	,	,	PUNCT
iajs-2653	216	7	c.g	c.g	PROPN
iajs-2653	216	8	.	.	PROPN
iajs-2653	216	9	;	;	PUNCT
iajs-2653	216	10	van	van	PROPN
iajs-2653	216	11	golen	golen	PROPN
iajs-2653	216	12	,	,	PUNCT
iajs-2653	216	13	k.l	k.l	PROPN
iajs-2653	216	14	.	.	PROPN
iajs-2653	216	15	;	;	PUNCT
iajs-2653	216	16	irani	irani	PROPN
iajs-2653	216	17	,	,	PUNCT
iajs-2653	216	18	j.	j.	PROPN
iajs-2653	216	19	;	;	PUNCT
iajs-2653	216	20	bottema	bottema	X
iajs-2653	216	21	,	,	PUNCT
iajs-2653	216	22	k.m	k.m	PROPN
iajs-2653	216	23	.	.	PROPN
iajs-2653	216	24	;	;	PUNCT
iajs-2653	216	25	bias	bias	NOUN
iajs-2653	216	26	,	,	PUNCT
iajs-2653	216	27	c.	c.	NOUN
iajs-2653	216	28	;	;	PUNCT
iajs-2653	216	29	de	de	X
iajs-2653	216	30	carvalho	carvalho	NOUN
iajs-2653	216	31	,	,	PUNCT
iajs-2653	216	32	m.	m.	NOUN
iajs-2653	216	33	;	;	PUNCT
iajs-2653	216	34	mesri	mesri	PROPN
iajs-2653	216	35	,	,	PUNCT
iajs-2653	216	36	e.a	e.a	PROPN
iajs-2653	216	37	.	.	PROPN
iajs-2653	216	38	;	;	PUNCT
iajs-2653	216	39	robins	robin	NOUN
iajs-2653	216	40	,	,	PUNCT
iajs-2653	216	41	d.m	d.m	PROPN
iajs-2653	216	42	.	.	PUNCT
iajs-2653	216	43	;	;	PUNCT
iajs-2653	216	44	dick	dick	PROPN
iajs-2653	216	45	,	,	PUNCT
iajs-2653	216	46	r.d	r.d	PROPN
iajs-2653	216	47	.	.	PROPN
iajs-2653	216	48	;	;	PUNCT
iajs-2653	216	49	brewer	brewer	PROPN
iajs-2653	216	50	,	,	PUNCT
iajs-2653	216	51	g.j	g.j	PROPN
iajs-2653	216	52	.	.	PROPN
iajs-2653	216	53	,	,	PUNCT
iajs-2653	216	54	copper	copper	NOUN
iajs-2653	216	55	deficiency	deficiency	NOUN
iajs-2653	216	56	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2653	216	57	special	special	ADJ
iajs-2653	216	58	issue	issue	NOUN
iajs-2653	216	59	1ihicpas	1ihicpas	NUM
iajs-2653	216	60	202	202	NUM
iajs-2653	216	61	ibn	ibn	PROPN
iajs-2653	216	62	al	al	PROPN
iajs-2653	216	63	-	-	PUNCT
iajs-2653	216	64	haitham	haitham	PROPN
iajs-2653	216	65	journal	journal	PROPN
iajs-2653	216	66	for	for	ADP
iajs-2653	216	67	pure	pure	ADJ
iajs-2653	216	68	and	and	CCONJ
iajs-2653	216	69	applied	apply	VERB
iajs-2653	216	70	science	science	NOUN
iajs-2653	216	71	https://doi.org/10.30526/2021.ihicpas.2653	https://doi.org/10.30526/2021.ihicpas.2653	PROPN
iajs-2653	216	72	for	for	ADP
iajs-2653	216	73	more	more	ADJ
iajs-2653	216	74	information	information	NOUN
iajs-2653	216	75	about	about	ADP
iajs-2653	216	76	the	the	DET
iajs-2653	216	77	conference	conference	NOUN
iajs-2653	216	78	please	please	INTJ
iajs-2653	216	79	visit	visit	VERB
iajs-2653	216	80	the	the	DET
iajs-2653	216	81	websites	website	NOUN
iajs-2653	216	82	:	:	PUNCT
iajs-2653	216	83	http://ihicps.com/	http://ihicps.com/	ADP
iajs-2653	216	84	c	c	NOUN
iajs-2653	216	85	h	h	NOUN
iajs-2653	217	1	e	e	NOUN
iajs-2653	217	2	m	m	VERB
iajs-2653	217	3	i	i	NOUN
iajs-2653	217	4	s	s	VERB
iajs-2653	217	5	t	t	PROPN
iajs-2653	217	6	r	r	NOUN
iajs-2653	217	7	y	y	NOUN
iajs-2653	218	1	|	|	ADV
iajs-2653	218	2	75	75	NUM
iajs-2653	218	3	induced	induce	VERB
iajs-2653	218	4	by	by	ADP
iajs-2653	218	5	tetrathiomolybdate	tetrathiomolybdate	NOUN
iajs-2653	218	6	suppresses	suppress	VERB
iajs-2653	218	7	tumor	tumor	NOUN
iajs-2653	218	8	growth	growth	NOUN
iajs-2653	218	9	and	and	CCONJ
iajs-2653	218	10	angiogenesis	angiogenesis	NOUN
iajs-2653	218	11	.	.	PUNCT
iajs-2653	219	1	cancer	cancer	NOUN
iajs-2653	219	2	res	re	NOUN
iajs-2653	219	3	.	.	PROPN
iajs-2653	219	4	2002	2002	NUM
iajs-2653	219	5	,	,	PUNCT
iajs-2653	219	6	62(17	62(17	PROPN
iajs-2653	219	7	)	)	PUNCT
iajs-2653	219	8	,	,	PUNCT
iajs-2653	219	9	4854–4859	4854–4859	NUM
iajs-2653	219	10	.	.	NOUN
iajs-2653	219	11	35	35	NUM
iajs-2653	219	12	.	.	PUNCT
iajs-2653	220	1	han	han	PROPN
iajs-2653	220	2	,	,	PUNCT
iajs-2653	220	3	i.w	i.w	PROPN
iajs-2653	220	4	.	.	PROPN
iajs-2653	220	5	;	;	PUNCT
iajs-2653	220	6	jang	jang	PROPN
iajs-2653	220	7	,	,	PUNCT
iajs-2653	220	8	j.y	j.y	PROPN
iajs-2653	220	9	.	.	PROPN
iajs-2653	220	10	;	;	PUNCT
iajs-2653	220	11	kwon	kwon	PROPN
iajs-2653	220	12	,	,	PUNCT
iajs-2653	220	13	w.	w.	PROPN
iajs-2653	220	14	;	;	PUNCT
iajs-2653	220	15	park	park	NOUN
iajs-2653	220	16	,	,	PUNCT
iajs-2653	220	17	t.	t.	PROPN
iajs-2653	220	18	;	;	PUNCT
iajs-2653	220	19	kim	kim	PROPN
iajs-2653	220	20	,	,	PUNCT
iajs-2653	220	21	y.	y.	PROPN
iajs-2653	220	22	;	;	PUNCT
iajs-2653	220	23	lee	lee	PROPN
iajs-2653	220	24	,	,	PUNCT
iajs-2653	220	25	k.b	k.b	PROPN
iajs-2653	220	26	.	.	PUNCT
iajs-2653	220	27	;	;	PUNCT
iajs-2653	221	1	kim	kim	PROPN
iajs-2653	221	2	,	,	PUNCT
iajs-2653	221	3	s.w	s.w	PROPN
iajs-2653	221	4	.	.	PROPN
iajs-2653	221	5	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	221	6	as	as	ADP
iajs-2653	221	7	a	a	DET
iajs-2653	221	8	prognostic	prognostic	ADJ
iajs-2653	221	9	marker	marker	NOUN
iajs-2653	221	10	in	in	ADP
iajs-2653	221	11	patients	patient	NOUN
iajs-2653	221	12	with	with	ADP
iajs-2653	221	13	bile	bile	NOUN
iajs-2653	221	14	duct	duct	NOUN
iajs-2653	221	15	cancer	cancer	NOUN
iajs-2653	221	16	,	,	PUNCT
iajs-2653	221	17	oncotarget	oncotarget	NOUN
iajs-2653	221	18	.	.	PUNCT
iajs-2653	221	19	2017	2017	NUM
iajs-2653	221	20	,	,	PUNCT
iajs-2653	221	21	8(17	8(17	NUM
iajs-2653	221	22	)	)	PUNCT
iajs-2653	221	23	,	,	PUNCT
iajs-2653	221	24	2902829037	2902829037	NUM
iajs-2653	221	25	.	.	PUNCT
iajs-2653	222	1	36.schapira	36.schapira	NUM
iajs-2653	222	2	,	,	PUNCT
iajs-2653	222	3	d	d	NOUN
iajs-2653	222	4	.v	.v	PROPN
iajs-2653	222	5	.	.	PUNCT
iajs-2653	222	6	;	;	PUNCT
iajs-2653	222	7	schapira	schapira	NOUN
iajs-2653	222	8	,	,	PUNCT
iajs-2653	222	9	m	m	PROPN
iajs-2653	222	10	.	.	PUNCT
iajs-2653	223	1	use	use	NOUN
iajs-2653	223	2	of	of	ADP
iajs-2653	223	3	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	223	4	levels	level	NOUN
iajs-2653	223	5	to	to	PART
iajs-2653	223	6	monitor	monitor	VERB
iajs-2653	223	7	response	response	NOUN
iajs-2653	223	8	to	to	ADP
iajs-2653	223	9	therapy	therapy	NOUN
iajs-2653	223	10	and	and	CCONJ
iajs-2653	223	11	predict	predict	VERB
iajs-2653	223	12	recurrence	recurrence	NOUN
iajs-2653	223	13	of	of	ADP
iajs-2653	223	14	breast	breast	NOUN
iajs-2653	223	15	cancer	cancer	NOUN
iajs-2653	223	16	.	.	PUNCT
iajs-2653	224	1	breast	breast	NOUN
iajs-2653	224	2	cancer	cancer	NOUN
iajs-2653	224	3	res	re	NOUN
iajs-2653	224	4	.	.	PUNCT
iajs-2653	225	1	treat.1983	treat.1983	PROPN
iajs-2653	225	2	,	,	PUNCT
iajs-2653	225	3	3(2),221	3(2),221	PROPN
iajs-2653	225	4	-	-	SYM
iajs-2653	225	5	224	224	NUM
iajs-2653	225	6	.	.	PUNCT
iajs-2653	226	1	37.upadhya	37.upadhya	NUM
iajs-2653	226	2	,	,	PUNCT
iajs-2653	226	3	s.	s.	PROPN
iajs-2653	226	4	;	;	PUNCT
iajs-2653	226	5	upadhya	upadhya	PROPN
iajs-2653	226	6	,	,	PUNCT
iajs-2653	226	7	s.	s.	PROPN
iajs-2653	226	8	;	;	PUNCT
iajs-2653	226	9	prabhu	prabhu	PROPN
iajs-2653	226	10	,	,	PUNCT
iajs-2653	226	11	k.s	k.s	PROPN
iajs-2653	226	12	.	.	PROPN
iajs-2653	226	13	serum	serum	PROPN
iajs-2653	226	14	glycoconjugates	glycoconjugate	NOUN
iajs-2653	226	15	and	and	CCONJ
iajs-2653	226	16	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	226	17	in	in	ADP
iajs-2653	226	18	cancer	cancer	NOUN
iajs-2653	226	19	of	of	ADP
iajs-2653	226	20	uterine	uterine	ADJ
iajs-2653	226	21	cervix	cervix	NOUN
iajs-2653	226	22	.	.	PUNCT
iajs-2653	227	1	indian	indian	PROPN
iajs-2653	227	2	j.	j.	PROPN
iajs-2653	227	3	clin	clin	PROPN
iajs-2653	227	4	.	.	PUNCT
iajs-2653	228	1	biochem	biochem	PROPN
iajs-2653	228	2	.	.	PUNCT
iajs-2653	229	1	2002	2002	NUM
iajs-2653	229	2	,	,	PUNCT
iajs-2653	229	3	17(1):20	17(1):20	PROPN
iajs-2653	229	4	-	-	SYM
iajs-2653	229	5	24	24	NUM
iajs-2653	229	6	.	.	PUNCT
iajs-2653	230	1	38.nayak	38.nayak	NUM
iajs-2653	230	2	,	,	PUNCT
iajs-2653	230	3	s.b	s.b	PROPN
iajs-2653	230	4	.	.	PROPN
iajs-2653	230	5	;	;	PUNCT
iajs-2653	230	6	bhat	bhat	PROPN
iajs-2653	230	7	,	,	PUNCT
iajs-2653	230	8	v.r.;upadhyay	v.r.;upadhyay	PROPN
iajs-2653	230	9	,	,	PUNCT
iajs-2653	230	10	d.	d.	PROPN
iajs-2653	230	11	;	;	PUNCT
iajs-2653	230	12	udupa	udupa	ADJ
iajs-2653	230	13	,	,	PUNCT
iajs-2653	230	14	s.l	s.l	PROPN
iajs-2653	230	15	.	.	PROPN
iajs-2653	230	16	copper	copper	PROPN
iajs-2653	230	17	and	and	CCONJ
iajs-2653	230	18	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	230	19	status	status	NOUN
iajs-2653	230	20	in	in	ADP
iajs-2653	230	21	serum	serum	NOUN
iajs-2653	230	22	of	of	ADP
iajs-2653	230	23	prostate	prostate	NOUN
iajs-2653	230	24	and	and	CCONJ
iajs-2653	230	25	colon	colon	NOUN
iajs-2653	230	26	cancer	cancer	NOUN
iajs-2653	230	27	patients	patient	NOUN
iajs-2653	230	28	.	.	PUNCT
iajs-2653	231	1	indian	indian	PROPN
iajs-2653	231	2	j.	j.	PROPN
iajs-2653	231	3	physiol	physiol	PROPN
iajs-2653	231	4	.	.	PUNCT
iajs-2653	232	1	pharmacol	pharmacol	PROPN
iajs-2653	232	2	.	.	PROPN
iajs-2653	233	1	2003	2003	NUM
iajs-2653	233	2	,	,	PUNCT
iajs-2653	233	3	47(1	47(1	NUM
iajs-2653	233	4	)	)	PUNCT
iajs-2653	233	5	,	,	PUNCT
iajs-2653	233	6	108110	108110	NUM
iajs-2653	233	7	.	.	PUNCT
iajs-2653	234	1	39	39	NUM
iajs-2653	234	2	.	.	PUNCT
iajs-2653	235	1	ozyilkan	ozyilkan	PROPN
iajs-2653	235	2	,	,	PUNCT
iajs-2653	235	3	o.	o.	PROPN
iajs-2653	235	4	;	;	PUNCT
iajs-2653	235	5	baltali	baltali	PROPN
iajs-2653	235	6	,	,	PUNCT
iajs-2653	235	7	e.	e.	PROPN
iajs-2653	235	8	;	;	PUNCT
iajs-2653	235	9	ozyilkan	ozyilkan	PROPN
iajs-2653	235	10	,	,	PUNCT
iajs-2653	235	11	e.	e.	PROPN
iajs-2653	235	12	;	;	PUNCT
iajs-2653	235	13	tekuzman	tekuzman	PROPN
iajs-2653	235	14	,	,	PUNCT
iajs-2653	235	15	g.	g.	PROPN
iajs-2653	235	16	;	;	PUNCT
iajs-2653	235	17	kars	kars	PROPN
iajs-2653	235	18	,	,	PUNCT
iajs-2653	235	19	a.	a.	NOUN
iajs-2653	235	20	;	;	PUNCT
iajs-2653	236	1	firat	firat	PROPN
iajs-2653	236	2	,	,	PUNCT
iajs-2653	236	3	d.	d.	PROPN
iajs-2653	236	4	ceruloplasmin	ceruloplasmin	PROPN
iajs-2653	236	5	level	level	NOUN
iajs-2653	236	6	in	in	ADP
iajs-2653	236	7	women	woman	NOUN
iajs-2653	236	8	with	with	ADP
iajs-2653	236	9	breast	breast	NOUN
iajs-2653	236	10	disease	disease	NOUN
iajs-2653	236	11	preliminary	preliminary	ADJ
iajs-2653	236	12	results	result	NOUN
iajs-2653	236	13	.	.	PUNCT
iajs-2653	237	1	acta	acta	PROPN
iajs-2653	237	2	oncol.1992	oncol.1992	PROPN
iajs-2653	237	3	,	,	PUNCT
iajs-2653	237	4	31(8	31(8	NUM
iajs-2653	237	5	)	)	PUNCT
iajs-2653	237	6	,	,	PUNCT
iajs-2653	237	7	843	843	NUM
iajs-2653	237	8	-	-	SYM
iajs-2653	237	9	846	846	NUM
iajs-2653	237	10	.	.	PUNCT
iajs-2653	238	1	40.çiğdem	40.çiğdem	NUM
iajs-2653	238	2	,	,	PUNCT
iajs-2653	239	1	y.	y.	NOUN
iajs-2653	239	2	;	;	PUNCT
iajs-2653	239	3	meral	meral	INTJ
iajs-2653	239	4	,	,	PUNCT
iajs-2653	239	5	f.	f.	PROPN
iajs-2653	239	6	;	;	PUNCT
iajs-2653	239	7	banu	banu	PROPN
iajs-2653	239	8	,	,	PUNCT
iajs-2653	239	9	ö.	ö.	PROPN
iajs-2653	239	10	serum	serum	PROPN
iajs-2653	239	11	copper	copper	PROPN
iajs-2653	239	12	and	and	CCONJ
iajs-2653	239	13	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	239	14	concentrations	concentration	NOUN
iajs-2653	239	15	in	in	ADP
iajs-2653	239	16	patients	patient	NOUN
iajs-2653	239	17	with	with	ADP
iajs-2653	239	18	primary	primary	ADJ
iajs-2653	239	19	breast	breast	NOUN
iajs-2653	239	20	cancer	cancer	NOUN
iajs-2653	239	21	.	.	PUNCT
iajs-2653	240	1	biochem	biochem	PROPN
iajs-2653	240	2	.	.	PUNCT
iajs-2653	241	1	soc	soc	PROPN
iajs-2653	241	2	.	.	PUNCT
iajs-2653	242	1	trans	trans	PROPN
iajs-2653	242	2	.	.	PROPN
iajs-2653	242	3	1996	1996	NUM
iajs-2653	242	4	,	,	PUNCT
iajs-2653	242	5	24(2	24(2	NUM
iajs-2653	242	6	)	)	PUNCT
iajs-2653	242	7	,	,	PUNCT
iajs-2653	242	8	321s	321s	PROPN
iajs-2653	242	9	.	.	PUNCT
iajs-2653	243	1	41.fan	41.fan	PROPN
iajs-2653	243	2	,	,	PUNCT
iajs-2653	243	3	j.	j.	PROPN
iajs-2653	243	4	;	;	PUNCT
iajs-2653	243	5	wan	wan	PROPN
iajs-2653	243	6	,	,	PUNCT
iajs-2653	243	7	y.	y.	PROPN
iajs-2653	243	8	;	;	PUNCT
iajs-2653	243	9	wang	wang	PROPN
iajs-2653	243	10	,	,	PUNCT
iajs-2653	243	11	y.;wei	y.;wei	PROPN
iajs-2653	243	12	,	,	PUNCT
iajs-2653	243	13	h.	h.	PROPN
iajs-2653	243	14	;	;	PUNCT
iajs-2653	243	15	zhao	zhao	PROPN
iajs-2653	243	16	,	,	PUNCT
iajs-2653	243	17	g.;li	g.;li	PROPN
iajs-2653	243	18	,	,	PUNCT
iajs-2653	243	19	s.	s.	PROPN
iajs-2653	243	20	;	;	PUNCT
iajs-2653	243	21	li	li	PROPN
iajs-2653	243	22	,	,	PUNCT
iajs-2653	243	23	m.	m.	NOUN
iajs-2653	243	24	;	;	PUNCT
iajs-2653	243	25	huang	huang	PROPN
iajs-2653	243	26	,	,	PUNCT
iajs-2653	243	27	m.	m.	NOUN
iajs-2653	243	28	;	;	PUNCT
iajs-2653	243	29	wang	wang	PROPN
iajs-2653	243	30	,	,	PUNCT
iajs-2653	243	31	t.	t.	PROPN
iajs-2653	243	32	the	the	DET
iajs-2653	243	33	relationship	relationship	NOUN
iajs-2653	243	34	between	between	ADP
iajs-2653	243	35	serum	serum	NOUN
iajs-2653	243	36	level	level	NOUN
iajs-2653	243	37	of	of	ADP
iajs-2653	243	38	copper	copper	NOUN
iajs-2653	243	39	and	and	CCONJ
iajs-2653	243	40	ceruloplasmin	ceruloplasmin	NOUN
iajs-2653	243	41	and	and	CCONJ
iajs-2653	243	42	pathologic	pathologic	ADJ
iajs-2653	243	43	and	and	CCONJ
iajs-2653	243	44	clinical	clinical	ADJ
iajs-2653	243	45	characteristics	characteristic	NOUN
iajs-2653	243	46	in	in	ADP
iajs-2653	243	47	early	early	ADJ
iajs-2653	243	48	breast	breast	NOUN
iajs-2653	243	49	cancer	cancer	NOUN
iajs-2653	243	50	patients	patient	NOUN
iajs-2653	243	51	.	.	PUNCT
iajs-2653	244	1	j.	j.	PROPN
iajs-2653	244	2	clin	clin	PROPN
iajs-2653	244	3	.	.	PUNCT
iajs-2653	245	1	oncol	oncol	ADJ
iajs-2653	245	2	.	.	PUNCT
iajs-2653	246	1	2018	2018	NUM
iajs-2653	246	2	,	,	PUNCT
iajs-2653	246	3	36(15	36(15	NUM
iajs-2653	246	4	)	)	PUNCT
iajs-2653	246	5	,	,	PUNCT
iajs-2653	246	6	e13504	e13504	NOUN
iajs-2653	246	7	-	-	PUNCT
iajs-2653	246	8	e13504	e13504	NOUN
iajs-2653	246	9	.	.	PUNCT
iajs-2653	247	1	42.dabek	42.dabek	NUM
iajs-2653	247	2	,	,	PUNCT
iajs-2653	247	3	j	j	PROPN
iajs-2653	247	4	.t	.t	PROPN
iajs-2653	247	5	.	.	PUNCT
iajs-2653	247	6	;	;	PUNCT
iajs-2653	248	1	hyvönen	hyvönen	NOUN
iajs-2653	248	2	,	,	PUNCT
iajs-2653	248	3	d	d	PROPN
iajs-2653	248	4	.	.	PUNCT
iajs-2653	248	5	m.	m.	NOUN
iajs-2653	248	6	;	;	PUNCT
iajs-2653	248	7	härkönen	härkönen	PROPN
iajs-2653	248	8	,	,	PUNCT
iajs-2653	248	9	m	m	PROPN
iajs-2653	248	10	.	.	PUNCT
iajs-2653	248	11	;	;	PUNCT
iajs-2653	248	12	adlercreutz	adlercreutz	ADJ
iajs-2653	248	13	,	,	PUNCT
iajs-2653	248	14	h.	h.	PROPN
iajs-2653	248	15	evidence	evidence	NOUN
iajs-2653	248	16	for	for	ADP
iajs-2653	248	17	increased	increase	VERB
iajs-2653	248	18	non	non	ADJ
iajs-2653	248	19	-	-	ADJ
iajs-2653	248	20	ceruloplasmin	ceruloplasmin	ADJ
iajs-2653	248	21	copper	copper	NOUN
iajs-2653	248	22	in	in	ADP
iajs-2653	248	23	early	early	ADJ
iajs-2653	248	24	-	-	PUNCT
iajs-2653	248	25	stage	stage	NOUN
iajs-2653	248	26	human	human	ADJ
iajs-2653	248	27	breast	breast	NOUN
iajs-2653	248	28	cancer	cancer	NOUN
iajs-2653	248	29	serum	serum	NOUN
iajs-2653	248	30	.	.	PUNCT
iajs-2653	249	1	nutr	nutr	PROPN
iajs-2653	249	2	.	.	PUNCT
iajs-2653	249	3	cancer	cancer	NOUN
iajs-2653	249	4	.	.	PUNCT
iajs-2653	250	1	1992	1992	NUM
iajs-2653	250	2	,	,	PUNCT
iajs-2653	250	3	17(2),195	17(2),195	NOUN
iajs-2653	250	4	-	-	PUNCT
iajs-2653	250	5	201	201	NUM
iajs-2653	250	6	.	.	PUNCT
iajs-2653	251	1	http://ihicps.com/	http://ihicps.com/	NOUN